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ABSTRACT 
The superfamily of nuclear receptors is a class of transcriptional regulators that includes 
the receptors for steroid hormones, thyroid hormones, retinoids and vitamin D. The 
superfamily also includes so-called orphan receptors, for which an activating ligand is 
unknown or not required. They regulate diverse biological processes, such as homeostasis, 
reproduction, development, and metabolism. To exert their functions in the activation of 
transcription, they need to recruit so-called coactivator protein complexes, many of which 
remodel the chromatin structure in promoter regions and help to recruit the basal RNA 
polymerase II transcription machinery.  
 
We and others identified the transcriptional coactivator PGC-1α. Its expression is induced 
by physiological signals such as cold, fasting, and exercise, and it turned out to be a central 
regulator of cellular energy homeostasis. The N-terminal part of PGC-1α harbors a strong 
transcriptional activation function and a nuclear receptor interaction domain. The C-
terminal half of PGC-1α harbors several interesting motifs, including two serine/arginine-
rich sequences, a putative RNA-binding domain, and an amino acid stretch containing a 
high percentage of glutamate residues.  
 
In this work, we describe the identification of proteins interacting with the C-terminal part 
of PGC-1α and the functional interaction of two of the identified proteins with PGC-1α. 
We show that the acetyltransferase Tip60 has both positive and negative effects on PGC-
1α-dependent transcription. In collaboration, we also show that the methyltransferase 
PRMT1 methylates PGC-1α and thereby enhances the activity of PGC-1α as a 
transcriptional coactivator. 
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CHAPTER I: INTRODUCTION 
Transcription 
In eukaryotes, transcription of genes is carried out by three different RNA polymerases. 
While RNA polymerase I is responsible for the production of a transcript that is processed 
to the 25S, 18S, and 5.8S RNA components of the ribosome (Grummt, 2003), RNA 
polymerase III transcribes the genes encoding the transfer RNAs, the 5S ribosomal RNA, 
and RNA components of the splicing apparatus (Geiduschek and Kassavetis, 2001; Huang 
and Maraia, 2001; Schramm and Hernandez, 2002). RNA polymerase II transcribes the 
protein-coding genes and some small nuclear RNAs (snRNAs) as well.  
 
Eukaryotic RNA-polymerase II is a large multi-subunit enzyme, which comprises of at 
least 12 distinct subunits and possessing a molecular mass of 500 kilodaltons (Cramer, 
2004; Dvir et al., 2001; Hahn, 2004). Transcription, like many other biological processes, 
can be divided into distinct steps, such as pre-initiation complex formation, open complex 
formation, initiation, promoter clearance, transcript elongation, and termination. Studies 
with purified proteins have revealed that transcription initiation requires, besides the RNA 
polymerase II, a minimum of five general initiation factors TFIIB, TFIID, TFIIE, TFIIF, 
and TFIIH. Transcription by RNA polymerase II begins with the assembly of the 
polymerase and the five general transcription factors at the promoter, followed by the 
ATP-dependent formation of the open complex and the subsequent transcription initiation. 
In the first step, the TATA-binding protein-containing TFIID complex binds a TA-rich 
sequence at the promoter and creates a recognition site for the RNA-polymerase II on the 
DNA. The other four TFIIs are then incorporated into the preinitiation complex in a 
defined order. Following formation of the fully assembled preinitiation complex, a DNA 
helicase activity, associated with TFIIH, catalyses the ATP-dependent unwinding of the 
DNA template at the transcriptional start site and forms the open complex. This is followed 
by the initiation and synthesis of the RNA transcript by RNA-polymerase II (Dvir et al., 
2001; Hahn, 2004). Each protein-coding gene has a unique, specific program of 
transcriptional control. Much of this specificity of these programs is determined by 
sequence specific DNA-binding proteins that bind to the proximal promoter and distal 
transcriptional regulatory sequences. Hence, DNA-specific transcriptional regulators, also 
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called transcription factors, interpret and transmit the information encoded in the primary 
DNA sequence of genes to the RNA polymerase transcriptional machinery (Kadonaga, 
2004).  
 
The nuclear receptor superfamily of transcription factors 
Nuclear receptors form a family of phylogenetically related proteins, encoded by 21 genes 
in the genome of the fly Drosophila melanogaster, 48 in humans, 49 in the mouse, and 
unexpectedly, more than 270 in the worm Caenorhabditis elegans (Robinson-Rechavi et 
al., 2003). Nuclear receptors are transcription factors that include the receptors for steroid 
hormones, thyroid hormones, retinoids and vitamin D . The superfamily also includes so-
called orphan receptors for which an activating ligand is unknown or not required (Beato et 
al., 1995; Mangelsdorf and Evans, 1995; Mangelsdorf et al., 1995; Robinson-Rechavi et 
al., 2003). They regulate diverse biological processes, such as homeostasis, reproduction, 
development and metabolism. Nuclear receptors share a common structural organization 
(Mangelsdorf et al., 1995; Robinson-Rechavi et al., 2003; Warnmark et al., 2003). They 
contain a conserved DNA-binding domain in the central part of the protein, which allows 
them to bind specific DNA elements in the regulatory regions of target genes and which is 
also involved in the dimerization of nuclear receptors. This dimerization includes 
homodimers as well as heterodimers. Most nuclear receptors contain two transcriptional 
activation domains, AF-1 and AF-2, through which activation of transcription is achieved. 
The AF-1 generally resides in the N-terminal region, while AF-2 is localized in the C-
terminal ligand binding domain (LBD). The LBD is structurally conserved between 
nuclear receptors and is formed by 11 to 12 α-helices, which are arranged together in an 
anti-parallel, three-layered sandwich with two to four β-strands included (Wurtz et al., 
1996). All crystal structures of LBDs bound to agonists show that the ligand binds to a 
hydrophobic cavity buried within the core of the LBD (Bourguet et al., 2000). The crystal 
structures reveal that in the unliganded form the most C-terminal helix projects away from 
the core structure, whereas in the agonist-bound structures this helix is folded up against 
the core, creating a lid over the ligand-binding pocket.  
 
How do activated nuclear receptors or other sequence-specific transcription factors activate 
transcription? In order to achieve activation of target genes, nuclear receptors recruit 
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transcriptional coactivators via protein-protein interactions (Kadonaga, 2004; Ptashne and 
Gann, 1997), which then act directly or indirectly to recruit and regulate the RNA 
polymerase II transcriptional machinery at the core promoter.  
 
Coactivator proteins in most cases interact with the AF-1 or with the AF-2. Almost all 
coactivators that have been identified as AF-2 interacting proteins contain one or several 
conserved leucine-rich motifs with the consensus sequence LXXLL and display agonist-
dependent interaction with nuclear receptors. The LXXLL motifs, also called NR boxes, 
have been demonstrated to be necessary and sufficient for the interaction between the 
receptor and the coactivator (Heery et al., 1997). In structures of nuclear receptors bound 
to peptides derived from coactivators, the LXXLL-motifs are part of an α-helix that binds 
to the hydrophobic AF-2 groove in the agonist-bound LBD (Darimont et al., 1998; Nolte et 
al., 1998; Shiau et al., 1998). The next section describes the structures and mechanisms of 
some transcriptional coactivators.  
 
Nuclear receptor coactivators 
Over the past decade, a large number of transcriptional coactivators has been identified and 
characterized, which act at different levels to achieve activation of gene expression. Some 
coactivators act as bridging factors between DNA-bound NRs and the basal transcription 
machinery and thereby stabilize the RNA polymerase II complex on gene promoters. 
Another class of coactivators are involved in the reorganization of chromatin. The 
chromatin structure of genes contributes significantly to the control of transcription. The 
basic unit of chromatin is the nucleosome, which consists of an octamer of histone 
proteins, around which the DNA is wrapped (Luger et al., 1997). The nucleosomes form an 
array that is ordered into a higher-order chromatin structure. The nucleosome structure and 
the histone-DNA interactions make the DNA of genes and their promoter regions difficult 
to access for the basal transcription machinery and thereby negatively regulate the 
transcription of genes. In a process, termed chromatin remodeling, the repressive 
chromatin structure is altered in a way that will allow the accessibility of the transcriptional 
machinery to gene promoters (Sif, 2004). ATP-dependent chromatin-remodeling 
complexes catalyze the mobilization or repositioning of nucleosomes or the alteration of 
histone-DNA contacts (Lusser and Kadonaga, 2003). Besides the chromatin-remodeling 
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complexes, many coactivators have been identified that catalyze post-translational 
modifications of histones. Such posttranslational modifications, including acetylation, 
methylation, phosphorylation, ubiquitination, and ADP-ribosylation control the association 
of histone binding proteins with chromatin, which can directly or indirectly lead to 
alterations in the chromatin structure or to the recruitment of the transcriptional machinery 
(Jenuwein and Allis, 2001; Shiio and Eisenman, 2003; Zhang, 2003).  
 
 
1. ATP-dependent chromatin remodeling complexes 
As mentioned above, chromatin structure represents a obstacle for DNA-binding proteins 
involved in transcriptional regulation or other processes like DNA repair and homologous 
recombination. It is therefore necessary to rearrange or mobilize the nucleosomes. This 
remodeling of the nucleosomes is achieved by the action of chromatin-remodeling 
complexes, which are a family of ATP-dependent molecular machines (Lusser and 
Kadonaga, 2003; Sif, 2004). Several such complexes have been identified in yeast, 
Drosophila, and human cells. Although the chromatin remodeling complexes differ in their 
composition and their biological function, they share the presence of a motor subunit that 
belongs to the Snf2-like family of ATPases. These ATPases are further subdivided, based 
on the presence of domains other than the ATPase domain. Members of the SNF2 
subfamily are the ATPases in the yeast SWI/SNF chromatin remodeling complex and in its 
human and drosophila homologs (Swi2p/Snf2, hBRM, hBRG, dBRM). These complexes 
consist of 9 to 14 subunits. They have well established roles in the activation of 
transcription and are recruited to chromatin via DNA-binding transcription factors, which 
are able to bind to regulatory sequences in chromatinized DNA. Changes in the chromatin 
structure caused by the action of the chromatin remodeling complexes can then facilitate 
the binding of other transcription factors and the general transcription machinery. 
 
 
2. Histone-modifying coactivators 
Several coactivators contain enzymatic activities that allow the coactivators to modify 
histone proteins and therefore to change the chromatin structure, which then allows easier 
binding of the basal transcription machinery to DNA. It was observed that the levels of 
transcription of a specific gene were in relationship to the acetylation status of the histones 
in that region with hyperacetylated regions being more actively transcribed than 
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hypoacetylated regions. This idea that the acetylation status of histones has an influence on 
the transcription of a specific gene was supported by the identification of mammalian 
transcriptional coactivators that posses intrinsic histone acetyltransferase (HAT) activity. 
The main targets of the HATs are the N-terminal tails of the core histones H2A, H2B, H3, 
and H4, which protrude away from the DNA. Besides acetylation, other post-translational 
modifications of histone proteins have an influence on the chromatin structure and thereby 
contribute to the regulation of gene expression. Various histone modifying proteins that 
can act as transcriptional coactivators have been identified and are described here briefly. 
 
 
CBP/p300 
CBP and p300 are two closely related proteins, which can be found in many multicellular 
organisms including humans, rodents, flies, worms, and plants, but not in lower eukaryotes 
such as yeast. CBP and p300 can interact with the basal transcription factor TFIID and can 
form a complex with RNA-polymerase II. In addition, they bind to a number of DNA 
sequence-specific transcription factors. By interacting simultaneously with the basal 
transcription machinery and one ore more upstream transcription factors, CBP and p300 
are believed to function as physical bridges or scaffolds and thereby stabilize the 
transcription complex. Moreover, CBP and p300 acetylate histones (Bannister and 
Kouzarides, 1996; Ogryzko et al., 1996) and other proteins involved in the regulation of 
transcription, such as transcription factors and coactivators, suggesting that CBP and p300 
regulate transcription at multiple levels (Chen et al., 1999b; Gu and Roeder, 1997). 
Acetylation of non-histone substrates can have either positive or negative effect on 
transcription. For example, CBP negatively regulates the activity of the transcriptional 
coactivator ACTR by acetylating its NR-box motif and thereby weakening its interaction 
with nuclear receptors (Chen et al., 1999b). 
 
 
GNAT-superfamily 
The GNAT superfamily of acetyltransferases (Gcn5-related N-acetyltransferases) includes 
the mammalian coactivator proteins GCN5 and p/CAF (p300/CBP associated factor) and 
other proteins found in prokaryotes, arabidopsis, yeast, drosophila, and mammals (Vetting 
et al., 2005). Both human GCN5 and p/CAF have been found to be subunits of large 
protein complexes that are composed of more than 20 polypeptides (Ogryzko et al., 1998). 
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The GCN5 and the p/CAF complexes seem to be virtually identical, except for the 
acetyltransferase subunit. The SAGA complex is the yeast homologue of the mammalian 
GCN5 and p/CAF complexes (Grant et al., 1997). The presence of similar complexes in 
mammals and yeast suggests a strong evolutionary conservation of this type of 
acetyltransferase machineries. GCN5 and p/CAF are able to acetylate histone H3 and H4, 
suggesting a role for these two proteins in chromatin remodeling. The GCN5, p/CAF and 
SAGA complexes may also act as adapters or scaffolds, since single subunits have been 
shown to interact with components of the general transcription machinery (Sterner et al., 
1999). 
 
 
MYST-Family 
Another group of evolutionarily conserved proteins is the MYST-family of 
acetyltransferases. This family of proteins is named after their founding members MOZ 
(Borrow et al., 1996), Ybf2/Sas3, Sas2 (Reifsnyder et al., 1996), and Tip60 (Kamine et al., 
1996). Additional members have been identified, including the yeast Esa1 (Smith et al., 
1998), the Drosophila MOF (Hilfiker et al., 1997), and the human MOF (Neal et al., 2000), 
HBO1 (Iizuka and Stillman, 1999), and MORF (Champagne et al., 1999). The MYST-
domain, which contains the acetyltransferase activity, is highly conserved between 
members of this protein family. Diverse functions have been assigned to the different 
members of the MYST-family. Esa1p, an essential MYST-family protein from yeast, has 
been implicated in cell cycle progression (Clarke et al., 1999), DNA repair (Bird et al., 
2002) and transcription regulation (Allard et al., 1999). The yeast proteins Sas2p and Sas3p 
have been shown to play a role in gene silencing (Reifsnyder et al., 1996), while dMOF 
was found to act in the dosage compensation of the X-chromosome (Hilfiker et al., 1997). 
The first human MYST protein that has been discovered and one of the best studied 
MYST-family members is Tip60 (Tat-interactive protein, 60 kDa) (Fig. 1.1). The MYST-
domain of Tip60, which contains the acetyl-CoA-binding site, is located in the C-terminal 
half of the protein. The N-terminal region of Tip60 contains a so-called CHROMO-
domain. Tip60 was identified as an interacting protein and coactivator of the HIV-Tat 
transactivator protein, hence its name (Kamine et al., 1996). Isolation of Tip60 cDNA in 
other studies identified a shorter form of Tip60 that misses exon 5 coding for 52 amino 
acids (Ran and Pereira-Smith, 2000; Sheridan et al., 2001). The longer, originally cloned 
variant was renamed Tip60α, while the shorter splice form is now know as Tip60β. Due to 
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its isolation as a interacting protein of cytosolic phospholipase A2 (cPLA2), Tip60 is also 
known as PLIP (cPLA-interacting protein) (Sheridan et al., 2001). A third splice form of 
Tip60 has been identified, whose hypethetical translation product contains a 33 amino acid 
insertion 4 amino acids after the first ATG codon (Legube and Trouche, 2003). No specific 
functions could be assigned to these additional 33 amino acids or the 52 amino acids 
encoded by exon 5. Tip60 is mainly localized in the cell nucleus, but it was detected in the 
cytosol and even at the plasma membrane as well (Halkidou et al., 2004; Lee et al., 2001; 
McAllister et al., 2002; Ran and Pereira-Smith, 2000; Sheridan et al., 2001; Sliva et al., 
1999). Northern blot and RT-PCR analysis of different mammalian tissues suggest that 
Tip60 is relatively highly expressed in several tissues, such as testis, brain, heart, liver, 
kidney and also in all cell lines tested so far (McAllister et al., 2002; Ran and Pereira-
Smith, 2000; Sheridan et al., 2001). A Tip60 complex consisting of at least 14 subunits 
could be biochemically purified from HeLa cells. Besides histone acetylase activity on 
chromatin, this complex possesses ATPase, DNA helicase, and strucural DNA-binding 
activities (Ikura et al., 2000). No difference in subunit composition between Tip60α and 
Tip60β complexes could be found (Doyon et al., 2004). Furthermore, the Tip60 complex 
has been demonstrated to be the mammalian homologue of the yeast NuA4 complex, 
which contains the yeast Tip60-homologue Esa1p as acetyltransferase (Doyon et al., 2004). 
In vitro acetylation assays have shown that free histones H2A, H3, and H4 are substrates 
for the acetyltransferase activty of Tip60 (Kimura and Horikoshi, 1998; Yamamoto and 
Horikoshi, 1997). In contrast to the Tip60 complex, monomeric Tip60 is not able to 
acetylate chromatin templates (Ikura et al., 2000). The demonstration that Tip60 is able to 
acetylate histones, like many coactivator proteins, suggests that Tip60 is involved in the 
regulation of transcription. A function of Tip60 in transcription was further supported by 
the finding that Tip60 interacts with and coactivates a number of nuclear receptors, 
including the androgen receptor (AR) (Brady et al., 1999; Gaughan et al., 2001; Gaughan 
et al., 2002). Tip60 was also shown to be recruited to the endogenous AR-regulated 
promoter of the prostate-specific antigen and endogenous RORα-induced genes during 
cerebellar development (Gold et al., 2003; Halkidou et al., 2003). An LXXLL-motif, which 
is also found in many other transcriptional coactivators, was identified in the very C-
terminal part of Tip60 and has been shown to be essential for the interaction with the AR 
(Gaughan et al., 2001). Besides being coactivated by Tip60, the AR is also a substrate for 
the Tip60 acetyltransferase activity (Gaughan et al., 2002). The activity of Tip60 as a 
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coactivator is not restricted nuclear receptors. It was also shown to enhance the 
transcriptional activity of NFκB transcription factors via indirect recruitment through Bcl-3 
(Dechend et al., 1999). The c-myc protein is another transcription factor that recruits Tip60 
and other components of the Tip60 complex to promoters, as shown by chromatin-
immunoprecipitation experiments (Frank et al., 2003). In addition, Tip60 was found to 
form a transcriptionally active trimeric complex together with the C-terminal domain of the 
amyloid precursor protein (APP) and Fe65 (Cao and Sudhof, 2001). This complex seems 
to be recruited to the endogenous promoter of the cytokine-induced KAI1 gene upon 
stimulation of cells with interleukin-1β (Baek et al., 2002). In addition, Tip60 
overexpression was shown to enhance the induction of the endogenous p53 target genes 
p21, GADD45, and Mdm2 after gamma irradiation of the cells. This effect could not be 
observed, when a acetyltransferase mutant of Tip60 was used. Tip60 not only seems to be 
an activator of transcription. There is also evidence that Tip60 is a negative regulator of 
transcription. Activation of CREB by protein kinase A has been shown to be inhibited by 
Tip60 (Gavaravarapu and Kamine, 2000). This inhibition seems to be mediated by direct 
interaction of Tip60 with CREB, since Tip60 binds to CREB in vitro. The negative effect 
of Tip60 on CREB-dependent transcription does not require the acetyltransferase activity 
of Tip60. In another study, Tip60 was found to repress STAT3-mediated transcription by 
the recruitment of the histone deacetylase HDAC7 (Xiao et al., 2003). Nordentoft and 
Jorgensen also provided evidence that Tip60 is a transcriptional corepressor. They 
demonstrated that overexpression of Tip60 enhanced the repressive effect of the 
transcriptional repressor protein TEL (Nordentoft and Jorgensen, 2003). The present 
knowledge about Tip60 suggest that this protein is a versatile transcriptional coregulator of 
different transcription factors. A significant number of reports have proposed an 
involvement of Tip60 and also the yeast homologue Esa1p in the regulation of apoptosis 
and DNA-repair. Ectopic expression of a mutated Tip60 lacking acetyltransferase activity 
resulted in cells with a defective double-strand DNA-break repair and a diminished 
apoptotic competence after gamma-irradiation (Ikura et al., 2000). In a similar study, 
overexpression of Tip60 enhanced the apoptosis induced by a intracellular carboxy-
terminal fragment of APP, while a mutant Tip60 lacking acetyltransferase activity 
decreased apoptosis (Kinoshita et al., 2002). Tip60 was also shown to potentiate serum 
deprivation-induced apoptosis (Sheridan et al., 2001). In mammalian cells, the response to 
DNA damage is in part controlled by the tumor suppressor p53, which activates the 
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transcription of genes involved in cell-cycle regulation, apoptosis, and DNA-repair. The 
involvement of Tip60 in p53 dependent transcription is further supported by the fact that 
both proteins accumulate after UV-irradiation and are targeted for proteosomal degradation 
by the ubiquitin-ligase Mdm2 (Legube et al., 2002) and, as mentioned above, 
overexpression of Tip60 enhances the expression of the p53-regulated p21, GADD45, and 
Mdm2 (Doyon et al., 2004). Finally, a role in the activation of RNA polI-regulated 45S 
ribosomal pre-RNA has been assigned toTip60. Tip60 localized to the nucleolus and was 
associated with the ribosomal pre-RNA promoter after release of cells from serum-
starvation (Halkidou et al., 2004).   
 
 
 
 
Figure 1.1. Schematic presentation of the structure of Tip60.  
Regions and protein motifs identified in Tip60 are highlighted. The protein domain encoded by 
exon 5 is present in Tip60α but not Tip60β. 
 
 
 
p160-coactivators 
The p160-family of transcriptional coactivators consists of the proteins SRC-1 (NcoA-1) 
(Onate et al., 1995), SRC-2 (GRIP1, TIF2, NcoA-2) (Hong et al., 1997; Voegel et al., 
1996), and SRC-3 (p/CIP, RAC3, ACTR, TRAM-1, AIB1) (Anzick et al., 1997; Chen et 
al., 1997; Li et al., 1997; Takeshita et al., 1997; Torchia et al., 1997) . All three members 
of the p160 family are able to interact with and coactivate many nuclear receptors and 
other transcription factors. Human and rodent SRC proteins are all approximately 160 kDa 
in size and have an overall 50-55% sequence similarity and a 43-48% sequence identity 
(Sterner and Berger, 2000; Xu and Li, 2003). The relatively conserved central region of the 
SRC members contains three LXXLL motifs that are responsible for the interaction with 
ligand-bound nuclear receptors. In the C-terminal part of each of the three proteins there 
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are two independent transcription activation domains that serve as platforms for the 
recruitment of other coactivators. The first activation domain interacts with the general 
transcriptional cointegrators CBP, p300, and p/CAF (Chen et al., 1997; Torchia et al., 
1997) . The second activation domain lies at the very C terminus. This part of SRC-1 has 
been shown to mediate the interaction with the methyltransferase CARM1 (Chen et al., 
1999a). The C-terminal domains of SRC-1 and SRC-3 have been demonstrated to harbor 
weak histone acetyltransferase activity (Chen et al., 1997; Spencer et al., 1997) raising the 
possibility that they play a direct role in chromatin remodeling. 
 
 
Methyltransferases PRMT1 and CARM1 
As mentioned earlier, methylation also seems to play an important role in the regulation of 
transcription. PRMT1 and CARM1 belong to the family of methyltransferases and have 
been demonstrated to act as coactivators of nuclear receptors (Koh et al., 2001) and other 
transcription factors, such as p53 (An et al., 2004). PRMT1 and CARM1 are quite different 
in size, but they share high sequence similarity in the central region, which contains the 
arginine-specific protein methyltransferase activity (Koh et al., 2001). Substrates of 
PRMT1 include RNA-binding proteins (Cote et al., 2003; Lin et al., 2002; Liu and 
Dreyfuss, 1995; Rajpurohit et al., 1994) and histone H4 (Strahl et al., 2001; Wang et al., 
2001), while CARM1 can methylate histone H3 (Chen et al., 1999a; Ma et al., 2001). One 
can envision many scenarios, in which methylation contributes to transcriptional 
regulation. PRMT1 and CARM1 might methylate other coactivators, thereby changing 
their transcriptional activity or creating new interaction surfaces for the interaction with 
downstream acting factors. It has been shown that PRMT1-methylated histone H4 is a 
better substrate for the acetyltransferase activity of p300 (Wang et al., 2001). On the other 
hand, acetylation of histone H3 by CBP seems to be a signal for the subsequent 
methylation by CARM1 (Daujat et al., 2002).  
 
3. The mediator complex 
The main function of the coactivators described so far is to permit access of the general 
transcription machinery to the DNA. Besides coactivators that harbor nucleosome 
remodeling or histone modifying activities, an other type of coregulator has been 
identified. A complex consisting of more than a dozen of proteins has been purified from 
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different organisms (Lusser and Kadonaga, 2003; Rachez and Freedman, 2001). The so-
called mediator complex enhances the transcriptional activities of nuclear receptors and 
other signal-dependent transcription factors in vitro. A 220 kDa subunit mediates the 
interaction of the mediator complex with ligand-activated nuclear receptors via two 
alternatively utilized LXXLL nuclear receptor interaction motifs (Yuan et al., 1998). The 
remaining components of the complex have no known enzymatic functions but are 
interacting with the RNA polymerase II and are thought to recruit the RNA polymerase II 
holoenzyme to promoters marked by transcription factors. 
 
 
Interplay between coactivators 
Besides the mentioned, well studied coactivators, many more cofactors with the ability to 
enhance transcription have been described. In respect of this large number of proteins and 
protein complexes, it is possible that different coactivator complexes are recruited to a 
specific promoter in an sequential fashion. One possible scenario would be that Brg/Brhm-
like complexes remodel chromatin to improve the access for other coactivator complexes. 
In a next step, p160 family coactivators together with histone acetyltransferases, such as 
CBP/p300 and p/CAF, or methyltransferases like CARM1 and PRMT1, would further 
modify the chromatin structure. Finally, recruitment of the mediator complex may bring 
RNA polymerase II to the promoter (Rosenfeld and Glass, 2001).  
 
The transcriptional coactivator PGC-1α 
Biological function of PGC-1α 
The transcriptional coactivator PGC-1α (peroxisome proliferator-activated receptor 
gamma coactivator alpha) was originally cloned as an interacting protein of the nuclear 
receptor PPARγ in a yeast two-hybrid screen, and as a protein enhancing GR signaling in a 
functional screen (Knutti et al., 2000; Puigserver et al., 1998). Northern blot analysis 
revealed a tissue specific expression of PGC-1α. High levels of PGC-1α mRNA can be 
found in skeletal muscle, heart, liver, brain, and brown adipose tissue (BAT) (Esterbauer et 
al., 1999; Knutti et al., 2000; Puigserver et al., 1998). The expression levels of PGC-1α in 
those tissues are highly regulated. PGC-1α is strongly induced at the transcriptional level 
in BAT and skeletal muscle when mice are exposed to cold (Puigserver et al., 1998). This 
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leads to a strong increase in the expression levels of respiratory chain uncoupling proteins 
(UCPs) (Puigserver et al., 1998), which makes the mitochondrial membrane permeable for 
protons. A leaky mitochondrial membrane does not allow the creation of a protein gradient 
for the generation of ATP. Instead, the energy released by the flow of the electrons in the 
respiratory chain is converted to heat (Puigserver and Spiegelman, 2003). Expression of 
UCP-1 is known to be regulated by the nuclear receptors PPARα, PPARγ, RAR, and TRα 
(Barbera et al., 2001; Cassard-Doulcier et al., 1994; Sears et al., 1996). Since PGC-1α can 
coactivate all those transcription factors, it is likely that PGC-1α is recruited to the UCP-1 
promoter through one or several of those receptors (Puigserver et al., 1998; Wu et al., 
1999). The production of heat in response to cold exposure, also called adaptive 
thermogenesis, is also increased by an enhanced mitochondrial biogenesis. Ectopic 
expression of PGC-1α leads to an increase in the number of mitochondria per cell 
(Lehman et al., 2000). In agreement with this observation, PGC-1α induces the expression 
of a number of mitochondrial proteins encoded in the nucleus, including cytochrome c, 
ATP-synthase β, cytochrome c-oxidase, and mtTFA (Wu et al., 1999). Many of those 
genes contain binding sites for the transcription factors NRF-1, NRF-2, and ERRα, all 
three of which have been shown to be induced and coactivated by PGC-1α (Schreiber et 
al., 2003; Wu et al., 1999). Not only exposure to cold, but also physical exercise induces 
the expression of PGC-1α in muscle of mice and humans (Baar et al., 2002; Goto et al., 
2000; Pilegaard et al., 2003). The cellular responses triggered by PGC-1α require an 
increase in the uptake and metabolism of fuels, like glucose and fat. PGC-1α has been 
shown to stimulate the expression of genes of fatty acid oxidation in cardiac cells, which is 
associated with an increase in fatty acid oxidation. PPARα seems to play an important 
role, since overexpression of this transcription factor increased the effect of PGC-1α (Vega 
et al., 2000). PGC-1α also induces expression of the insulin-sensitive glucose transporter 
GLUT4 and increases glucose uptake. This is partially mediated by coactivation of the 
muscle transcriptional regulator MEF2C by PGC-1α (Michael et al., 2001). Although 
humans don’t have a clear depot of brown fat, it could be shown that human white 
adipocytes acquired features of brown adipocytes upon adenoviral overexpression of PGC-
1α, which induced the expression of UCP1, respiratory chain proteins, and fatty acid 
oxidation enzymes (Tiraby et al., 2003). If the energy consumed by adaptive 
thermogenesis and physical exercise is not replenished, the blood glucose levels drop and 
trigger the release of the hormones glucagon and glucocorticoids, which signal the liver to 
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release glucose. The liver has to pathways to produce glucose. The first is glycogenolysis, 
the breakdown of glycogen, that occurs after a relatively short term fast. The second 
pathway is glyconeogenesis, the de novo synthesis of glucose from precursors such as 
lactate, pyruvate, glycerol, or alanine. This pathway comes into play when all stored 
glycogen has been consumed. It has been shown that fasting of mice, induces the 
expression of PGC-1α in liver, which then helps to induce the expression of the key 
gluconeogenic enzymes phosphoenolpyruvate carboxykinase (PEPCK), fructose 1,6-
bisphosphatase, and glucose-6-phosphatase (Yoon et al., 2001). It could be shown that the 
expression of PGC-1α is directly activated by cAMP response element-binding protein 
(CREB), a transcription factor activated by glucagon and cAMP, through binding to the 
PGC-1α promoter (Herzig et al., 2001). The mechanistic basis for the activation of the 
gluconeogenic enzymes by PGC-1α was studied using the promoter of PEPCK. Two 
transcription factors, hepatocyte nuclear factor 4-alpha (HNF4α) and the glucocorticoid 
receptor, seem to play important roles in the activation of the gluconeogenic enzymes by 
PGC-1α (Rhee et al., 2003; Yoon et al., 2001). The importance of PGC-1α in the 
regulation of energy metabolism prompted many researchers to investigate whether 
aberrant levels of PGC-1α can be a factor in the development of type II diabetes mellitus 
and obesity. Type II diabetes mellitus is characterized by disturbances in the regulation of 
the blood glucose level, which can be caused by diminished insulin-stimulated glucose 
uptake by skeletal muscle and fat cells, by increased hepatic glucose production, or 
impaired insulin secretion by pancreatic β cells. Constantly elevated blood glucose levels 
can lead to atherosclerotic vascular disease, blindness, amputation, and kidney failure. 
Support for a role of PGC-1α in the development of diabetes comes from a report that 
shows elevated PGC-1α levels in the liver of diabetic mice (Lane et al., 2002). Several 
studies have shown that the oxidative phosphorylation genes are coordinately 
downregulated in muscles of diabetic patients. Interestingly, the PGC-1α mRNA was also 
reduced, suggesting that the repressed PGC-1α levels contribute to decreased energy 
expenditure and to the development of diabetes (Mootha et al., 2003; Patti et al., 2003). 
Mutations in the PGC-1α gene locus have been associated with an increase in 
susceptibility to type II diabetes (Ek et al., 2001; Hara et al., 2002).  
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Molecular mechanisms of PGC-1α 
As described in a previous section, many coactivators enhance transcription by having 
enzymatic activities that serve to remodel chromatin. PGC-1α does not have significant 
homology to other coactivator families. In addition, it does not harbor a recognizable HAT 
domain and does not seem to have this intrinsic enzymatic activity. PGC-1α is a protein 
build of 798 amino acids. Database searches for sequences with similarities to PGC-1α 
have identified the coactivators PRC and PGC-1β (also called PERC) and defined a new, 
small family of coactivators (Andersson and Scarpulla, 2001; Kressler et al., 2002). Figure 
1.2 shows a schematic presentation of PGC-1α. By definition, transcriptional coactivators 
do not bind regulatory DNA elements directly, rather are they recruited by DNA-binding 
transcription factors. PGC-1α uses several motifs or domains to interact with transcription 
factors. PGC-1α contains three so-called L-motifs (L1, L2, and L3) of which L2 matches 
the consensus sequence LXXLL present in many proteins interacting with the ligand-
binding domain of nuclear receptors. L2 lies between amino acids 144 and 148 and 
mediates the interaction with all nuclear receptors tested so far (Schreiber et al., 2003; 
Tcherepanova et al., 2000; Vega et al., 2000). The atypical L-motif (L3) between amino 
acids 210 and 214 has been shown to strongly contribute to the interaction with the orphan 
nuclear receptor ERRα (Schreiber et al., 2003). A proline-rich domain between amino 
acids 180-403 interacts with PPARγ and NRF-1 (Wu et al., 1999). Finally, a domain 
ranging from amino acids 400 to 570 interacts with the transcription factor MEF2C 
(Michael et al., 2001). PGC-1α is a transcriptional coactivator that enhances transcription 
from promoters where it has been recruited to. Early studies demonstrated that the N-
terminal part PGC-1α harbors a potent transcription activation domain, which when fused 
to the yeast GAL4-DNA-binding domain, strongly activates the expression of GAL4-
responsive reporter constructs (Knutti et al., 2000). Activation of transcription may occur 
through the recruitment of the trancriptional coactivators SRC-1 and CBP/p300 or the 
RNA polymerase machinery (Monsalve et al., 2000; Puigserver et al., 1999). The L-motifs 
and the transcription activation domain of PGC-1α described above are typical for 
transcriptional coactivators. What distinguishes PGC-1α from most known coactivators are 
the serine/arginine-rich domains (SR) and the putative RNA recognition motif (RRM) 
located in its C-terminal part. Such protein motifs are characteristic for proteins acting in 
RNA processing (Blencowe et al., 1999; Graveley, 2000). It has also been shown that 
proteins containing paired SR and RRM motifs can interact with the C-terminal domain of 
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the RNA polymerase  II, suggesting a link between transcription and pre-RNA processing 
(Hirose and Manley, 2000). It is now widely accepted that the SR-domains of SR proteins 
function as protein interaction domains. SR-domains can be extensively phosphorylated. 
Such phosphorylation has been shown to regulate the subnuclear localization of SR-
proteins or the interaction with other proteins, both of which may change the ability of SR 
proteins to regulate splicing. A possible role for PGC-1α in the regulation of alternative 
splicing is supported by the observation that PGC-1α expression can alter the processing of 
a model mRNA, but only when it is loaded onto the promoter of the gene by interacting 
with a transcription factor (Monsalve et al., 2000). In addition to the role in the regulation 
of splicing, the C-terminal domains have also been shown to interact with the mediator 
complex (Wallberg et al., 2003).  
 
 
 
Figure 1.2. Schematic presentation of the structure of PGC-1α.  
Parenthesis indicate the interaction domains with different proteins. The activation domain (AD), 
the LxxLL-motifs (L2 and L3), the SR-rich region (SR), the E-rich region (E), and the RNA-
recognition motif (RRM) are indicated by gray or black boxes.  
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Post-translational regulation of PGC-1α 
As described above, a number of pathways are switched on by the induction of PGC-1α in 
animals or by the overexpression of PGC-1α in cell culture systems. The activity of PGC-
1α as transcriptional coactivator is definitively regulated at the transcriptional level. It is 
now becoming evident that the activity of PGC-1α is also regulated at the 
posttranscriptional level. It has been shown that cytokines like interleukin 1α, interleukin 
1β, and tumor necrosis factor alpha increase the transcriptional activity of PGC-1α through 
direct phosphorylation by the mitogen activated protein kinase p38, resulting in the 
stabilization and activation of the PGC-1α protein (Puigserver et al., 2001). Displacement 
of a molecular repressor protein was suggested as the mechanism for the increase of the 
PGC-1α activity by the p38 phosphorylation (Knutti et al., 2001). Further studies led to the 
identification of p160 myb binding protein (p160MBP) as a PGC-1α interacting protein, 
whose overexpression decreased the PGC-1α activity. Most importantly, the interaction of 
p160MBP with PGC-1α was weaker when PGC-1α was phosphorylated by p38 (Fan et al., 
2004). 
 
Aim of this study 
Transcriptional coactivators can use several different mechanisms to translate the signal of 
DNA-bound transcription factors into activation of gene expression. Coactivators can 
recruit the basal transcription machinery to promoters by acting as bridges between 
transcription factors and the transcription machinery. Many coactivators posses ATP-
dependent chromatin remodeling activity or other enzymatic activities for the modification 
of histones or other proteins involved in transcription with acetyl-groups, methyl-groups, 
phosphate, ubiquitin, or SUMO . At the same time, the activity of many coactivators has 
been shown to be modulated by post-translational modifications. Understanding the 
mechanisms used by the coactivator PGC-1α to enhance transcription and how its activity 
is regulated is still a major challenge.  
 
Previous work in our laboratory has suggested that the C-terminal part of PGC-1α, which 
encodes two SR-rich domains and a putative RNA recognition motif, contributes to the 
coactivation of nuclear receptor responses (Knutti et al., 2000). We hypothesized that 
PGC-1α recruits, via its C-terminal domains, proteins that allow PGC-1α to reach its full 
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activity by either being a subunit of a PGC-1α complex or by posttranslationally 
modifying and regulating PGC-1α.  A yeast two-hybrid screen was chosen to identify 
proteins interacting with the C-terminal domains of PGC-1α. Such proteins may explain 
the importance of the PGC-1α C-terminal domains in the regulation of transcription. In 
addition, they may help to identify unknown functions of PGC-1α or possible mechanisms 
for the regulation of the PGC-1α transcriptional activity.  
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CHAPTER II: EXPERIMENTAL PROCEDURES 
Plasmids 
PGC-1α constructs: In frame fusions of amino acids 189-798, 294-798, 408-798, or 506-
798 of PGC-1α to the yeast GAL4-DBD were generated by cloning either an EcoRI/SalI, 
XbaI/SalI, StuI/SalI or NcoI/SalI fragments from pBS/HA-hPGC-1α (Knutti et al., 2000) 
into pGBKT7 (Clontech). If necessary, the ends were treated with Klenov polymerase 
and/or mung bean nuclease before ligation to obtain the correct reading frame. For the 
construction of the in frame fusion of amino acids 91-798 to the GAL4-DBD a NdeI/EcoRI 
fragment from pcDNA3/HA-PGC-1α.91-408 coding for amino acids 91-189 of PGC-1α 
and an EcoRI/SalI fragment from pBS/HA-PGC-1α (Knutti et al., 2000) coding for amino 
acids 190-798 of PGC-1α were ligated into pGBKT7. Plasmid pBS/2xFlag-PGC-1α was 
constructed by replacing the NdeI/XhoI fragment of pBS/2xFlag-Clk1 with the NdeI/XhoI 
fragment of pBS/HA-PGC-1α (Knutti et al., 2000). A BamHI/NotI fragment from 
pBS/2xFlag-PGC-1α containing the PGC-1α cDNA downstream of the two Flag-tag-
coding sequence was subcloned into pcDNA3 to give pcDNA3/2xFlag-PGC-1α. Plasmid 
pcDNA3/HA-PGC-1α for the expression of HA-tagged PGC-1α in mammalian cell has 
been described (Knutti et al., 2000). For the generation of the PGC-1 deletion variants ∆6, 
∆SR, ∆E, ∆RRM, N754, and ∆SR/E/RRM the plasmid pBS/HA-PGC-1α (Knutti et al., 
2000) was used as template. Variant ∆6 was made by PCR-amplification of a DNA 
fragment encoding amino acids 566-798 of PGC-1 using primers CAG TCT AGA CGC 
TCT CGT TCA AGG TCC and GTA ATA CGA CTC ACT ATA  GGG C. The PCR-
fragment was then digested with XbaI and XhoI and used to replace the wildtype 
XbaI/XhoI-fragment of pBS/HA-PGC-1α. Variant N754 was constructed in a similar 
manner using primers GGT GAC CAT GAC TAT TGC and GAC TGA CTC GAG TTA 
CTT GCG TCC ACA AAA GTA C. To make PGC-1α construct SR/E/RRM (aa 565-754), 
primers TAC GCC GGT CAT ATG CGC TCT CGT TCA AGG TCC and GAC TGA CTC 
GAG TTA CTT GCG TCC ACA AAA GTA C were used to PCR-amplify a DNA-
fragment encoding amino acids 565-754 of PGC-1α. The PCR-product was digested with 
NdeI and XhoI and used to replace the NdeI/XhoI fragment of pBS/HA-PGC-1α. PGC-1α 
variants ∆SR, ∆E, ∆RRM, and ∆SR/E/RRM were constructed by a two-step PCR-method. 
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In the first round, primer C8/1190 was used in combination with primers ATA CCT GGG 
CAT CCT TTG GGG TCT TTG (for ∆SR), CAC ACG GCG CCG ACG GCT GTA GGG 
CGA TC (for ∆E), GAA AAA TTG CTC TTC AAT TGC CTT CTG (for ∆RRM), and 
GAA AAA TTG CAT CCT TTG GGG TCT TTG (for ∆SR/E/RRM) to amplify the 5’-
flanking sequences of the sequences to be deleted. Primer GTA ATA CGA CTC ACT 
ATA GGG C was used with primers CAA AGG ATG CCC AGG TAT GAC AGC TAC 
(for ∆SR), AGC CGT CGG CGC CGT GTG ATT TAT GTC (for ∆E), ATT GAA GAG 
CAA TTT TTC AAG TCT AAC (for ∆RRM), and CAA AGG ATG CAA TTT TTC AAG 
TCT AAC (for ∆SR/E/RRM) to amplify the 3’-flanking-sequences of the sequences to be 
deleted. Corresponding pairs of 5’- and 3’-flanking regions generated in the first round 
were used as template for the second PCR-round with primers GGT GAC CAT GAC TAT 
TGC and GTA ATA CGA CTC ACT ATA GGG C. The generated PCR-products 
harboring the deletions were digested with XbaI and XhoI and used to replace the wildtype 
XbaI/XhoI-fragment of pBS/HA-PGC-1α. For the construction of the expression vectors 
for the PGC-1 variants having lysine to arginine substitutions in the putative SUMOylation 
motifs, a similar two-step PCR-method was used. To introduce the K184R mutation, a 
PCR was performed with primer pairs GCT TTC TGG GTGGAC TCA AGT GG / GCA 
ATT GTG CGC ACT GAG AAT TCA TGG AGC and CTC AGT GCG CAC AAT TGC 
AGG GTT TGT TC / GTG GTG GGT GGA GTT AGG CCT GCA G and pBS/2xFlag-
PGC-1α as template. In the second step, the two PCR-products of the first step, which 
overlap by 18 nucleotides, were used as template for a PCR with primers GCT TTC TGG 
GTG GAC TCA AGT GG and GTG GTG GGT GGA GTT AGG CCT GCA G. The 
resulting amplification product, containing the K184R mutation in the putative 
SUMOylation motif, was cut with NheI and EcoRI to replace the corresponding wildtype 
fragment in pBS/2xFlag-PGC-1α. To introduce the K646R mutation, PCR was performed 
with primer pairs GAC TAG CCA TGG ATG GCC / AGG CTG CGT CGC GAA GAA 
TAT CGC AGA GAG and TTC TTC GCG ACG CAG CCT CTC GTG CTG ATA TTC C 
/ GTA ATA CGA CTC ACT ATA GGG C and pBS/2xFlag-PGC-1α as template. In the 
second step, the two PCR-products of the first step, which overlap by 18 nucleotides, were 
used as template for primers GAC TAG CCA TGG ATG GCC and GTA ATA CGA CTC 
ACT ATA GGG C. The resulting amplification product, containing the K646R mutation in 
the putative SUMOylation motif, was cut with AgeI and XhoI to replace the corresponding 
wildtype fragment in pBS/2xFlag-PGC-1α. To confirm the presence of the right deletions 
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and to exclude unwanted mutations, all constructs were sequenced. For expression in 
mammalian cells, the HA-tagged or 2xFlag-tagged PGC-1α variants were subcloned as 
BamHI/NotI fragments into pcDNA3 to generate pcDNA3/HA-PGC-1α.∆6, pcDNA3/HA-
PGC-1α.∆SR, pcDNA3/HA-PGC-1α.∆E, pcDNA3/HA-PGC-1α.∆RRM, pcDNA3/HA-
PGC-1α.∆SR/E/RRM, pcDNA3/HA-PGC-1α.N754, pcDNA3/HA-PGC-1α.SR/E/RRM, 
pcDNA3/2xFlag-PGC-1α.184R, and pcDNA3/2xFlag-PGC-1α.646R. To make 
pcDNA3/GAL4DBD-PGC-1α.91C, a DNA sequence coding for amino acids 91-798 of 
PGC-1α was subcloned in frame behind the GAL4-DBD of plasmid pcDNA3/GAL4DBD 
(Kressler et al., 2002).   
 
 
Constructs for proteins identified to interact with PGC-1α. To make pcDNA3/2xFlag-
Clk1, the complete ORF of human Clk1 was PCR amplified with the oligonucleotides 
GGA TCC ATG GAC TAC AAG GAT CAC GAC GGT GAC TAC AAG GAT GAC 
GAT GAC AAG CAT ATG AGA CAC TCA AAG AGA AC (containing BamHI, NcoI 
sites,  two Flag-tags, NdeI site and 27 nucleotides of the Clk1 sequence; the underlined 
ATG is the translation initiation codon of Clk1) and oligonucleotide GAC TGA CTC GAG 
CTA TAT ACT TTT CTT CAG (containing an XhoI site and 15 nucleotides of Clk1; 
natural stop codon of Clk1 is underlined) using the yeast two-hybrid clone 1 as template, 
and cloned into BamHI/XhoI restricted pBS/HA-PGC-1α, which gave rise to the plasmid 
pBS/2xFlag-Clk1. The sequence of the cloned Clk1 cDNA and the Flag-tag was verified 
by sequencing. The full length 2xFlag-Clk1 was then subcloned as a BamHI/NotI fragment 
into pcDNA3 (Invitrogen) downstream of the cytomegalovirus enhancer to give 
pcDNA3/2xFlag-Clk1. The full length cDNA of HM-1 was PCR-amplified using 
oligonucleotides CGA ATT CAT ATG AAC GAT TGG ATG CCC and GAC TGA CTC 
GAG CTA CTT GCC TCT TTC CTT C and yeast two-hybrid clone 39 as template. 
Tip60β was amplified with oligonucleotides CGA ATT  CAT ATG GCG GAG GTG GGG 
GAG ATA ATC GAG and GAC TGA CTC GAG TCA CCA CTT CCC CCT CTT G and 
yeast two-hybrid clone 15 as template. Tip60α was amplified with the same 
oligonucleotides but with HepG2 cDNA as template. For the amplification of the Skip 
ORF, oligonucleotides CGA ATT CAT ATG GCG CTC ACC AGC TTT TTA C and 
GAC TGA CTC GAG CTA TTC CTT CCT CCT CTT C were used with yeast two-hybrid 
clone 251 as template. The full length cDNAs of HM-1, Tip60α, Tip60β and Skip were cut 
Chapter II: Experimental procedures 
_______________________________________________________________________ 
 34
with NdeI and XhoI and used to replace the NdeI/XhoI fragment of pBS/2xFlag-Clk1 to 
generate pBS/2xFlag-HM-1, pBS/2xFlag-Tip60α, pBS/2xFlag-Tip60β, and pBS/2xFlag-
Skip, which were all verified by sequencing. The 2xFlag-tagged version of the HM-1, 
Tip60α, Tip60β, and Skip cDNAs were then subcloned as BamHI/NotI fragments into 
pcDNA3 (Invitrogen) to give pcDNA3/2xFlag-HM-1, pcDNA3/2xFlag-Tip60α, 
pcDNA3/2xFlag-Tip60β, and pcDNA3/2xFlag-Skip. For the in vitro 
transcription/translation of the PGC-1α-interacting proteins, the inserts of the isolated 
library plasmids were cut out as NcoI/XhoI fragments and used to replace the  NcoI/SalI 
fragment of pGEM4/HA-PGC-1α.  
 
Tip60 constructs. Construction of the Tip60α and Tip60β expression constructs have 
been described above. The Tip60 point mutants were generated by fusion PCR. To 
introduce the mutations in the acetyl-CoA binding motif (Q377E,G380E),  two PCRs were 
performed with primer pairs CGA ATT  CAT ATG GCG GAG GTG GGG GAG ATA 
ATC GAG / GTA CTC GCG ACG CTC GTA GGG AGG CAG GGT TAG and TAC 
GAG CGT CGC GAG TAC GGC AAG CTG CTG ATC GAG TTC AGC / GAC TGA 
CTC GAG TCA CCA CTT CCC CCT CTT G and pBS/2xFlag-Tip60α as template. In the 
second step, the two PCR-products of the first step, which overlap by 18 nucleotides, were 
used as template for primers CGA ATT  CAT ATG GCG GAG GTG GGG GAG ATA 
ATC GAG and GAC TGA CTC GAG TCA CCA CTT CCC CCT CTT G. The resulting 
amplification product, containing the Q377E and G380E, was cut with BglI and PstI to 
replace the corresponding wildtype fragment in pBS/2xFlag-Tip60α. To introduce the 
mutations in the LXXLL motif (L489/492/493A), two PCRs were performed with primer 
GTC ATG ACA GAG TAT GAC / CCG AGC TGC CCG CTT GGC CAT GGC CCG 
CTC ATG GCC ATC and ATG GCC AAG CGG GCA GCT CGG ATC GAC TCC AAG 
TGT CTG / GTA ATA CGA CTC ACT ATA GGG C and pBS/2xFlag-Tip60α as 
template. In the second step, the two PCR-products of the first step, which overlap by 18 
nucleotides, were used as template for primers GTC ATG ACA GAG TAT GAC and GTA 
ATA CGA CTC ACT ATA  GGG C. The resulting amplification product, containing the 
L489A, L492A and L493A mutations, was cut with PstI and SalI to replace the 
corresponding wildtype fragment in pBS/2xFlag-Tip60α. To make the Tip60 variants 
N147 and 148C,  fragments coding for amino acids 1-147 or 148-513 of Tip60α were 
amplified with primer pairs CGA ATT CAT ATG GCG GAG GTG GGG GAG ATA ATC 
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GAG/ GAC TGA CTC GAG TCA CGT TGA GCG GTG GTT GGG or CGA ATT CAT 
ATG AAA CGG AAG GTG GAG GTG/ GAC TGA CTC GAG TCA CCA CTT CCC 
CCT CTT G. The two PCR products were cut with NdeI/XhoI, and used to replace the 
NdeI/XhoI fragment of pBS/2xFlag-Tip60α. All Tip60 variants were verified by 
sequencing and cloned into pcDNA3 (Clontech) (BamHI/NotI), pGBKT7 (Clontech) 
(NdeI/SalI), pcDNA3/VP16 (BamHI/NotI), pGEX-4T-3 (Pharmacia) (BamHI/SalI), and 
pAdlox (BamHI/XhoI). Oligonucleotide pairs GAT CCC CAC GTC TGG ATG AAT 
GGG TGT TCA AGA GAC ACC CAT TCA TCC AGA CGT TTT TTG GAA A / AGC 
TTT TCC AAA AAA CGT CTG GAT GAA TGG GTG TCT CTT GAA CAC CCA TTC 
ATC CAG ACG TGG G and GAT CCC CGC CAC GAC GAC ATC GTC ACT TCA 
AGA GAG TGA CGA TGT CGT CGT GGC TTT TTG GAA A / AGC TTT TCC AAA 
AAG CCA CGA CGA CAT CGT CAC TCT CTT GAA GTG ACG ATG TCG TCG TGG 
CGG G were annealed and cloned into BglII/HindIII-restricted pAdSUPER (Schreiber et 
al., 2003). The resulting plasmids pAdSUPER/Tip60-4 and pAdSUPER/Tip60-19 were 
used for the generation of adenoviral vectors expressing siRNAs directed against Tip60. 
 
Other constructs. Expression vectors for the rat glucocorticoid receptor (p6RGR) 
(Godowski et al., 1988), p52 (pMT2T-p52) (Chang et al., 1994), APP , Fe65 
(pCMV5/Fe65) (Cao and Sudhof, 2001), and Bcl-3 (pFlag-CMV2-Bcl-3) (Westerheide et 
al., 2001) as well as the luciferase reporter constructs pTAT3-luc, pTAT1-luc, pMMTV-
luc (Iniguez-Lluhi et al., 1997), and pGK-1 (Webb et al., 1995), and p2xκBSV40 (Pan and 
McEver, 1995) have been described. To construct the luciferase reporter pERRα-luc, the 
ERRα-responsive sequences of the ESRRA promoter (nt –537 to –829 nt, relative to 
transcription initiation site) were amplified by PCR and subcloned upstream of the minimal 
alcohol dehydrogenase promoter of pLuc (Iniguez-Lluhi et al., 1997). 
 
Yeast two-hybrid screen 
Yeast strain AH109 (Clontech) was simultaneously transformed with pGBKT7/PGC-
1α.294C  or pGBKT7/PGC-1α.506C and a human skeletal muscle cDNA library 
(Clontech) according to the lithium acetate method and then plated on selection medium 
(SD –Trp, -Leu, -His, -Ade, 15mM 3-AT). Library plasmids from 401 positive clones were 
recovered and reintroduced into yeast strain AH 109 to confirm the interactions. Strength 
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of the interactions was determined by measuring β-galactosidase activity in yeast strain CG 
187 [CG1945 x Y187 (Clontech)]. Positive clones were sequenced using an ABI prism 
sequencer and primer TAC CAC TAC AAT GGA TG.   
 
Adenoviruses 
Adenoviral vectors were generated by CRE-lox mediated recombination in CRE8 cells 
(Hardy et al., 1997). 90% confluent CRE8 cells (Hardy et al., 1997), grown in a 10 cm 
tissue culture plate, were transfected with 3 µg of purified Ψ5 adenovirus DNA and 10 µg 
of the corresponding pAdlox or pAdSUPER shuttle plasmids according to the calcium 
phosphate protocol. After 5-8 days and the formation of a few plaques, cells were washed 
from the plate and collected by centrifugation. The supernatant was removed except for 1 
ml that was used to resuspend the cells. 10 µl of this cell suspension was used to infect 
fresh CRE8 cell grown on a 10 cm plate. The rest was frozen at –70°C. After most of the 
infected cells had detached from the plate, they were harvested and resuspended as 
described above. The previous infection step was repeated one more time. The resulting 
cell suspension was used for the isolation of single adenovirus clones by the plaque assay. 
 
For the plaque assay, CRE8 cells were split into 6-well tissue culture plates and grown to 
about 90% confluence. Serial dilutions of an adenoviral stock solution were prepared in 1 
ml media each. The media on the CRE8 cells were removed and replaced with the 
adenovirus dilutions. After a one hour incubation at 37°C, the media were aspirated and the 
cells were overlaid with 2 ml of a 45°C warm agar solution (growth media containing 0.6% 
agar). To let the agar cool down the cells were incubated at room temperature for 30 min. 
Finally, 4 ml media was added to each well on top of the agar layer. Plaques were counted 
and isolated at 5-7 days after infection.  
 
Adenoviral vectors for HA-PGC-1α and GFP have been described (Schreiber et al., 2003). 
 
Cell Lines, Transfections, and Infections  
COS7, U2OS, and SAOS2-GR(+) (Rogatsky et al., 1997), and CRE8 (Hardy et al., 1997) 
cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 9% fetal calf 
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serum. For SAOS2-GR(+) cells, charcoal stripped serum was used and the medium was 
supplemented with 200µg/ml G418. 
 
For transfections, cells were incubated with a calcium phosphate/DNA precipitate. For the 
transfection of cells grown in 35 mm wells, the DNA to be transfected was mixed, and 
water was added to a final volume of 180 µl. 60 µl of a 1 M CaCl2 Solution were added to 
the DNA mix. After a 15 min incubation, 240 µl of a 2 x HBS (pH 6.98) solution was 
added. The solution was mixed well by pipetting up and down and then divided into two 
35 mm wells containing 1.5 ml media each. For luciferase assays, transfections included 
200 ng of p6R-lacZ (Pearce and Yamamoto, 1993) for normalization of transfection 
efficiency. About 16 h after transfection, the precipitate was removed by two washes with 
PBS (w/o Ca2+ and Mg2+) and fresh medium was added to the cells. Cell lysates were 
prepared 40 hr after transfection using 100 µl reporter lysis buffer (Promega) and assayed 
for luciferase and β-galactosidase activity. Luciferase values normalized to the β-
galactosidase activity are referred to as luciferase units. 
 
For infections, SAOS2 (GR+) or U2OS cells were plated at 1.0 x 105 cells per well in a 
six-well plate or at 106 cells per 10 cm dish. Cells were infected with viruses at a 
multiplicity of infection as indicated in the figure legends. 2 hr later, cells were washed and 
replenished with fresh media.  
 
Western blot analysis 
Whole cells extracts were prepared by boiling the cells in TSD-buffer (50 mM Tris-HCl 
pH7.5, 1% SDS, 5 mM DTT) for 5 min. The insoluble material was removed by 
cetrifugation at RT for 5 min and the supernatant was diluted 1:10 in NP-40 lysis buffer 
(50mM Tris-HCl pH 8, 150 mM NaCl, 0.5 % NP-40, 1 mM EDTA, 1mM PMSF, protease 
inhibitors). After the addition of SDS-PAGE loading buffer the samples were boiled for 5 
min. For the separate analysis of NP-40-soluble and NP-40-insoluble cellular components, 
cells extracts were prepared in NP-40 lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 8, 
1 mM EDTA, 0.5% NP-40, protease inhibitors). Insoluble material was pelleted by 
centrifugation for 10 min at 4°C. The supernatant was transferred to a fresh tube and boiled 
for 5 min after the addition of SDS-PAGE loading buffer. The pelleted material was 
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solubilized by boiling for 5 min. in NP-40 lysis buffer supplemented with SDS-PAGE 
loading buffer. The resulting samples were resolved by SDS-PAGE and transferred to 
nitrocellulose or PVDF membranes. Western blot analysis was performed using antibodies 
against PGC-1α (Schreiber et al., 2003) and the Flag-epitope (Sigma). 
 
Co-immunoprecipitation 
To study protein-protein interactions in cells, various expression plasmids were transfected 
into COS7 cells according to the calcium phosphate method. When SAOS-GR(+) cells 
were used, they were infected with adenoviruses expressing either GFP, HA-PGC-1α, 
2xFlag-Tip60α or 2xFlag-Tip60α.mHAT. 24 h after infection, cell extracts were prepared 
by incubating cells in 1 ml NP-40 lysis buffer (50mM Tris-HCl pH 8, 150 mM NaCl, 0.5 
% NP-40, 1 mM EDTA, 1 mM PMSF, 1 x protease inhibitors, 1x phosphatase inhibitors) 
for 15 min. Extracts were spun at 14000 rpm for 10 min. The pellet was discarded. For the 
immunoprecipitation of PGC-1α complexes, the cell extracts were first precleared with a 
mixture of protein A/G sepharose for 1 h. Extracts were then incubated with anti-PGC-1α 
antibody (1:500) (Schreiber et al., 2003) for 2 hr followed by an incubation with a mixture 
of protein A/G sepharose for 1 hr. Sepharose with the bound proteins was washed three 
times with lysis buffer. For the immunoprecipitation of Tip60 complexes, 5 µl anti-Flag-
agarose (Sigma) diluted with 15 µl sepharose were mixed with the cell extracts which were 
then rotated at 4°C for 2 hours. Beads with the bound proteins were washed three times 
with lysis buffer. Immunocomplexes were released by boiling in SDS-PAGE loading 
buffer, resolved by SDS-PAGE and transferred to a PVDF or nitrocellulose membrane. 
PGC-1α was detected using anti-PGC-1α antiserum (Schreiber et al., 2003). The Flag-
tagged proteins Tip60, HM-1, Skip, and Clk1 were detected with an anti-Flag antibody 
(Sigma).   
 
RNA Analysis 
Total RNA was isolated using the TRIzol reagent (Invitrogen) and checked for its integrity 
by agarose gel electrophoresis and ethidium bromide staining. RNA (400 ng) was 
converted to cDNA using the Superscript Reverse Transcriptase Kit (Invitrogen) and 
random hexamer primers according to manufacturer’s instructions. Real-time PCR with the 
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Chromo4 (MJ Research) was used for the amplification and quantification of Cyt c, ERRα, 
IL22R, BBS1, p21, and GAPDH cDNA. PCR reactions were performed in 20 µl reactions 
using 2 µl cDNA, 500 nM specific primers, and the SYBRgreen kit (ABI). The sequences 
of the primers and the sizes of the products were: CCA GTG CCA CAC CGT TGA A 
(exon 2) and TCC CCA GAT GAT GCC TTT GTT (exon 3) for Cyt c (product 136 bp), 
AAG ACA GCA GCC CCA GTG AA (exon 4/5) and ACA CCC AGC ACC AGC ACC T 
(exon 6) for ERRα (product 254 bp), CGT GAA ATT CCA GTC CAG CAA (exon 2) and 
CGG TGA CCC TGG CAT AGT AGA (exon 3) for IL22R (product 212 bp), CAC ACC 
TTT TCT GCC TGCC T (exon 2) and TTT CGG TCA TCA CCA GTG GTC (exon 4) for 
BBS1 (product 136 bp), CGG GAT GAG TTG GGA GGA G (exon 1) and CGG CGT 
TTG GAG TGG TAG AA (exon 2) for p21 (product 212 bp), and GAA GGT GAA GGT 
CGG AGT C (exon 2) and GAA GAT GGT GAT GGG ATT TC (exon 4) for GAPDH 
(product 226 bp). A melting curve from 65°C to 95°C was at the end of the reaction was 
used to check the purity and nature of the products. 
 
In vitro protein interaction assays 
Single colonies of E. coli strain BL21 transformed with plasmids expressing GST or the 
GST-PGC-1α fusions were grown overnight in liquid LB medium containing 50 µg/ml 
ampicillin. The next morning, the cultures were diluted to an OD600 of 0.1 in LB medium 
containing ampicillin and 2% glucose and grown to an OD600 of approximately 0.5. 
Expression of the GST-fusion proteins was then induced by the addition of IPTG to a final 
concentration of  0.5 mM and by incubation for 2 to 3 hours more, shaking and at RT.  
Bacteria were pelleted at 4°C, washed once with ice-cold PBS, and resuspended in PBS 
(1/20 of the original culture volume). The cell suspension was sonicated 5 x 30 sec on ice. 
NP-40 to a final concentration of 0.5% was added to the cell suspension, which was then 
incubated on ice for 30 min. Insoluble cell debris was pelleted at 9000 g for 30 min at 4°C. 
The supernatant was incubated with glutathione sepharose (1/1000 of original culture 
volume, Amersham) for 20 min at room temperature. The beads with the bound GST-
fusions were washed twice with PBS containing 0.5% NP-40 and once with binding buffer 
(20 mM Tris, pH8, 75 mM KCl, 3 mM MgCl2, 1 mM EDTA, 10 % glycerol, 0.05 % NP-
40, 1 mM PMSF, and protease inhibitors). After the three wash steps the beads were 
resuspended in ice-cold binding buffer  and the concentration of the GST-fusion proteins 
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was determined using the Bradford assay. [35S]methionine-labeled proteins were produced 
with the TNT reticulocyte lysate in vitro transcription and translation kit (Promega) using 
0.5 µg of template plasmid in a final volume of 20 µl. About 1 µg of GST or GST-fusion 
proteins bound to the glutathione beads were mixed with 5 µl of in vitro-translated 
[35S]methionine-labeled proteins in binding buffer. The reaction volumes were 150 µl. 
After binding for 1 hour at room temperature, the beads were washed three times with 
wash buffer buffer (20 mM Tris, pH8, 75 mM KCl, 3 mM MgCl2, 1 mM EDTA, 10 % 
glycerol, 0.05 % NP-40, 1 mM PMSF, and protease inhibitors). Bound proteins were then 
released by boiling in SDS-sample buffer and resolved by SDS-PAGE. The gel was 
incubated in fixing solution (45% methanol, 10% acetic acid) for 30 min and in 1 M 
sodium salicylate for 20 min and finally dried.  Bound proteins were detected by 
autoradiography.  
 
In vitro acetylation assay 
Expression of maltose binding protein (MBP), the MBP-PGC-1α fusions, GST-Tip60α, 
and GST-Tip60α.mHAT was induced in E. coli strain BL21 with 0.5 mM IPTG for 3 
hours at RT. MBP and the MBP-PGC-1α fusions were purified on amylose beads (NEB). 
The GST-Tip60 fusions were purified on glutathione beads (Amersham Biosciences). 
Bound GST-fusions were eluted twice with elution buffer (50 mM Tris pH8, 150 mM 
NaCl, 0.1 mM EDTA, 10 mM glutathione). About 1 µg of MBP or the MBP-PGC-1α 
constructs bound to the amylose beads were mixed with about 2 µg GST-Tip60α or GST-
Tip60α.mHAT in the reaction buffer containing 50 mM Tris, pH 8, 150 mM NaCl, 0.1 
mM EDTA, 5 mM sodium butyrate, 1 mM PMSF, and 0.5 µl [3H]-acetyl-coenzyme A 
(Amersham) and incubated at 30°C for 1 hour. Proteins were resolved by 5-15% gradient 
SDS-PAGE. The gel was then incubated in fixing solution (45% methanol, 10% acetic 
acid) for 30 min and in the amplify solution (Amersham) for 20 min and finally dried.  
Acetylated proteins were detected by autoradiography.  
 
Pulse-chase experiment 
On day 1, COS7 cells were transfected with expression plasmids for Flag-tagged PGC-1α, 
HA-tagged Tip60α, or vector alone in 10 cm tissue culture plates. The next morning, cells 
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were split into 3 cm plates (1/6 of a 10 cm plate into a 3 cm plate). On day three, β-
galactosidase activity of one 3 cm plate of each condition was measured to confirm similar 
transfection efficiencies. The cells of the remaining plates were washed once with PBS 
(without Ca2+ and Mg2+) for 5 min before they were incubated with 500 µl starvation 
medium (DMEM w/o methionine and cysteine) per 3 cm plate for 30 min. The starvation 
medium was removed and replaced with 500 µl labeling medium (starvation medium 
containing [35S]-labeled methionine and cysteine). After one hour incubation with labeling 
medium, cells were washed once with warm PBS (without Ca2+ and Mg2+). Cells were then 
incubated with 2 ml chase medium (DMEM, 10 % FBS, 2 mM methionine, 2 mM 
cysteine) per 3 cm plate. 0, 1, 2, 3, or 4  hours after addition of the chase medium, cells of 
one plate of each condition were washed once with cold PBS and harvested in 500 µl PBS 
(without Ca2+ and Mg2+), transferred to a 1.5 ml screw cap tube and centrifuged for 1 min 
at 4°C. The supernatant was removed and the cell pellets were frozen in liquid nitrogen and 
stored at –70°C. The frozen cells were resuspended in 50 µl TSD-buffer (50 mM Tris pH 
7.5, 1% SDS, 5 mM DTT) and boiled for 5 min. The cell lysates were spun at RT for 5 min 
to pellet the insoluble material. The supernatant was transferred to a fresh tube and diluted 
with 600 µl of TNN-buffer (50 mM Tris pH 7.5, 250 mM NaCl, 5 mM EDTA, 0.5% NP-
40). 5 µl anti-Flag-agarose (Sigma) diluted with 15 µl sepharose were then added to each 
sample, which were then rotated at 4°C for 2 hours. The beads were washed 4 times with 
TNN-buffer. Bound proteins were released with SDS-PAGE sample buffer and resolved on 
a 7.5 % SDS-PAGE gel. The gel was then incubated in fixing solution for 30 min and in 
enhancing solution (1 M sodium salicylate) for 20 min and finally dried. [35S]-labeled 
PGC-1α was detected by autoradiography. 
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CHAPTER III: IDENTIFICATION OF PROTEINS INTERACTING 
WITH THE C-TERMINAL PART OF PGC-1α 
The C-terminal part of PGC-1α contributes to the full activity of PGC-1α as a 
transcriptional coactivator 
PGC-1α was identified as a transcriptional coactivator for nuclear receptors (Knutti et al., 
2000; Puigserver et al., 1998). When this work started, little was know about the 
mechanisms used by PGC-1α to enhance transcription. A potent transcription activation 
domain has been mapped to its first approximately 200 amino acids, which were shown to 
bind the coactivators and acetyltransferases CBP and SRC-1 (Knutti et al., 2000; 
Puigserver et al., 1999; Puigserver et al., 1998). Our laboratory has shown that deletion of 
this region completely abolishes the ability of PGC-1α to enhance the activity of the 
glucocorticoid receptor (GR) on a reporter plasmid controlled by three glucocorticoid 
responsive enhancer elements derived from the tyrosine aminotransferase (TAT) promoter 
(TAT3-luc) in COS7 cells, suggesting that the N-terminal 200 amino acids contain the only 
autonomous transcription activation domain of PGC-1α (Knutti et al., 2000). A PGC-1α 
variant consisting of only the first 408 amino acids (N408) displayed a reduced ability to 
coactivate the GR compared to wild type PGC-1α (Fig. 3.1B). This reduced activity could 
neither be attributed to a lower expression level (Fig. 3.1D) nor to a defective nuclear 
localization of this PGC-1α variant (Knutti et al., 2000). When a luciferase reporter under 
control of the mouse mammary tumor virus promoter (MMTV-luc) was used, the 
contribution of the C terminus to the PGC-1α activity seemed even more pronounced, 
while the C terminus seemed to be dispensable for the coactivation of a luciferase reporter 
under control of only one GR-responsive enhancer element from the TAT promoter 
(TAT1-luc) (Fig. 3.1B).  
Chapter III: Identification of proteins interacting with the C-terminal part of PGC-1α 
________________________________________________________________________ 
 44
The glutamine-rich region contributes to the coactivator function of PGC-1α 
To narrow down the region in the PGC-1α C terminus that contributes to the coactivator 
function, we constructed five PGC-1α deletion variants, each lacking a specific domain in 
the C-terminal part (Fig. 3.1A). An expression plasmid for the GR and the luciferase 
reporter TAT3-luc were cotransfected into COS7 along with control vector or the different 
PGC-1α constructs. The results shown in Figure 3.1B demonstrate that deletion of the E-
rich region reduces the coactivator function of PGC-1α to a similar extent as deletion of 
the whole C-terminal half, while deletion of the other domains did not affect the PGC-1α 
function significantly. We repeated the above experiment with the luciferase reporter under 
control of the mouse mammary tumor promoter (MMTV-luc) and with the luciferase 
reporter under control of only one GR-responsive element of the TAT promoter (TAT1-
luc). The contribution of the C-terminal part and also the E-rich region to the PGC-1α 
coactivator function was even more pronounced with the MMTV-luc reporter (Fig. 3.1B). 
No reduced coactivator activity of the PGC-1α constructs lacking the whole C-terminal 
half or only the E-rich domain was observed when the TAT1-luc reporter was used (Fig. 
3.1B). To confirm that all PGC-1α deletion constructs are expressed at levels that are at 
least as high as those of wild type PGC-1α, we performed a western blot analysis. Deletion 
constructs ∆6, ∆E, and N754 show similar expression levels as wild type PGC-1α, while 
the deletion variants ∆SR and ∆RRM show significantly higher expression levels (Fig. 
3.1C). These result suggests that the E-rich region of PGC-1α plays a significant role in the 
coactivation of the GR-dependent transcription of the TAT3 and MMTV luciferase 
reporters. 
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Figure 3.1. Ability of various PGC-1α deletion constructs to coactivate the glucocorticoid 
receptor (GR).  
(A) Schematic presentation of the PGC-1α constructs used.  
(B) A plasmid expressing the rat GR was cotransfected into COS7 cells along with a control vector 
or the indicated PGC-1α deletion constructs and one of the luciferase reporters TAT3-luc, MMTV-
luc , or TAT1-luc. Cells were treated with 50 nM corticosterine for 24 hours and assayed for 
luciferase activity. Results are expressed as fold enhancement by the PGC-1α constructs. Results in 
the absence of PGC-1α was set equal to 1.  
(C) Western blot showing the expression levels of the different PGC-1α constructs. 
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The SR-rich region, the E-rich region, and the RRM mediate PGC-1α dimerization 
No function had been assigned to the E-rich region of PGC-1α so far. Our lab found that 
PGC-1α can homodimerize via the C-terminal half in a yeast two-hybrid assay (Knutti et 
al., 2000). This prompted us to test whether the E-rich region forms the protein surface that 
mediates the homodimerization of PGC-1α. To narrow down the region required for the 
PGC-1α homodimerization, we performed a yeast two-hybrid interaction assay with amino 
acids 294-798 of PGC-1α fused to the GAL4 DBD and the PGC-1α deletion constructs 
used in the previous experiments fused to the GAL4 AD (Fig. 3.2A). As shown in figure 
3.2B, coexpression of amino acids 294-798 of PGC-1α fused to the GAL4 DBD and full 
length PGC-1α fused to the GAL4-AD led to a nice induction of the GAL4-responsive β-
galactosidase reporter. As mentioned above, deletion of PGC-1α amino acids 409-798 in 
the GAL4-AD-fusion construct completely abolished the interaction with the bait 
construct.   Also, deletions of the SR-rich, the E-rich region, or the RRM strongly reduced 
the ability of PGC-1α to homodimerize, while constructs ∆6 and N754 still allowed 
dimerization. Having shown this, we wanted to know if a PGC-1α fragment encompassing 
the SR-rich, E-rich, and RRM regions is sufficient for interaction with the bait construct. 
Figure 3.2B shows that a fragment of PGC-1α encompassing those three domains is indeed 
sufficient for interaction with the bait construct. We also tested the interaction of a 
fragment containing the SR-rich, E-rich, and RRM domain fused to the GAL4-DBD with 
either full length PGC-1α or only a fragment containing the SR-rich, E-rich, and RRM 
domains fused to the GAL4-AD. The results confirmed that the region of PGC-1α 
encompassing the SR-rich, E-rich, and RRM domains is indeed sufficient for dimerization 
(Fig. 3.2B). Since the SR-rich, the E-rich, and RRM regions are all required for the 
homodimerization of PGC-1α, but only the deletion of the E-rich region significantly 
reduces the ability of PGC-1α to coactivate the GR in the transient transfection 
experiments, we conclude that lack of dimerization is not sufficient to explain the reduced 
coactivator activity of a PGC-1α construct lacking the E-rich region. Thus one or several 
other functions must be encoded by the E-rich region that are required for the full activity 
of PGC-1α in the transient transfection assays.  
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Figure 3.2. Mapping of the PGC-1α dimerization domain.  
(A) Yeast strain GC187 carrying a GAL4-responsive b-galactosidase reporter was transformed 
with a plasmid expressing a fusion of the yeast GAL4-DBD to amino acids 294-798 of PGC-1α 
and a plasmid expressing the GAL4-AD, either alone, or fused to one of the indicated PGC-1α 
deletion constructs.  
(B) Same as in A, exept that a PGC-1α fragment encompassing the SR-rich, E-rich, and RRM 
domains fused to the GAL4-DBD was used as bait. 
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Identification of proteins interacting with the C-terminal domains of PGC-1α 
The coactivators CBP, SRC-1, and several transcription factors were known to interact 
with PGC-1α at the beginning of these studies. All these proteins make contact with N-
terminal activation domain or the L-motif L2 of PGC-1α. We knew that the C-terminal 
domains of PGC-1α are important for full transcriptional activity PGC-1α in certain 
experimental setups (Fig. 3.1). Since no proteins were known to interact with the C-
terminal domains of PGC-1α and could point to a function of this part of the protein, we 
decided to perform a yeast two-hybrid screen to identify proteins interacting with the C-
terminal part of PGC-1α. The yeast strain AH109 (Clontech) was chosen for this screen, 
because it harbors four different GAL4-regulated reporter constructs that allow to detect 
and measure protein-interaction. The next step was to construct a GAL4-DBD fusion of a 
PGC-1α fragment, for which we wanted to find  interacting proteins. Such a bait construct 
had to fulfill several criteria: (i) since the goal was to identify proteins interacting with the 
C-terminal domains of PGC-1α, the bait construct had to contain those PGC-1 domains, 
(ii) the PGC-1α domains fused to the GAL4-DBD should be in a conformation that would 
allow specific interactions, (iii) the bait construct should not significantly activate the 
reporter constructs by itself. To find a bait construct that fulfills these criteria, expression 
vectors for five different PGC-1α fragments [91C (aa 91-798), 189C (aa 189-798), 294C 
(aa 294-798), 408C (aa 408-798), and 506C (aa 506-798)] fused to the GAL4 DBD were 
constructed. They all contain the C-terminal half of PGC-1α and therefore fulfill the first 
criteria. To test for their ability to activate transcription of the GAL4-regulated HIS3 
reporter, they were transformed into yeast strain AH109 along with the empty library 
vector (pACT2) and spotted on medium selecting for the induction of the GAL4-regulated 
HIS3 reporter. All five bait constructs contained some residual transcription activation 
activity, indicated by the appearance of small yeast colonies after a few days. The chemical 
compound 3-amino-triazole (3-AT) can be used to inhibit small amounts of His3p protein 
resulting from weak transcriptional activity of the GAL4 fusion proteins used as bait. We 
tested different 3-AT concentrations and found that we could inhibit the growth of small 
colonies due to background transcriptional activity of the bait constructs 189C, 294C, and 
506C with 3-AT concentrations of 15 mM or higher. It was not possible to inhibit the 
background transcriptional activities of the bait-constructs 91C, and 408C by 3-AT 
sufficiently. To test for a correct conformation of the five bait constructs, they were 
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transformed into yeast strain AH109 along with the empty library vector (pACT2) or an 
expression vector for a fusion of full length PGC-1α to the GAL4 activation domain 
(pACT2/HA-PGC-1) and plated on medium selecting for the induction of the GAL4-
regulated HIS3 reporter. Cotransformation of the five bait constructs together with full 
length PGC-1α fused to the GAL4-AD allowed nice growth of the yeast cells, which is an 
indication for a dimerization of PGC-1α and therefore a correct conformation of all five 
bait-constructs. Based on the background activities of the tested GAL4-DBD-PGC-1α 
fusions, we decided to use the constructs 294C and 506C as baits for the yeast two-hybrid 
screen.  
 
Having found convenient bait constructs and the appropriate screen conditions, we had to 
decide what tissue we wanted to screen for PGC-1α-interacting proteins. Since PGC-1α 
seems to be highly expressed in skeletal muscle, proteins that cooperate with PGC-1α in 
the regulation of transcription should be expressed in this tissue as well (Esterbauer et al., 
1999; Knutti et al., 2000; Puigserver et al., 1998). We therefore decided to screen a skeletal 
muscle library fused to the GAL4 AD (Clontech) for PGC-1α-interacting proteins. In a 
first round of transformation, we cotransformed yeast strain AH109 with the bait construct 
294C and the skeletal muscle cDNA library and plated them on growth medium selecting 
for protein interactions. In a second round of transformation, we used the bait construct 
506C. The first round of transformation resulted in approximately 150000 transformant. 
The first 210 colonies that grew on the plates were picked and restreaked on selective 
medium. The second round of transformation resulted in approximately 1 million 
transformants. The first 250 colonies that grew were picked and restreaked on selective 
medium. The library plasmids from the picked colonies were isolated, amplified, 
retransformed into the yeast strain AH109 together with the respective bait construct, and 
spotted on the same medium that was used for the screen. This procedure eliminated about 
half of the isolated clones as false positives. The positive clones were transformed into the 
yeast strain CG187 [CG1945 x Y187 (Clontech)] together with the bait construct 294C or 
506C and analyzed for the expression of the GAL4-responsive β-galactosidase reporter. 
Around 400 nucleotides of the cDNA-inserts of 80 positive clones were sequenced and 
blasted against the NCBI database to determine the identity of the isolated cDNAs.  
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Identified proteins 
Table 3.1 lists the names of the proteins identified in the screen and how many times their 
encoding cDNAs were isolated. The isolated genes are grouped according to their function. 
The largest group consists of proteins that have been implicated in the regulation of gene 
expression. A second group is formed by proteins implicated in pre-mRNA processing. 
The identification of these proteins is in agreement with a report attributing such a function 
to PGC-1α (Monsalve et al., 2000). A third group consists of proteins that have a 
connection to ubiquitin- or SUMO-related processes. The remaining identified proteins 
have either structural roles (fourth group) or are implicated in processes other than the 
proteins of the first four groups. The following section briefly describes some of the 
identified proteins.   
 
 
Group 1: Proteins implicated in transcriptional regulation 
 
NRF-1 is a transcription factor that has been shown to interact with PGC-1α in previous 
studies (Wu et al., 1999).  
 
ERRα is a member of the nuclear receptor family of transcription factors and was already 
known to interact with PGC-1α (Schreiber et al., 2003). The identification of ERRα in this 
screen could not be expected, since the region of PGC-1α that contains the L-motifs 2 and 
3 and mediates the interaction with ERRα was not present in the bait constructs. This 
suggests that ERRα also interacts with a region of PGC-1α other than the L-motifs.  
 
Tip60 was first identified as protein interacting with the HIV-1 Tat transactivator (Kamine 
et al., 1996). It has been shown to act as a positive and also as a negative transcriptional 
coregulator of steroid receptors and other families of transcription factors. Tip60 has 
acetyltransferase activity and is part of a large protein complex with ATPase and DNA 
helicase activities (Ikura et al., 2000). 
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Skip/NCoA-62 has been identified as an interacting protein of the protooncogene SKI and 
as a transcriptional regulator in a variety of signal transduction pathways including TGF-β, 
nuclear receptors, Notch, and retinoblastoma signaling (Dahl et al., 1998; Figueroa and 
Hayman, 2004a; Leong et al., 2001; Prathapam et al., 2002). However, Skip has also been 
identified in purified spliceosomal complexes (Neubauer et al., 1998). A possible role of 
SKIP in the process of pre-mRNA splicing is supported by the demonstration that human 
Skip can functionally substitute for the mRNA splicing gene PRP45 of S. cerevisiae 
(Figueroa and Hayman, 2004b). Thus, this protein also belongs to the group 2 of the 
identified PGC-1α interacting proteins. 
 
HPIP is an interacting protein of the homeodomain transcription factor PBX1. HPIP and 
PBX1 are thought to regulate transcription (Abramovich et al., 2002; Abramovich et al., 
2000). 
 
TSPYL was cloned based on its sequence similarity to TSPY, a member of the 
TSPY/SET/NAP1L1 family of nucleosome assembly proteins (Vogel et al., 1998). 
Members of this protein family have been shown to assemble chromatin during cell 
division but also to regulate transcription. Their ability to bind histone proteins and their 
interaction with transcriptional coactivators, such as p300, has led to the hypothesis that 
they may act as integrators between chromatin and transcriptional coactivator proteins 
(Shikama et al., 2000). 
 
 
Group 2: Proteins implicated in the regulation of pre-mRNA processing 
 
Clk1, Clk3, and Clk4 are three closely related dual-specificity kinases. Members of this 
family of proteins have been shown to regulate splicing, possibly by interacting with and 
phosphorylating a series of SR-domain splice factors (Colwill et al., 1996; Duncan et al., 
1997; Duncan et al., 1998; Hartmann et al., 2001; Prasad et al., 1999).  
 
HM-1 is another protein with a putative role in pre-mRNA splicing. It has been identified 
as a single-strand DNA-binding protein. The aminoterminal half of HM-1 displays high 
amino acid sequence similarity with the U1-70K splicing factor a component of the U1 
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snRNP complex. The C-terminal half of HM-1 includes several Arg/Glu, Arg/Asp, and 
Arg/Ser dipeptides, which are often found in splicing factors (Adams et al., 1998). 
 
SAF-B was first isolated as a protein that binds to scaffold/matrix attachment regions, i.e. 
DNA-sequences that mediate the anchoring of chromatin to the nuclear matrix. It harbors 
domains characteristic of RNA-processing proteins, interacts with RS-containing splicing 
factors and hnRNPs, and can alter splice site selection in vivo (Arao et al., 2000; Li et al., 
2003; Nayler et al., 1998; Nikolakaki et al., 2001; Renz and Fackelmayer, 1996; Weighardt 
et al., 1999). Like the above described Skip, SAF-B is involved in both splicing regulation 
and also transcription regulation. SAF-B has been shown to bind to and regulate the 
HSP27 promoter (Oesterreich et al., 1997). 
 
 
Group 3: Proteins playing a role in ubiquitination of SUMOylation 
 
hHR23A, one of two human homologues of the yeast Rad23 protein, has two UBA 
(ubiquitin-associated) domains, both of which can bind ubiquitin. It also contains an N-
terminal UBL (ubiquitin-like) domain that binds S5a and S2, two components of the 26S 
proteasome, suggesting that hHR23A is involved in the delivery of polyubiquitinated 
proteins to the proteasome (Arao et al., 2000; Li et al., 2003; Nayler et al., 1998; 
Nikolakaki et al., 2001; Renz and Fackelmayer, 1996; Weighardt et al., 1999). 
 
USP25 is a protein with high homology to members of the ubiquitin protease family 
(UBP). UBPs belong to a complex family of deubiquitinating enzymes that specifically 
cleave ubiquitin conjugates on a great variety of substrates. These enzymes have an 
essential role in protein degradation via the 26S proteasome and thus regulate many 
cellular pathways (Valero et al., 2001; Valero et al., 1999).  
 
UBE2I, also known as UBC9, and PIASx stimulate the attachment of SUMO (small 
ubiquitin-like modifiers) to target proteins by acting as the E2 conjugating enzyme and the 
E3 ligase, respectively. Many different proteins, among them nuclear receptors and nuclear 
receptor coactivators have been suggested to be SUMOylated by UbE2I and PIASx 
(Kotaja et al., 2002; Ohshima et al., 2004; Tian et al., 2002). 
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Interestingly, some of these proteins cannot be clearly grouped into one of the above 
groups. For example, Skip is an abundant protein of spliceosomes but can also coactivate 
the nuclear receptor VDR. Similarly, SAF-B can affect alternative splicing, but also 
influence the transcriptional activity of the estrogen regulated HSP27 promoter. Given that 
many of these proteins have not been extensively studied, the classification presented 
above may change upon further characterization. 
 
 
Confirmation of the interactions identified in the two-hybrid screen 
To determine which of the proteins identified in the yeast two-hybrid screen are likely to 
interact with PGC-1α, we tested their ability to bind PGC-1α in an in vitro binding assay. 
An in frame GST-fusion of PGC-1α and GST control protein alone were expressed in 
bacteria, bound to glutathione beads and incubated with the candidate proteins, which had 
been in vitro translated and [35S]methionine-labeled. As shown in Figure 3.3A, all tested 
proteins except for PIASx bound to GST-PGC-1α but not to control GST alone, 
confirming the interactions found in the yeast two-hybrid screen. To test if the proteins 
identified in the yeast two-hybrid screen are also able to form stable complexes with PGC-
1α in mammalian cells, we performed co-immunoprecipitation experiments with a selected 
subset of the identified protein. I focused on proteins having proposed functions in the 
regulation of gene transcription or the regulation of splicing. Using the polymerase chain 
reaction, we amplified the complete open reading frames of Clk1, HM-1, Tip60α, Tip60β, 
and Skip and cloned them into mammalian expression vectors. To be able to detect the 
translation products of those genes, a double Flag-tag was inserted in frame upstream of 
the first ATG codon of each cDNA. COS7 cells were transfected with each of the five 
proteins alone, with PGC-1α alone, or cotransfected with PGC-1α and each of the five 
proteins. Protein complexes containing the PGC-1α-interacting proteins were 
immunoprecipitated using anti-Flag sepharose and analyzed by western blot for the 
presence of PGC-1α. As shown in figure 3.3B, only immunoprecipitation of Tip60α and 
Tip60β reproducibly coimmunoprecipitated a significant percentage of the PGC-1α 
protein. This coimmunoprecipitation of PGC-1α was specific, since no PGC-1α was 
detected in the absence of overexpressed Tip60α or Tip60β. No PGC-1α could be detected 
that coimmunoprecipitated with Clk1, HM-1 or Skip ( data not shown). The strong 
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interaction of PGC-1α and the two Tip60 splice forms prompted us to study the functional 
interaction of those proteins in more detail. The results are described and discussed in the 
next chapter.  
 
The fact that not all tested proteins interacted with PGC-1α in vitro or in the 
coimmunoprecipitation assays does not mean that they would not interact with PGC-1α 
under different conditions. Further experiments will be necessary to find a possible 
interaction between these proteins and PGC-1α. It will also be interesting to determine 
whether PGC-1α interacts with one of the proteins of groups four and five, which do not 
have an obvious functional connection to PGC-1α. Demonstration of an interaction 
between one or several of these proteins with PGC-1α may identify new biological 
functions of PGC-1α.  
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Figure 3.3. Interaction between PGC-1α and identified proteins in vitro and in vivo .  
(A) GST-pulldown experiments confirm interactions found in the yeast two-hybrid screen. Control 
GST protein alone or PGC-1α fused to GST were immobilized on glutathione agarose beads and 
incubated with different in vitro-translated and [35S]-methionine-labeled proteins. After the beads 
were washed, bound proteins were eluted, resolved by SDS-PAGE and visualized by 
autoradiography.  
(B) PGC-1α forms a complex with Tip60α and Tip60β in mammalian cells.  
COS7 cells were transfected with the indicated proteins. 40 h after transfection, cell lysates were 
prepared and subjected to immunoprecipitation using anti-Flag agarose. Purified protein complexes 
were resolved by SDS-PAGE and analysed by western blot using anti-Flag and anti-PGC-1α 
antibodies. 
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Abstract 
The transcriptional coactivator PPAR gamma coactivator 1 alpha (PGC-1α) is a key 
regulator of metabolic processes such as mitochondrial biogenesis and respiration in 
muscle and gluconeogenesis in the liver. We describe here the identification of the MYST-
family acetyltransferase Tip60 as a PGC-1α-interacting protein. Tip60 has been shown to 
be a positive and negative coregulator for many transcription factors such as nuclear 
receptors, p53, c-myc, and others. We mapped the interaction surface for Tip60 to a region 
encompassing amino acids 482-565 of PGC-1α. In previous studies, this domain has also 
been shown to mediate the interaction of PGC-1α with nuclear respiratory factor 1 (NRF-
1). Overexpression of Tip60 by transfection or by infection using adenoviral vectors 
repressed the PGC-1α-dependent expression of all exogenous reporter constructs and 
endogenous genes tested. We also found that PGC-1α enhances expression of the 
endogenous cell cycle regulator p21, whose expression has previously been shown to be 
enhanced by Tip60. The PGC-1α-dependent induction of p21 was strongly reduced by the 
expression of Tip60 lacking acetyltransferase activity or by siRNA-mediated knock-down 
of endogenous Tip60, suggesting a requirement for the Tip60 acetytransferase activity in 
the PGC-1α-dependent transcription of p21. Our results also suggest a gene specific 
functional interaction between PGC-1α and Tip60. 
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Introduction 
Proteins regulating gene expression have to integrate information from many different 
signaling pathways to adjust the amount of a specific gene product to the physiological 
conditions. Alterations in gene expression are in many cases regulated by changes in the 
amount or the activity of DNA-binding transcription factors but also transcriptional 
coactivators. The transcriptional coactivator PGC-1α was originally cloned as an 
interacting protein of the nuclear receptor PPARγ in a yeast two-hybrid screen, and as a 
protein to enhance GR signaling in a functional screen (Knutti et al., 2000; Puigserver et 
al., 1998). It has been shown to interact and coactivate several members of the nuclear 
receptor family, as well as other transcription factors (Boustead et al., 2003; Delerive et al., 
2002; Hentschke et al., 2002; Knutti et al., 2000; Michael et al., 2001; Oberkofler et al., 
2003; Schreiber et al., 2003; Tcherepanova et al., 2000; Vega et al., 2000; Wu et al., 1999). 
The expression PGC-1α is induced in a tissue selective manner and in response to 
metabolic needs. Exposure to cold leads to the induction of PGC-1α in brown fat and in 
muscle (Puigserver et al., 1998), starvation induces PGC-1α expression in heart and liver 
(Herzig et al., 2001; Yoon et al., 2001), and physical exercise upregulates the expression of 
PGC-1α in muscle (Baar et al., 2002; Goto et al., 2000; Norrbom et al., 2004; Pilegaard et 
al., 2003). Under these condtions PGC-1α induces the expression of genes that increase the 
ability of cells to mobilize and utilize stored energy (Barbera et al., 2001; Herzig et al., 
2001; Lehman et al., 2000; Vega et al., 2000; Wu et al., 1999; Yoon et al., 2001). PGC-1α 
contains a transcriptional activation domain in the N-terminal 200 amino acids (Knutti et 
al., 2000). The binding sites for serveral transcription factors resides in the central part of 
PGC-1α (aa 200-465). The C-terminal 350 amino acids of PGC-1α harbor two SR-rich 
regions and and RNA recognition motif, which have been shown to be important for RNA 
processing by PGC-1α (Monsalve et al., 2000).   
 
Tip60, a protein localized mainly to the nucleus, is a member if the MYST family of 
acetyltranferases, which are highly conserved from yeast to humans. Two splice variants 
have been identified, Tip60α and Tip60β, resulting from differential splicing of exon 5 
(Ran and Pereira-Smith, 2000; Sheridan et al., 2001). Tip60 can acetylate histones, as well 
as transcritpion factors, such as AR and UBF1, suggesting a role of Tip60 in chromatin 
remodeling and regulation of gene expression (Gaughan et al., 2002; Halkidou et al., 2004; 
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Kimura and Horikoshi, 1998; Yamamoto and Horikoshi, 1997). Indeed, it acts as a 
cofactor for a variety of transcription regulators, like HIV-1 Tat (Kamine et al., 1996), 
nuclear receptors (Brady et al., 1999), p53 (Doyon et al., 2004), and the cytoplasmic 
domain of APP complexed to Fe65 (Cao and Sudhof, 2001).  On the other hand, Tip60 has 
been shown to act as a repressor of the transcritipional factors CREB, STAT3, TEL, and 
E2F (Gavaravarapu and Kamine, 2000; Nordentoft and Jorgensen, 2003; Taubert et al., 
2004; Xiao et al., 2003). Tip60 and its yeast homologue Esa1p have both been linked to 
DNA double strand break repair (Bird et al., 2002; Ikura et al., 2000). DNA damage 
response is mediated in part by the transcription factor p53. Tip60 has recently been shown 
to enhance the transcription of p53 target genes after gamma-irradiation (Doyon et al., 
2004). Tip60 also interacts with plasma membrane associated receptors for IL-9 and 
endothelin, suggesting a role in the signal transduction in response to extracellular stimuli 
(Lee et al., 2001; Sliva et al., 1999). 
 
We describe here the identification of Tip60α and Tip60β as PGC-1α-interacting proteins. 
We map the binding site for Tip60α to a region between amino acids 482-565 of PGC-1α. 
We show that overexpression of Tip60 by transfection or by infection using adenoviral 
vectors repressed the PGC-1α-dependent expression of several exogenous reporter 
constructs and the endogenous PGC-1α target genes ERRα and cytochrome c. This 
repressive effect of Tip60 depended partially on its acetyltransferase activity. We also 
found that PGC-1α enhances p53-dependent expression of the endogenous cell cycle 
regulator p21 after gamma-irradiation. This PGC-1α-mediated transcription was not 
affected by overexpression of wildtype Tip60, but was dramatically reduced by the 
expression of a Tip60 lacking acetyltransferase activity or by siRNA-mediated knock-
down of endogenous Tip60, suggesting a requirement for Tip60 and its acetytransferase 
activity in the PGC-1α-dependent transcription of p21.  These results demonstrate that 
Tip60 can cooperate with PGC-1α in gene expression, but that Tip60 can also negatively 
regulate the transcriptional activity of PGC-1α. 
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Experimental Procedures 
Plasmids and Adenoviral Vectors 
In frame fusions of amino acids 294-798 or 506-798 of PGC-1α to the yeast GAL4-DBD 
used for the two-hybrid screen were generated by cloning either StuI/SalI or NcoI/SalI 
fragments from pBS/HA-hPGC-1α (Knutti et al., 2000) into pGBKT7 (Clontech). PGC-1α 
variants ∆6, ∆SR/E/RRM, 409C, N482, N565, N754, 565-754, 294-565, and 341-565 used 
in the yeast two-hybrid interaction assay were generated by standard PCR methods in 
pBS/HA-hPGC-1α (Knutti et al. 2000) and verified by sequencing. Deletion variants 
294C, N408 have been described (Knutti et al. 2000). All PGC-1α deletion contructs were 
cloned into pGADT7 (Clontech) in frame behind the yeast GAL4 activation domain. 
Expression plasmids pcDNA3/HA-hPGC-1 (Knutti et al., 2000) and p6RGR (Godowski et 
al., 1988) as well as the luciferase reporter constructs pTAT3-luc (Iniguez-Lluhi et al., 
1997), pGK-1 (Webb et al., 1995) have been described. To construct the luciferase reporter 
pERRα-Luc, the ERRα-responsive sequences of the ESRRA promoter (nt –537 to –829 nt, 
relative to transcription initiation site) were amplified by PCR and subcloned upstream of 
the minimal alcohol dehydrogenase promoter of pLuc. To make pcDNA3/GAL4DBD-
hPGC-1α.91C, a DNA sequence coding for amino acids 91-798 of PGC-1α was subcloned 
in frame behind the GAL4-DBD of plasmid pcDNA3/GAL4DBD (Kressler et al., 2002). 
All Tip60 expression vectors are derived from plasmids pBS/2xFlag-Tip60α and 
pBS/2xFLAG-Tip60β, which carry the Tip60α and Tip60β cDNAs downstream of the 
2xFlag epitope-encoding sequence. To make pBS/2xFlag-Tip60β, the Tip60β open reading 
frame was PCR-amplified using the positive yeast two-hybrid cDNA clone as template and 
primers CGA ATT  CAT ATG GCG GAG GTG GGG GAG ATA ATC GAG and GAC 
TGA CTC GAG TCA CCA CTT CCC CCT CTT G and then cloned as NdeI/XhoI 
fragment into pBS/2xFLAG. The same primers were used to obtain full length Tip60α 
from HepG2 cDNA. The Tip60 acetyltransferase mutant (Q377E, G380E) was generated 
by standard PCR methods. All Tip60 variants were verified by sequencing and were cloned 
into pcDNA3 (Clontech) (BamHI/NotI), pGBKT7 (Clontech) (NdeI/SalI), pcDNA3/VP16 
(BamHI/NotI), pGEX-4T-3 (Pharmacia) (BamHI/SalI), and pAdlox (BamHI/XhoI). More 
information on the plasmids is available on request. Adenoviral vectors for HA-PGC-1α 
and GFP have been described (Schreiber et al., 2003). Flag-tagged Tip60α and 
Tip60α.377/80E expressing adenoviruses were constructed by the same method. 
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Oligonucleotide pairs GAT CCC CAC GTC TGG ATG AAT GGG TGT TCA AGA GAC 
ACC CAT TCA TCC AGA CGT TTT TTG GAA A / AGC TTT TCC AAA AAA CGT 
CTG GAT GAA TGG GTG TCT CTT GAA CAC CCA TTC ATC CAG ACG TGG G 
and GAT CCC CGC CAC GAC GAC ATC GTC ACT TCA AGA GAG TGA CGA TGT 
CGT CGT GGC TTT TTG GAA A / AGC TTT TCC AAA AAG CCA CGA CGA CAT 
CGT CAC TCT CTT GAA GTG ACG ATG TCG TCG TGG CGG G were annealed and 
cloned into pAdSUPER (Schreiber et al., 2003). The resulting plasmids 
pAdSUPER/Tip60-4 and pAdSUPER/Tip60-19 were used for the generation of adenoviral 
vectors expressing siRNAs for Tip60. 
 
Yeast two-hybrid screening 
Yeast strain AH109 (Clontech) was transformed with pGBKT7/hPGC-1α.294C or 
pGBKT7/hPGC-1α.506C and a human skeletal muscle cDNA library according to the 
lithium acetate method and then plated on selection medium (SD –Trp, -Leu, -His, -Ade, 
15 mM 3-AT). Library plasmids from 401 positive clones were recovered and reintroduced 
into yeast strain AH 109 to confirm the specificity of the interactions. Strength of the 
interactions was determined by measuring β-galactosidase activity in yeast strain CG 187 
(CG1945 x Y187 (Clontech)). 80 Positive clones were sequenced using an ABI prism 
sequencer.  
 
Protein interaction assays 
GST-fusion proteins expressed in E. coli were purified on glutathione beads. 
[35S]methionine-labelled PGC-1α was produced with the TNT reticulocyte lysate in vitro 
transcription and translation kit (Promega) with pcDNA/HA-PGC-1α as template. About 1 
µg of GST , GST-Tip60α, or GST-Tip60β bound to the glutathione beads were mixed with 
5 µl of in vitro translated PGC-1α in binding buffer containing 20 mM Tris, pH8, 75 mM 
KCl, 3 mM MgCl2, 1 mM EDTA, 10 % glycerol, 0.05 % NP-40, 1 mM PMSF, and 
protease inhibitors. After binding for 1 hour at room temperature, the beads were washed 
three times with binding buffer. Bound proteins were then released in SDS-sample buffer 
and resolved by SDS-PAGE. The gel was dried and bound PGC-1α was detected by 
autoradiography.  
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Yeast two-hybrid interaction assay 
Plasmids expressing GAL4 DBD and GAL4 AD fusions were introduced into yeast diploid 
cells (CG1945 X Y187; Clontech), which carry a GAL4-driven his3 reporter. 
Transformants were grown in 96 well plates, washed once with water, and diluted to an 
OD600 of 0.1. Five microliters of each yeast culture were spotted on SD medium lacking 
Trp and Leu to check for viability of the yeast cells and on SD medium lacking Trp and 
Leu as well as His and containing 5 mM 3-aminotriazol to select for protein-protein 
interactions.    
 
Cell Lines, Infections, and Transfections 
COS7, SAOS2-GR(+) (Rogatsky et al., 1997) and U2OS cells were grown in Dulbecco’s 
modified Eagle’s medium supplemented with 9% fetal calf serum. For SAOS2-GR(+) 
cells, charcoal stripped serum was used and the medium was supplemented with 200mg/ml 
G418. For infection, 1.5 x 105 cells per well in a six-well dish or  106 cells per 10 cm dish 
were plated. Cells were infected with viruses at a multiplicity of infection as indicated in 
the figure legends. 2 hr later, cells were washed and replenished with fresh media. For 
transfections, cells were incubated with a calcium phosphate/DNA precipitate. 
Transfections included 200 ng of p6R-lacZ for normalization of transfection efficiency. 
Cell lysates were prepared 40 hr after transfection and assayed for luciferase and β-
galactosidase activity. Luciferase values normalized to the β-galactosidase activity are 
referred to as luciferase units.   
 
Western blot analysis  
Protein extracts of SAOS2-(GR+) cells were prepared in RIPA buffer containing 50 mM 
Tris-HCl pH 8, 150 mM NaCl, 1% Nonidet P-40, 1% sodium deoxycholate, 1 mM EDTA, 
0.1% SDS, 1 mM PMSF, protease inhibitors, and phosphatase inhibitors. Proteins were 
resolved by SDS-PAGE and transferred to nitrocellulose membranes. PGC-1α and Tip60 
were detected using an anti-PGC-1α antibody (Schreiber et al., 2003) or an anti-Flag 
antibody (Sigma), respectively.   
 
Co-immunoprecipitation 
Approximately 106 SAOS-GR(+) cells on a 10 cm dish were infected with adenoviruses 
expressing either GFP, HA-PGC-1α, 2xFlag-Tip60α or 2xFlag-Tip60α.mHAT. 24 h after 
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infection, cell extracts were prepared by incubating cells in 1 ml NP-40 lysis buffer (50mM 
Tris-HCl pH 8, 150 mM NaCl, 0.5 % NP-40, 1 mM EDTA, 1mM PMSF, protease 
inhibitors, phosphatase inhibitors) for 15 min. Extracts were spun at 14000 rpm for 10 min. 
The pellet was discarded. The extracts were precleared with a mixture of protein A/G 
sepharose beads. Extracts were incubated with anti-PGC-1α antibody (Schreiber et al., 
2003) for 2 hr followed by an incubation with a mixture of protein A/G sepharose beads 
for 1 hr. Beads were washed three times with lysis buffer. Immunocomplexes were 
resoloved by SDS-PAGE and transferred to a PVDF membrane. PGC-1α and Tip60 were 
detected using a-PGC-1α (Schreiber et al., 2003) and anti-Flag (Sigma) antibodies.   
 
RNA Analysis 
Total RNA was isolated using the TRIzol reagent (Invitrogen) and checked for its integrity 
by agarose gel electrophoresis and ethidium bromide staining. RNA (400 ng) was 
converted to cDNA using the Superscript Reverse Transcriptase Kit (Invitrogen) and 
random hexamer primers according to manufacturer’s instructions. Realtime PCR with the 
Chromo4 (MJ Research) was used for the amplification and quantitation of Cyt c, ERRα, 
p21, and GAPDH cDNA. PCR ractions were performed in 20 µl reaction using 2 µl 
cDNA, 500 nM specific primers, and the SYBRgreen kit (ABI). The sequences of the 
primers and the sizes of the products were: CCA GTG CCA CAC CGT TGA A (exon 2) 
and TCC CCA GAT GAT GCC TTT GTT (exon 3) for Cyt c (product 136 bp), AAG ACA 
GCA GCC CCA GTG AA (exon 4/5) and ACA CCC AGC ACC AGC ACC T (exon 6) 
for ERRα (product 254 bp), CGG GAT GAG TTG GGA GGA G (exon 1) and CGG CGT 
TTG GAG TGG TAG AA (exon 2) for p21 (product 212 bp), and GAA GGT GAA GGT 
CGG AGT C (exon 2) and GAA GAT GGT GAT GGG ATT TC (exon 4) for GAPDH 
(product 226 bp). A melting curve from 65°C to 95°C at the end of each reaction was used 
to check the purity and nature of the products. 
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Results 
Identification of Tip60 as a PGC-1α-interacting protein 
To identify proteins that cooperate with PGC-1α in gene expression or that regulate the 
activity of PGC-1α, we performed a yeast two-hybrid screen. A region of PGC-1α 
encompassing residues 294-798 fused to the GAL4-DBD was used to screen a human 
skeletal muscle cDNA expression library fused to the GAL4-activation domain for PGC-
1α interacting partners. Clone 15 interacted specifically with GAL4-PGC-1α.294-798, 
since no interaction was observed with the GAL4-DBD alone. Sequence analysis of clone 
15 revealed a 100% identity to Tip60β, a splice variant of the MYST family 
acetyltransferase Tip60α. We tested the interaction of clone 15, full length Tip60α, and 
Tip60β with PGC-1α.294-798 in a quantitative yeast two-hybrid assay. As shown in figure 
4.1A, clone 15, Tip60α, and Tip60β interacted with PGC-1α. To confirm the interaction 
between PGC-1α and Tip60 found in the yeast two-hybrid system, we performed in vitro 
binding assays. GST-fusions of Tip60α and Tip60β were immobilized on glutathione 
sepharose beads and incubated with in vitro translated, [35S]methionone-labeled PGC-1α. 
As shown in figure 4.1B, PGC-1α associates with GST-Tip60α and GST-Tip60β, but fails 
to bind to the control GST protein. We next wanted to know whether PGC-1α and Tip60α 
form a complex in mammalian cells. To this end, we expressed a Gal4DBD fusion of 
amino acids 91-798 of PGC-1α and a VP16AD fusion of full length Tip60α in COS7 cells 
and tested for PGC-1α – Tip60α interaction using the mammalian two-hybrid assay. 
Figure 4.1C shows that coexpression of  the Gal4DBD-PGC-1α.91C and VP16AD-Tip60α 
lead to a higher expression of the GAL4 responsive luciferase reporter than coexpression 
of Gal4DBD-PGC-1α.91C and VP16AD alone, Gal4DBD and VP16AD-Tip60α, or 
Gal4DBD and VP16AD, suggesting a specific interaction between PGC-1α and Tip60α. 
To determine whether PGC-1α and Tip60α form a stable complex in mammalian cells, we 
infected SAOS2-GR(+) cells with adenoviruses expressing PGC-1α and Flag epitope 
tagged Tip60α. After 24 hours, cell extracts were prepared and immunoprecipitated with 
anti-PGC-1α antibody. Western blot analysis with anti-PGC-1α and anti-Flag antibody 
showed that Tip60 associates specifically with PGC-1α, since no Tip60 could be detected 
in the immunoprecipitate, when the cells were infected with GFP instead of PGC-1α (Fig. 
4.1D). 
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Figure 4.1. PGC-1α and Tip60 interact in vitro and in vivo. 
(A) Yeast two-hybrid strain GC187 was transformed with plasmids expressing GAL-DBD-PGC-
1α.294C and the GAL4-AD, either alone, fused to clone 15, Tip60α, or Tip60β and then assayed 
for β-gal activity. 
(B) COS7 cells were transfected with the GAL4 responsive luciferase reporter pGK-1 and the 
indicated plasmids. 40 h after infection, cells were assayed for luciferase activity. 
(C) Control GST alone or either Tip60α or Tip60β fused to GST were immobilized on glutathione 
sepharose beads and incubated with in vitro translated, [35S]-methionine labeled PGC-1α. After the 
beads were washed, bound PGC-1α was eluted, resolved by SDS-PAGE and visualized by 
autoradiography.  
(D) SAOS2-GR(+) cells were infected with the indicated combinations of adenoviruses expressing 
GFP, HA-PGC-1α, 2xFlag-Tip60α and Tip60α.mHAT at an moi of 10. 24h after infection, cell 
extracts were prepared and subjected to immunoprecipitation with anti-PGC-1α antibody. PGC-1α 
and Tip60 were detected by western blot using anti-PGC-1α and anti-Flag antiserum respectively.  
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Mapping of the Tip60 interaction domain in PGC-1α 
To map the region of PGC-1α required for the interaction with Tip60α, a yeast two-hybrid 
assay was performed using full length Tip60α fused to the GAL4-DBD and either full 
length PGC-1α or PGC-1α deletion variants fused to the GAL4 AD shown in figure 4.2A. 
None of the GAL4AD-PGC-1α fusions activated the expression of the his3 reporter when 
coexpressed with the GAL4-DBD alone. To confirm that all GAL4-PGC-1α fusions are 
expressed, we checked the interaction of the C-terminal PGC-1α deletion variants with the 
GR-LBD fused to the GAL4-DBD and the interaction of the N-terminal PGC-1α deletion 
constructs with GAL4-DBD-PGC-1α.294C. Interaction of PGC-1α with the GR-LBD and 
PGC-1α homodimerization in a yeast two-hybrid assay have been described (Knutti et al., 
2000). Tip60α fused to the GAL4-DBD did not interact with the GAL4-AD but interacted 
with full length PGC-1α showing that Tip60α and PGC-1α interact independent of which 
of the two proteins is fused to the GAL4-DBD or the GAL4-AD (compare to Fig 4.1A). As 
shown in figure 4.2B, C-terminal truncations of PGC-1α up to amino acid 565 did not 
affect the growth of the yeast cells on the selective medium. Only yeast cells containing the 
PGC-1α construct N482 or N408 lost their ability to grow under the selective conditions. 
When we tested N-terminal PGC-1α truncations, we found that the first 408 amino acids of 
PGC-1α are dispensable for the interaction with Tip60α. When the PGC-1α constructs 
409C was tested, no interaction with Tip60α could be detected. These results suggest that 
amino acids 409-565 of PGC-1α contain a domain that is required for the interaction with 
Tip60α. We also tested three internal PGC-1α deletion constructs for the interaction with 
Tip60α. The only deletion in PGC-1α that completely abolished the interaction with 
Tip60α is ∆6, which lacks amino acids 409-565. This is in agreement with the results 
above. Unexpectedly, also PGC-1α construct ∆4 showed a strongly reduced interaction 
with Tip60α. This might be attributed to a unfavorable conformation of constructs ∆4, 
although the interaction with the GR-LBD does not seem to be disturbed by this deletion. 
Finally, we could show that amino acids 294-565 and even the amino acids 341-565 of 
PGC-1α are sufficient for the interaction with Tip60α, while a PGC-1α fragment 
harboring the SR and RRM domains could not interact with Tip60α. 
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Figure 4.2. Mapping of the Tip60α interaction domain in PGC-1α. 
(A) Schematic representation of the PGC-1α constructs fused to the GAL4-AD used for the yeast 
two-hybrid protein-protein interaction assay.  
(B) Indicated combinations of GAL4-DBD and GAL4-AD fusion-constructs were transformed into 
yeast strain CG187. Transformants were grown in liquid media overnight, washed in water and 
spotted on selective media containing 5 mM 3-aminotriazole and lacking histidine, tryptophan, and 
leucine. For the assay of the PGC-1α – GR-LBD interaction, the media contained 25 mM 
corticosterone. 
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Tip60a represses PGC-1a dependent gene expression.  
Since Tip60 can be a coactivator and harbors acetyltransferase activity, we next tested 
whether Tip60 cooperates with PGC-1α in PGC-1α-dependent gene regulation. For this, 
we first transfected COS7 cells with expression vectors for the glucocorticoid receptor 
(GR) and PGC-1α, along with a GR-responsive luciferase reporter, as well as expression 
vectors for Tip60α, Tip60β, and an acetyltransferase mutant of Tip60α (Tip60α.mHAT). 
40 hours post-transfection, cells were treated with 50 nM corticosterone for 4 hours and 
then lysed for luciferase assays. If Tip60 collaborated with PGC-1α, we would expect a 
positive effect on the PGC-1α-dependent expression of the luciferase reporter by 
overexpressed wildtype Tip60 and a negative effect by overexpressed Tip60 
acetyltransferase mutant. However, overexpression of both Tip60α and Tip60β markedly 
reduced PGC-1α transcriptional activity, while the Tip60 variant that has no 
acetyltransferase activity did not repress the PGC-1α transcriptional activity (Fig. 4.3A). 
We also performed similar experiments with two other luciferase reporter constructs. As 
shown in figure 4.3B, Tip60α also repressed the transcriptional activity of PGC-1α, when 
a luciferase reporter under control of the ERRα promoter was used. In contrast to the 
previous experiment, the Tip60α acetyltransferase mutant also repressed the PGC-1α 
activity, but to a lesser extend than wildtype Tip60α. Furthermore, we repeated the 
experiment with a third luciferase reporter under control of the cytochrome c promoter, 
which has been shown to be upregulated by PGC-1α. In this experiment both Tip60α 
wildtype and acetyltransferase mutant repressed the PGC-1α-dependent expression of the 
luciferase reporter to a similar extent (Fig. 4.3C). To show in a different assay that Tip60 
represses the transcriptional activity of PGC-1α, we assayed the expression of a luciferase 
reporter under control of GAL4-UAS by full-length PGC-1α fused to the GAL4-DBD with 
or without overexpressed Tip60α or Tip60α acetyltransferase mutant. As observed in the 
previous experiments, Tip60α strongly repressed the PGC-1α-dependent expression of the 
luciferase reporter (Fig. 4.3D). Also the Tip60α acetyltransferase mutant reduced the PGC-
1α transcriptional activity, but about 10 times less than wildtype Tip60α. The repressive 
effect of Tip60α on the PGC-1α transcriptional activity was specific, since overexpression 
of Tip60 did not affect the GAL4-VP16 dependent expression of the luciferase reporter 
(Fig. 4.3D). 
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Figure 4.3. Tip60 represses PGC-1α activity. 
(A) COS7 cells were transfected with a GR-responsive luciferase reporter TAT3-luc (100 ng), an 
expression plasmid for rat GR (100 ng), a PGC-1α expression vector (500 ng) or control vector 
pcDNA3, and  the indicated Tip60 constructs (1 µg). 40 h after transfection, cells were treated with 
50 nM corticosterone for 4 h and then assayed for luciferase activity. 
(B) COS7 cells were transfected with 100 ng of a luciferase reporter regulated by the ERRa-
promoter and vectors expressing PGC-1α (100 ng) and Tip60α (100 ng). Luciferase activity was 
measured 40 h post-transfection. 
(C) As in B, except, that cells were transfected with a luciferase reporter regulated by the 
cytochrome c promoter. 
(D) Transcriptional activities of PGC-1α or VP16 fused to the GAL4-DBD in the presence or 
absence of Tip60 were measured in COS7 cells using a luciferase reporter regulated by 5 copies of 
the GAL4-UAS. 50 ng of the GAL4-PGC-1α expression plasmid, 10ng of the GAL4-VP16, and 
100 ng of the Tip60 expression vectors were transfected. Luciferase activity was determined 40 h 
after transfection. 
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Tip60 represses PGC-1a-dependent expression of endogenous genes.  
We next asked, if Tip60 has also a repressive effect on the expression of endogenous PGC-
1α target genes. To test this, we infected SAOS2-GR(+) cells with adenoviruses 
expressing GFP, PGC-1α, Tip60α, and Tip60α.mHAT. Cells were infected with the Tip60 
viruses or the control virus expressing GFP on day one. The next day, cells were infected 
with the viruses expressing PGC-1α or GFP, respectively. We looked at the expression of 
cytochrome c and ERRα, two well established PGC-1α targets, under the different 
conditions. Overexpression of both Tip60α wildtype and acetyltransfease mutant almost 
completely prevented the PGC-1α-dependent induction of the cytochtome c mRNA, while 
there was a weaker but still significant inhibition of the ERRα mRNA induction (Fig. 
4.4A). Tip60α and the Tip60α acetyltransferase mutant did not significantly reduce the 
Cyt c and ERRα mRNA level in the absence of PGC-1α, showing that the repressive effect 
was specific for PGC-1α. Figure 4.4B shows that the expression levels of PGC-1α are not 
reduced by the overexpression of Tip60. 
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Figure 4.4. Tip60α and Tip60α.mHAT repress PGC-1α dependent gene expression. 
(A) SAOS2-GR(+) cells were infected with adenoviruses expressing either GFP, 2xFlag-Tip60α or 
2xFlag-Tip60α.mHAT at an moi of 50. 24 hours later, cells were infected with adenoviruses 
expressing GFP or HA-PGC-1α at an moi of 30. Another 24 hours later, RNA was isolated, and 
mRNA levels of Cyt c and ERRα were analysed by quantitative PCR, normalized to GAPDH and 
expressed relative to levels in cells infected with GFP alone. (* : p-value < 0.05, ns: non 
significant) 
(B) SAOS2-GR(+) cells were infected as described in A. Protein extracts were prepared 24 
hours after the infection with PGC-1α adenovirus and subjected to western blot analysis. 
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PGC-1α induces the expression of endogenous Tip60-regulated genes 
Tip60 has been shown to enhance the expression of p21 through p53 after gamma-
irradiation (Doyon et al., 2004). This effect was shown to depend on the acetyltransferase 
activity of Tip60. To test if PGC-1α can enhance the expression of p21, we transfected 
U2OS cells with adenoviruses expressing GFP or PGC-1α. 24 after infection, the cells 
were irradiated with 10 Gy for 17 minutes to induce the p53-dependent expression of p21. 
As shown in figure 4.5A, PGC-1α enhanced the expression of p21. The induction of the 
p21 expression by PGC-1α was more pronounced after cells had been irradiated with 10 
Gy for 17 min.   
 
We then wanted to know whether PGC-1α and Tip60α act synergistically in the 
enhancement of p21 expression. To this end, U2OS cells were infected with adenoviruses 
expressing PGC-1α and Tip60α wildtype or the Tip60α variant lacking acetyltransferase 
activity. Like PGC-1α, also Tip60α induced the expression of p21 after irradiation of the 
cells (Fig. 4.5B). Surprisingly, also the Tip60 acetyltransferase mutant induced p21 
expression. Coexpression of Tip60 and PGC-1α did not lead to a higher expression of 21 
that expression of either protein alone. Interestingly, overexpression of the Tip60 
acetyltransferase mutant almost completely blocked the PGC-1α-dependent p21 
expression, suggesting a requirement for the Tip60 acetyltransferase activity in the 
induction of p21 by PGC-1α (Fig. 4.5B).  
 
Endogenous Tip60 is required for PGC-1α-dependent expression of p21 
To determine the role of endogenous Tip60 in PGC-1α-dependent expression of p21, we 
used adenoviruses expressing siRNA to reduce Tip60 mRNA levels in U2OS cells (Fig. 
4.5C). Two days later, the siRNA-treated or untreated U2OS cells were subsequently 
infected with adenovirus vectors encoding GFP or PGC-1α. As described above, PGC-1α 
expression led to increases in the levels of the endogenous p21 mRNAs. However, this 
induction by PGC-1α was dramatically inhibited in the cells treated with siRNA against 
Tip60, compared with the cells that were not exposed to the siRNA (Fig. 4.5C). Thus, 
endogenous levels of Tip60 contribute to the ability of PGC-1α to induce the expression of 
p21. 
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Figure 4.5. Tip60 is required for PGC-1α-mediated p21 expression. 
(A) U2OS cells in 12-well plates were infected with adenoviruses expressing GFP or PGC-1α. The 
next day, GFP- and PGC-1α-infected cells were irradiated with  10 Gy for 17 min. 5 h later, cells 
were harvested and the mRNA levels for the p21gene were determined by quantitative PCR and 
normalized to the levels of GAPDH mRNA.  
(B) U2OS cells were infected with adenoviruses expressing GFP, PGC-1α, Tip60α wild type, or 
Tip60α acetyltransferase mutant as shown in the figure. After the infection, cells were treated as 
described in (A). The mRNA levels for p21 was determined by quantitative PCR and normalized to 
the GAPDH mRNA levels. 
(C) U2OScells were infected with adenoviruses expressing siRNA against Tip60 (AdsiTip60) or an 
adenovorus expressing no siRNA (AdSUPER). Two day later, cells were infected with 
adenoviruses expressing GFP or PGC-1α. 24 h later, cells were irradiated as described in (A) and 
mRNA levels for p21 was determined by quantitative PCR and normalized to the GAPDH mRNA 
levels.  
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Discussion 
Gene transcription is in many cases regulated by the amounts of transcription factors that 
bind to regulatory sequences in the promoter region of specific genes. Identification and 
study of the nuclear receptor coactivator PGC-1α, a major regulator of metabolic functions 
in several tissues, demonstrates that the expression level of a single coactivator can lead to 
dramatic changes in gene expression and induce complete cellular programs. Expression 
levels of PGC-1α are induced by cold in brown fat and skeletal muscle, where it activates 
mitochondrial biogenesis and respiration. In the liver, PGC-1α is induced by fasting. This 
leads to increased mitochondrial β-oxidation of fatty acids and gluconeogenesis. Although 
the transcription activity of PGC-1α is regulated at the transcriptional level, recent work in 
our lab and by others has provided evidence for posttranslational regulation of this 
coactivator (Ichida et al., 2002; Knutti et al., 2001; Puigserver et al., 2001). Despite the the 
knowledge about PGC-1α that has accumulated over the past years, not much is known 
about the mechanisms that are used by PGC-1α to activate transcription. 
 
In this study we describe the identification of Tip60 as a PGC-1α-interacting protein in a 
yeast two-hybrid screen using amino acids 294-798 of human PGC-1α as bait. We then 
showed that PGC-1α interacts with both Tip60α and Tip60β. Using a yeast two-hybrid 
assay, we were able to narrow down the Tip60α binding surface to amino acids 482-565 of 
PGC-1α. This region of PGC-1α doesn’t contain any predicted motifs. The only function 
that has been assigned to this region is that it is important for the interaction of PGC-1α 
with the muscle specific transcription factor MEF2C (Michael et al., 2001). 
Overexpression of Tip60 using transient transfection or adenoviral vectors repressed PGC-
1α-dependent transcription. Tip60 was first described as coactivator of several 
transcription factors including nuclear receptors. Besides having positive effects on 
transcription, Tip60 has also been shown to act as a corepressor. This repressive effect has 
been attributed to the recruitment of histone deacetylases by Tip60 to promoters (Lee et al., 
2001; Xiao et al., 2003). We tried to block the inhibitory effect of Tip60 on the PGC-1α 
transcriptional activity by treating the cells with the deacetylase inhibitors TSA and 
nicotinamide. In the presence of those drugs Tip60 still repressed the PGC-1α activity, 
arguing against a involvement of histone deacetylases (data not shown). Tip60 has been 
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shown to be able to acetylate histones and other proteins like the androgen receptor. We 
constructed a Tip60 mutant (377E, 380E) that has lost its acetyltransferase activity. We 
found that this Tip60 mutant had in one case no effect on the PGC-1α transcriptional 
activity, in other cases a weaker effect that wild type Tip60, and in some experiments the 
same effect as wild type Tip60, depending on the experimental setup we used to measure 
the transcriptional activity of PGC-1α. Despite an obvious role for the acetyltransferase 
activity of Tip60 in the repression of PGC-1α-dependent transcription, we were not able to 
show conclusively that PGC-1α is acetylated by Tip60 (data not shown). 
 
We not only observed negative effects of Tip60 on the PGC-1α transcriptional activity. 
Our results suggest that PGC-1α is able to induce the expression of the p53 target p21. In 
contrast to our other results, Tip60 does not repress the PGC-1α-dependent expression of 
p21, instead, Tip60 seemed to be required for the induction of the p21 expression by PGC-
1α. Not only depletion of endogenous Tip60 by RNA interference blocked PGC-1α-
dependent expression of p21. A similar effect was achieved by the overexpression of a 
Tip60 variant lacking acetyltransferase activity. Since this Tip60 mutant might act as a 
dominant negative protein, our results suggest that the acetyltransferase activity of Tip60 is 
required for the expression of p21 by PGC-1α. Further experiments will be necessary to 
find out how PGC-1α enhances the expression of p21. Since Tip60 is able to induce the 
expression of p21 in the absence of PGC-1α, it is possible that PGC-1α is recruited to the 
p21 promoter by direct interaction with Tip60. In a second model, PGC-1α interacts 
directly with transcription factors on the promoter and then recruits Tip60 for the 
activation of p21. In such a scenario, Tip60 would be able to enhance the expression of p21 
in a PGC-1α-dependent and a PGC-1α-independent manner. 
 
A functional interaction between PGC-1α and Tip60 in the regulation of gene expression 
might be a valuable target for the treatment of metabolic disorders, like diabetes, caused by 
an aberrant activity of PGC-1α. We have shown, that the expression levels of Tip60 can 
have big effects on PGC-1α-dependent gene expression. It has been published that 
phosphorylation of Tip60 increases its acetyltransferase activity (Lemercier et al., 2003). It 
is therefore possible that posttranslational modifications of Tip60 change the degree, by 
which it influences the PGC-1α transcriptional activity. Furthermore, two reports describe 
Chapter IV: PGC-1α interacts with the acetyltransferase Tip60 
________________________________________________________________________ 
 80
an interaction of Tip60 with the integral membrane proteins IL9R and the endothelin 
receptor (Lee et al., 2001; Sliva et al., 1999). Therefore, activation of membrane associated 
hormone receptors may regulate the activity of PGC-1α, where Tip60 plays the messenger 
between the plasma membrane and the nucleus.  
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CHAPTER IV SUPPLEMENTARY DATA 
The C-terminal part of Tip60 interacts with PGC-1α 
To determine the domain of Tip60α that mediates the interaction with PGC-1α, we tested 
the N-terminal domain and the C-terminal domain of Tip60α for their ability to interact 
with PGC-1α in a GST-pulldown experiment. The N-terminal domain of Tip60 harbors a 
CHROMO-domain, while the C-terminal part contains the MYST-domain with the acetyl-
CoA binding motif (Fig. 1.1). As shown in figure S4.1B, in vitro-translated 
[35S]methionine-labeled PGC-1α interacted with GST-fusions of Tip60α and Tip60β, 
while it did not interact with control GST alone. Thus, consistent with our findings from 
the yeast two-hybrid assay in figure 4.1A, presence of the amino acids encoded in the 
alternatively-spliced exon 5, present only in Tip60α, was not required or did not 
significantly affect the interaction with PGC-1α. Amino acids 1-147 of Tip60α fused to 
GST were not able to pull down PGC-1α, while amino acids 148-513 of Tip60α interacted 
with PGC-1α to a similar extent as full length Tip60α or Tip60β (Fig. S4.1B). This lead us 
to the conclusion that the MYST domain or the region between the exon 5-encoded amino 
acids and the MYST-domain mediates the interaction with PGC-1α. Using the same assay, 
we also demonstrated that the two point-mutations in the acetyl-CoA binding motif that 
destroy the acetyltransferase activity do not significantly affect the interaction with PGC-
1α (Fig. S4.1B). 
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Figure S4.1. Mapping of PGC-1α-interaction domain in Tip60.  
(A) Schematic presentation Tip60 variants.  
Dark boxes indicate the Exon 5-encoded region and the MYST-domain with the acetyl-CoA 
binding motif. Asterixs indicate the Q377E and G380E mutations in the Tip60 acetyltransferase 
mutant. 
(B) PGC-1α interacts with the C-terminal part of Tip60. Control GST protein alone or GST-fusions 
of the Tip60 variants shown in A were bound to glutathione agarose and incubated for 1 hour with 
in vitro-translated [35S]-methionine-labeled PGC-1α. After the beads were washed, bound proteins 
were resolved by SDS-PAGE and visualized by autoradiography.  
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Effects of the Tip60 overexpression on PGC-1α expression 
We proposed that Tip60 can be a negative regulator of the transcriptional activity of PGC-
1α (chapter IV). To test the possibility that overexpression of Tip60 reduces PGC-1α-
dependent transcription just by reducing the expression levels of PGC-1α, we analyzed the 
protein levels of PGC-1α in the presence and absence of overexpressed Tip60 variants. 
COS7 cells were transfected with expression vectors for PGC-1α alone or together with 
different Tip60 variants. 40 hours after transfection, total cells extracts were prepared by 
boiling the cells in SDS-lysis buffer buffer. Western blot analysis revealed that the PGC-
1α protein levels were dramatically increased in the cells that overexpressed Tip60 (Fig. 
S4.2A). Only the Tip60 construct N147, which lacks the whole C-terminal part including 
the MYST domain, did not increase the PGC-1α levels. Since N147 was the only construct 
that did not interact with PGC-1α in vitro, this suggests that a direct interaction between 
PGC-1α and Tip60 is necessary for the Tip60-dependent increase in the PGC-1α protein 
levels. We also observed that the elevated levels of PGC-1α are accompanied by a 
appearance of a faster migrating PGC-1α species, which seems to be more abundant than 
the slower migrating form.  
 
To determine whether the increased PGC-1α levels caused by overexpressed Tip60 are due 
to an enhanced synthesis rate of PGC-1α or due to a prolonged half-life of PGC-1α, We 
performed a pulse-chase experiment in COS7 cells. As shown in figure S4.2B, the half-life 
of PGC-1α in the absence of overexpressed Tip60 is in the range of 1.5 hours, in 
agreement with a previous report (Puigserver et al., 2001). Overexpression of Tip60α did 
not significantly increase the levels of radioactively labeled PGC-1α at timepoint zero, 
arguing against an enhanced synthesis rate of PGC-1α. However, overexpression of 
Tip60α dramatically prolonged the half-life of PGC-1α to more than 4 hours. In this 
experiment, it was also apparent that Tip60α overexpression induces a faster migrating 
PGC-1α species.   
 
Analysis of PGC-1α protein in earlier studies (data not shown), did not show clear 
differences in the levels of PGC-1α in extracts from cells not overexpressing Tip60 and 
from cells overexpressing Tip60. The major difference of those experiments with the 
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experiments shown in figure S4.2A is that the cell extracts were prepared using an NP-40 
lysis buffer and that only the soluble fraction was analyzed. The fact that the elevated 
PGC-1α levels caused by the overexpression of Tip60 could only been seen in extracts 
with complete extraction of all nuclear proteins suggested that overexpression of Tip60 
leads to an accumulation of PGC-1α protein in an NP-40-insoluble cellular/nuclear 
compartment. Therefore, we next determined the ratios of the PGC-1α levels in the NP-40-
soluble and insoluble fraction. To this end, COS7 cells were transfected with PGC-1α 
alone or cotransfected with PGC-1α and various Tip60 variants. Cells were then lysed with 
NP40 lysis buffer. Both the NP-40-soluble and insoluble fractions of the lysates were 
boiled in SDS-PAGE sample buffer and analyzed by western blot. As shown figure S4.2C, 
the steady state levels of the NP-40-soluble PGC-1α did not change dramatically upon 
overexpression of Tip60, but there was a dramatic increase in the amounts of PGC-1α 
protein in the NP-40-insoluble fraction. Most interestingly, the majority of the insoluble 
PGC-1α consisted of the faster migrating PGC-1α species. The appearance of a new PGC-
1α form caused by the overexpression of Tip60 could be the result of a posttranslational 
modification of PGC-1α. These results suggest that this posttranslational modification 
leads to the accumulation of PGC-1α in the insoluble fraction. However, it is also possible 
that the posttranslational modification is a consequence of the accumulation of PGC-1α in 
a new, insoluble compartment.  
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Figure S4.2. Tip60 stabilizes PGC-1α protein.  
(A) Overexpression of Tip60 increases the steady-state protein levels of PGC-1α.  
COS7 cells were cotransfected with expression vectors for PGC-1α and various Tip60 variants. 
Total protein extracts were prepared by boiling the cells in SDS-lysis buffer. Expression levels of 
PGC-1α and the Tip60 constructs was determined by western blot analysis.  
(B) The half-life of PGC-1α is prolonged by Tip60 overexpression. 
COS7 cells were transfected with a plasmid expressing PGC-1α, alone, or together with a plasmid 
expressing Tip60α. A pulse-chase experiment was used to determine the half-life of PGC-1α in the 
absence and presence of overexpressed Tip60α. 
(C) Tip60 overexpression leads to the accumulation of PGC-1α in an NP-40 insoluble cellular 
compartment. 
COS7 cells were transfected with expression vectors for PGC-1α and various Tip60 constructs. 40 
h post transfection cells were lysed in NP-40 lysis buffer. Both NP-40 and NP-40 insoluble cell 
material was subjected to western blot anylysis. 
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Can Tip60 acetylate PGC-1α in vitro ? 
The repressive effect of Tip60 on the PGC-1α transcriptional activity depends in some 
cases entirely, in some cases partially on the acetyltransferase activity of Tip60. These 
results prompted us to test whether PGC-1α could be a substrate for the acetyltransferase 
activity of Tip60. In a first experiment, COS7 cells were transformed with the PGC-1α 
expression construct alone or in combination with a plasmid expressing Tip60α or the 
Tip60α acetyltransferase mutant. 40 h post-transfection, cell lysates were prepared and 
immunoprecipitated with an anti-PGC-1α antibody. Immunocomplexes were resolved by 
SDS-PAGE and subjected to western blot analysis using an anti acetyl-lysine antibody. No 
band corresponding to the size of PGC-1α could be detected (data not shown). The 
reactivity of antibodies raised against acetylated-lysine residues can be strongly influenced 
by the amino acids surrounding an acetylated lysine. In can happen that an acetylated 
lysine residue is not recognized. Thus, the lack of detection of acetylation in this assay was 
not conclusive.  
 
We therefore chose an in vitro approach to detect a possible acetylation of PGC-1α by 
Tip60. Fusions of three different PGC-1α constructs to MBP, and fusions of Tip60α and 
the Tip60α acetyltransferase mutant to GST were expressed in E. coli and purified using 
amylose and glutathione beads, respectively. MBP and the MBP-PGC-1α constructs were 
then incubated with GST-Tip60α or GST-Tip60α.mHAT in the presence of tritium labeled 
acetyl-coenzyme A, which served as acetyl donor in this reaction, thereby allowing an easy 
detection of acetylated proteins by autoradiography. As shown in figure S4.3, Tip60α 
strongly acetylated histones, which are well established substrates of Tip60 (Creaven et al., 
1999; Kimura and Horikoshi, 1998; Lemercier et al., 2003; Yamamoto and Horikoshi, 
1997). As expected, the Tip60 acetyltransferase mutant did not acetylate histones. No 
acetylation of control MBP or full length PGC-1α could be detected. A very faint band, 
which may correspond to the PGC-1α N565 construct, was visible. This band could not be 
detected, when the Tip60 acetyltransferase was used.  
 
These results suggest that PGC-1α is not a good substrate for the Tip60 acetyltransferase 
activity in vitro. Further experiments in vivo with other detection methods than anti-
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acetyllysine antibodies will be necessary to show a possible acetylation of PGC-1α by 
Tip60. An efficient acetylation of PGC-1α may require the whole Tip60 complex, as 
shown for the acetylation of chromatin templates by Tip60 (Ikura et al., 2000). 
 
 
 
 
 
 
Figure S4.3. Acetylation of PGC-1α by Tip60α in vitro.  
Histone proteins, maltose binding protein (MBP), alone, or fused to full length PGC-1α, or amino 
acids 1-565 of PGC-1α (N565) were incubated with GST-fusions of Tip60α wild type or 
acetyltransferase mutant and [3H]-labeled acetyl-CoA. After reactions had been stopped, proteins 
were resolved by SDS-PAGE and acetylated proteins were detected by autoradiography. Asteriks 
indicates a band that may correspond to acetylated MBP-PGC-1α.N565.    
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Regulation of other non-NR transcription factors by PGC-1α and Tip60 
Our results have shown that overexpression of Tip60 reduces PGC-1α-dependent gene 
expression in several experiments. However, we also found that PGC-1α enhances the 
expression of p21, which requires Tip60. Since Tip60 has been shown to be a coactivator 
for several transcription factors, we wanted to know whether PGC-1a can enhance the 
expression of genes other than p21 that have been previously shown to be activated by 
Tip60.  
 
Tip60 has also been reported to be in a ternary transcriptionally active complex together 
with the intracellular domain of the amyloid precursor protein (APP) and Fe65. The very 
low transcriptional activity of a GAL4-DBD fusion of Tip60 was shown to be dramatically 
enhanced by the simultaneous overexpression of APP and Fe65 but not by either of the two 
proteins alone (Cao and Sudhof, 2001). We were able to reproduce the results of Cao and 
Sudhof, but no further activation of the Tip60/APP/Fe65-complex by PGC-1α was 
observed. PGC-1α rather seemed to have a negative, if any role, in the activity of the 
Tip60/APP/Fe65-complex (Fig. S4.4.A)  
 
Two reports suggest that Tip60 is a coactivator for homodimers of the NFκB-family 
transcription factor p52, where Bcl-3 is thought to mediate the interaction of p52 and 
Tip60 (Baek et al., 2002; Dechend et al., 1999). To test whether PGC-1α acts 
synergistically with Tip60 and Bcl-3 in the activation of a p52-regulated promoter, we 
transformed COS7 cells with a luciferase reporter under control of the P-selectin promoter, 
an expression vector for p52, and plasmids expressing Tip60α, Bcl-3, and PGC-1α. As 
shown in Figure S4.4B, PGC-1α, either alone or in combination with Tip60α and Bcl-3,  
did not coactivate p52. 
 
A recent report suggested that Tip60 is actively involved in the activation of the 45S 
ribosomal pre-RNA through acetylation of the transcription factor UBF1, as well as 
through the direct recruitment of Tip60 to the human ribosomal gene promoter (Halkidou 
et al., 2004). Recruitment of Tip60 to the ribosomal RNA promoter after release of cells 
from starvation was followed by acetylation of histone H4 at this promoter, suggesting that 
Tip60 not only acetylated UBF but also histone H4. In support of these findings, the yeast 
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homologue of Tip60 has been shown to play a role in the regulation of the transcription of 
ribosomal RNA. PGC-1α has been shown to induce cellular programs that allow the cells 
to adapt to limited energy availability. We therefore considered a model, in which PGC-1α 
represses ribosomal RNA synthesis by downregulating the Tip60 activity. To test this 
model, we serum-starved SAOS2 cells overnight to shut off the ribosomal RNA synthesis 
and to induce the release of Tip60 from the promoter. Occupancy of the rRNA promoter by 
Tip60 and acetylated histone H4 in cells expressing no PGC-1α and cells overexpressing 
PGC-1α was measured before and after incubation of the cells in serum containing 
medium using chromatin immunoprecipitation assays. We were not able to show Tip60 
binding to the rRNA promoter under any conditions. We detected acetylated histone H4 
associated with the rRNA promoter, but the levels did not differ significantly under no-
serum and serum conditions. Treatment of cells with rapamycin, a strong inhibitor of 
rRNA synthesis (Mayer et al., 2004), also did not reduce the acetylation of histone H4. In 
addition, no reproducible effect on the level of histone H4 was observed (data not shown). 
In conclusion, our experiments did not provide any support for a role of Tip60 or PGC-1α 
in RNA polymerase I-regulated transcription. However, not all possible optimizations of 
the experimental setup have been tried, and it may still be worth running these experiments 
under different conditions.  
Chapter IV supplementary data 
________________________________________________________________________ 
 94
 
 
Figure S4.4. Regulation of Tip60-mediated transcription by PGC-1α. 
(A) PGC-1a does not further enhance the transcriptional activity of the Tip60, APP, Fe65 complex.  
COS7 cell were transfected with a p52 regulated luciferase reporter construct and expression 
vectors for GAL4-Tip60α, PGC-1α, APP, and Fe65 as indicated. 40 h post transfection, luciferase 
activity was determined. The Results show the enhancement of the luciferase activity. Results in 
the presence of GAL4-Tip60α was set equal to 1. 
(B) PGC-1α is not able to coactivate the NFκB transcription factor p52. 
COS7 cells were transfected with a GAL4-regulated luciferase reporter plasmid and expression 
vectors for the proteins shown in the figure. 40 h after transfection, cells were assayed for 
luciferase and β-galactosidase activity. Results are expressed as fold enhancement of the 
expression of the reporter construct. Results in the presence of p52 alone was set equal to 1. 
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Abstract 
Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) is a tissue-specific 
and inducible transcriptional coactivator for several members of the nuclear receptor 
family and plays a key role in energy metabolism. PRMT1, the major mammalian protein 
arginine methyltransferase, is also known to be a nuclear receptor coactivator. We report 
here that the activity of PGC-1α is potentiated by PRMT1, in a manner dependent on the 
specific methyltransferase activity of PRMT1. A glutamate-rich region upstream from the 
RNA binding motif in the C-terminal domain of PGC-1α is methylated by PRMT1 in 
vitro. Mutations of three substrate arginines in this region of PGC-1α abolish the 
cooperative function of PGC-1α and PRMT1, and compromise the ability of PGC-1α to 
induce endogenous target genes. Finally, we show that endogenous PRMT1 contributes to 
PGC-1α coactivator activity, and to the induction of genes important for mitochondrial 
biogenesis. Thus, the function of PGC-1α is regulated by arginine methylation. 
 
Keywords: arginine methylation/ coactivator/ mitochondrial biogenesis/ nuclear receptor/ 
transcription 
Running title: Regulation of PGC-1α by arginine methylation 
Subject Categories: Chromatin & Transcription/ Proteins 
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Introduction 
Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) is a transcriptional 
coactivator for many members of the nuclear hormone receptors (NRs) superfamily, 
including peroxisome proliferator-activated receptor γ (PPARγ), the thyroid hormone 
receptors (TR), retinoid acid receptors, glucocorticoid receptor (GR), and estrogen receptor 
(ER), as well as other types of DNA-binding transcription factors such as nuclear 
respiratory factor 1 (NRF-1) (Knutti & Kralli 2001; Puigserver & Spiegelman 2003). PGC-
1α harbors leucine-rich motifs (also called LXXLL motifs or NR boxes), which bind to the 
hormone-activated NRs. The N-terminal region contains a strong autonomous activation 
domain, which binds to other well-known coactivators such as SRC-1 and CBP and is 
required for the coactivator function of PGC-1α (Puigserver et al, 1999). The C-terminal 
region of PGC-1α contains an RNA recognition motif (RRM) and an RS domain (rich in 
Arg and Ser residues), both of which are characteristic of proteins involved in splicing, 
such as hnRNP and SR proteins. Indeed, PGC-1α not only functions as a transcriptional 
coactivator, but can also influence splicing patterns of specific transcripts (Monsalve et al, 
2000). Deletions within the C-terminal domain disrupt the ability of PGC-1α to associate 
with RNA polymerase II, RNA processing factors and the Mediator, and to induce target 
genes, suggesting that this region contains both transcriptional coactivator and splicing 
regulator functions (Monsalve et al, 2000; Wallberg et al, 2003). 
 
PGC-1α mRNA is predominantly expressed in heart, brown adipose tissue, kidney, 
skeletal muscle, and liver (Puigserver et al, 1998; Knutti et al, 2000), and its expression is 
induced in response to stimuli known to regulate metabolic activity. For example, PGC-1α 
expression is induced in brown adipose tissue and skeletal muscle by exposure to cold 
(Puigserver et al, 1998; Boss et al, 1999), in muscle in response to physical exercise (Goto 
et al, 2000), and in the liver and heart in response to short-term fasting (Lehman et al, 
2000; Herzig et al, 2001; Yoon et al, 2001). In accordance with the nature of the stimuli 
that induce its expression, PGC-1α regulates a broad range of metabolic processes, 
including mitochondrial biogenesis, respiration, and gluconeogenesis, and thus enables 
physiologic adaptation to the energy needs imposed by the stimuli (Knutti & Kralli 2001; 
Puigserver & Spiegelman 2003; Kelly & Scarpulla 2004). These effects of PGC-1α are 
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mediated by several DNA-binding transcription factors. Mitochondrial biogenesis and the 
stimulation of oxidative phosphorylation in particular require the cooperation of PGC-1α 
with the nuclear respiratory factors, NRF-1 and NRF-2, and the orphan nuclear receptor 
ERRα (estrogen-related receptor α) (Wu et al, 1999; Schreiber et al, 2004; Mootha et al, 
2004). PGC-1α is an essential coactivator for ERRα, enabling the induction of the ERRα 
gene, which is auto-regulated in a positive feedback loop, as well as the induction of other 
ERRα target genes that encode proteins important for mitochondrial biogenesis and 
function (Huss et al, 2002; Schreiber et al, 2003; Schreiber et al, 2004; Laganiere et al, 
2004; Mootha et al, 2004). 
As the major protein arginine methyltransferase (PRMT) in mammalian cells (Tang et al, 
2000a), PRMT1 methylates many RNA-binding proteins (Rajpurohit et al, 1994; Liu & 
Dreyfuss 1995; Li et al, 2002; Cote et al, 2003), as well as histone H4 (Chen et al, 1999; 
Strahl et al, 2001; Wang et al, 2001). Arginine methylation has been implicated in the 
regulation of many cellular processes (Lee et al, 2004), including signal transduction 
(Bedford et al, 2000; Tang et al, 2000b; Mowen et al, 2001), subcellular localization of 
proteins (McBride et al, 2000; Yun & Fu 2000), protein-protein interactions (Bedford et al, 
2000; Friesen et al, 2001), and transcriptional regulation (Wang et al, 2001; Xu et al, 2001; 
Ma et al, 2001; An et al, 2004). Indeed, PRMT1 serves as a coactivator for NRs (Koh et al, 
2001) and other DNA-binding transcription factors, such as p53 (An et al, 2004) and YY1 
(Rezai-Zadeh et al, 2003). Once recruited to the target gene promoter region through direct 
or indirect association with the DNA-bound transcription factor, PRMT1 cooperates with 
other histone-modifying enzymes to lead to chromatin remodeling and transcriptional 
activation (Koh et al, 2001; Metivier et al, 2003; An et al, 2004).  
 
Since PGC-1α contains an RNA-binding domain and many RNA-binding proteins are 
substrates for PRMT enzymes, we tested whether PGC-1α could be methylated on arginine 
residues by PRMT1 or the related PRMT family member CARM1 (Chen et al, 1999). 
Furthermore, because some PRMTs act as coactivators for NRs and other transcription 
factors, we investigated whether PGC-1α could cooperate with PRMTs as coactivators.  
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Materials and Methods 
Plasmids 
The following plasmids were previously described: pcDNA3-HA-PGC-1α encoding full-
length human PGC-1α (Knutti et al, 2000); pSG5.HA-PRMT1 encoding HA epitope-
tagged PRMT1 (Koh et al, 2001); GST-PRMT1, encoding a GST-PRMT1 fusion protein 
(Lin et al, 1996); pSG5.HA-CARM1 encoding HA-CARM1 and pGEX4T1.CARM1 
encoding GST-CARM1 (Chen et al, 1999); pHE0, encoding human estrogen receptor α 
(Green et al, 1988); and the luciferase reporter plasmid MMTV(ERE)-LUC (Umesono & 
Evans 1989).  
 
Construction of plasmids encoding fragments of PGC-1α fused to GST: PCR amplified 
fragments, representing the following PGC-1α fragments aa 1-306; aa 306-532; aa 532-
640 and aa 640-798, were inserted into the BamHI and XhoI sites of pGEX4T1; 
pGEX4T3-RS encoding PGC-1α(566-632), pGEX4T3-E encoding PGC-1α(632-676), and 
pGEX4T3-RRM encoding PGC-1α(676-755) were constructed by inserting the 
appropriate DNA fragments, amplified from pcDNA3-HA-PGC-1α as a template and with 
primers containing BamHI and SalI sites, into the BamHI and SalI sites of pGEX4T3. The 
following mutations were generated with the Quickchange site-directed mutagenesis kit 
(Stratagene), using the corresponding wild type plasmids as templates: pSG5.HA-
PRMT1(E153Q); pGEX4T3-E(R4K), containing R644K, R647K, R651K, and R652K 
mutations; pGEX4T3-E(R3K), containing R665K, R667K, and R669K mutations; 
pcDNA3-HA-PGC-1α(R3K). Construct pcDNA3-HA-PGC-1α.∆C (566-755), has been 
generated by fusion PCR and verified by sequencing. To construct the luciferase reporter 
pERRα-Luc, the ERRα-responsive sequences of the ESRRA promoter (nt –537 to –829 nt, 
relative to transcription initiation site) were amplified by PCR and subcloned upstream of 
the minimal alcohol dehydrogenase promoter of pLuc (Iñiguez-Lluhí et al, 1997).  
 
Cell Culture and Transfection 
CV-1 and COS7 cells (Gluzman 1981) were maintained in Dulbecco modified Eagle 
medium (DMEM) supplemented with 10% fetal bovine serum and seeded in 12-well 
dishes for transient transfections as described previously (Ma et al, 1999). pSG5.HA and 
pcDNA3.1 empty vectors were added to all transfections to balance the total amount of 
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DNA used for each transfection. After transfection, cells were grown in medium 
supplemented with 5% charcoal-stripped fetal bovine serum for 40 h before harvest; where 
indicated, medium was supplemented with 20 nM estradiol (E2) during the last 30 h of 
growth. Luciferase assays were performed by using the Promega Luciferase Assay Kit 
according to manufacturer's protocols. Luciferase activity is shown as the mean and range 
of variation of two transfected cell cultures. Because some coactivators enhance the 
activities of so-called constitutive promoters, constitutive reporter plasmids (e.g. β-
galactosidase) were not used to normalize the luciferase activities. Instead, such internal 
controls were used strategically to monitor transfection efficiency. 
 
Adenovirus infections and RNA analysis 
Adenoviral vectors expressing GFP and PGC-1α were used to infect SAOS2 cells as 
described previously (Schreiber et al, 2003). Adenoviruses expressing PGC-1α R3K were 
constructed by using the insert of pcDNA3-HA-PGC-1α R3K. Total RNA was isolated 
using the TRIzol reagent (Invitrogen), cDNA was synthesized with the SuperScript Choice 
system (Invitrogen), and specific transcripts were quantified by quantitative real-time PCR 
using the SYBR Green PCR system (Applied Biosystems) and the Chromophore detection 
system (MJ Research) (Fig. 5A) or the ABI PRISM® 7700 Detection System (Fig. 5B). 
Gene-specific primers were described previously for human ERRα (Schreiber et al, 2003) 
and for human cytochrome c (Schreiber et al, 2004). For human GAPDH the sequences of 
the PCR primers used were 5’-GAAGGTGAAGGTCGGAGTC-3’ and 5’-
GAAGATGGTGATGGGATTTC-3’. ERRα and Cytc mRNA levels have been normalized 
to GAPDH mRNA levels, and estimated using standard curves (Schreiber et al, 2004) (Fig. 
5A) or the Ct method cited in ABI User Bulletin #2 (Fig. 5B). 
 
Methylation assays 
Substrates and enzymes were prepared as recombinant GST fusion proteins and eluted 
from glutathione-agarose beads (Sigma) with 20 mM glutathione (Koh et al, 2001). The 
methylation assays were performed in HMT Buffer (20 mM Tris-HCl, pH 8.0, 200 mM 
NaCl, 0.4 mM EDTA) as follows: 1 µg of GST fused to PGC-1α full-length or fragments 
was incubated with 1 µg of GST-PRMT1 or GST-CARM1 and 7 µM S-adenosyl-L-[3H-
methyl]methionine ([3H]AdoMet: specific activity 14.7 Ci/mmol) in 30 µl of HMT buffer 
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for 1 h at 30 °C. Reactions were stopped by addition of SDS sample buffer and analyzed 
by 12% SDS-PAGE and fluorography. 
 
RNA interference and immunoblots 
The following siRNA oligonucleotides for human PRMT1 were designed using the Target 
Finder program (Ambion), and chemically synthesized by the USC Norris Comprehensive 
Cancer Center Microchemical Core: siRNA#1 sense: 5’-
AGAUUACUACUUUGACUCCdTdT-3’; siRNA#1 antisense: 5’-
GGAGUCAAAGUAGUAAUCUdTdT-3’; siRNA#2 sense: 5’-
CUUAUGUUUUUAUAUGGUUdTdT-3’; siRNA#2 antisense: 5’-
AACCAUAUAAAAACAUAAGdTdT-3’. Annealed siRNAs were transfected with 
lipofectamine 2000 (Invitrogen), according to manufacturer’s protocol, into COS7 cells 
seeded in 24-well plates, 48 h before DNA transfection. Luciferase assays were performed 
48 h after DNA transfection. Parallel cell extracts were prepared at the same time in SDS 
sample buffer, separated by 12% SDS-PAGE and transferred on PVDF membrane. 
Immunoblots were then performed with the anti-PRMT1 antibody (Abcam), and after 
stripping, with antibody against β-actin (Santa Cruz). For SAOS2 cells, siRNA#1 was 
transfected with lipofectamine 2000 24 h before infection with virus at a multiplicity of 
infection of 10. Total RNA was isolated 24 h after virus infection and analyzed by 
quantitative real-time PCR as described above. 
Chapter V: Activation of nuclear receptor coactivator PGC-1α by arginine methylation 
________________________________________________________________________ 
 103
Results 
PRMT1 and its enzymatic activity stimulate PGC-1α coactivator activity 
As demonstrated previously (Knutti et al, 2000; Tcherepanova et al, 2000), PGC-1α can 
enhance the activity of ERα on a reporter plasmid controlled by estrogen responsive 
enhancer elements (Fig. 5.1). A 2-fold enhancement of reporter gene expression was 
observed when PGC-1α was co-expressed with ERα. Co-expression of PRMT1 with PGC-
1α dramatically increased the reporter gene activity observed with PGC-1α alone or 
PRMT1 alone. In contrast, co-expression of another coactivator in the arginine 
methyltransferase class CARM1 (Chen et al, 1999; An et al, 2004), had little or no effect 
on PGC-1α activity. The functional synergy between PGC-1α and PRMT1 was completely 
dependent on the integrity of the LXXLL motifs of PGC-1α, which are responsible for 
binding hormone-activated ERα, and the N-terminal activation domain of PGC-1α 
(Supplement Fig. 1). Thus, the effect of PRMT1 in this case depends entirely on the 
integrity of the coactivator functions of PGC-1α, suggesting that PRMT1 is amplifying the 
coactivator function of PGC-1α. The fact that PGC-1α and PRMT1 cooperated to enhance 
the transcriptional activity of other NRs as well, such as GR and TR (Supplement Fig. 2), 
suggests that PRMT1 stimulates the coactivator function of PGC-1α in a variety of 
transcriptional complexes.  
 
To test whether the methyltransferase activity of PRMT1 is required for its synergistic 
coactivator function with PGC-1α, we used an enzymatically deficient mutant of PRMT1. 
X-ray crystal structures of PRMT1 and PRMT3 (Zhang et al, 2000; Zhang & Cheng 2003) 
indicated that two Glu residues that are highly conserved in the PRMT family form salt 
bridges with the two terminal guanidino group nitrogen atoms of the substrate arginine 
residue. In PRMT1, mutation of either of these conserved residues, Glu144 and Glu153, to 
Gln completely or nearly abolishes enzymatic activity (Zhang & Cheng 2003) (Supplement 
Fig. 3). The PRMT1 E153Q mutant failed to stimulate PGC-1α coactivator activity (Fig. 
1), although it was expressed at levels comparable to that of wild type PRMT1 
(Supplement Fig. 3). Thus, the specific protein arginine methyltransferase activity of 
PRMT1 (but not CARM1) is necessary for the enhancement of coactivator function of 
PGC-1α. The requisite substrate that is methylated by PRMT1 to cause the enhancement 
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of PGC-1α activity could be histone H4 (Chen et al, 1999; Wang et al, 2001) or a 
component of the transcription machinery that has not been previously characterized as a 
PRMT1 substrate, including PGC-1α itself.  
 
 
Figure 5.1. Specific and cooperative coactivator function between PGC-1α and PRMT1.  
CV-1 cells were transiently transfected with MMTV(ERE)-LUC reporter plasmid (250 ng) and 
expression vectors encoding ER (0.1 ng), PGC-1α (50 ng) and PRMT1 wild type,  PRMT1 E153Q 
mutant or CARM1 (250 ng). Transfected cells were grown in culture medium with 20 nM 
estradiol, and extracts of the harvested cells were tested for luciferase activity. The results 
presented are from a single experiment representative of four independent experiments. 
 
 
 
PRMT1 methylates PGC-1α 
Since PGC-1α contains an RNA binding domain and many RNA binding proteins are 
known to be substrates for arginine methylation, we tested whether PGC-1α could be 
methylated by PRMT1. For this, recombinant PGC-1α fused to GST was incubated with 
bacterially-expressed GST-PRMT1 in the presence of [3H]AdoMet. As seen in Fig. 2A, 
PRMT1 led to the methylation of PGC-1α. In contrast, the methyltransferase CARM1 was 
not able to methylate PGC-1α (Fig. 2A), even though it was active on other CARM1 
substrates (data not shown). The differing abilities of the two methyltransferases to modify 
specifically PGC-1α is in agreement with the finding that PRMT1, but not CARM1, 
enhances PGC-1α activity. 
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To map the region that becomes methylated, recombinant GST fusion proteins representing 
various fragments of PGC-1α were incubated with GST-PRMT1 in the presence of 
[3H]AdoMet (Fig. 2B). While N-terminal fragments containing amino acids 1 to 306 or 
306 to 532 were not methylated, PRMT1 methylated two different C-terminal fragments of 
PGC-1α (amino acids 532-640 and a subfragment of amino acids 640-798). Note that the 
full length fragment 640-798 was not methylated but a truncated fragment was (asterisk in 
last lane of Fig. 2B, left panels). Since the GST protein is fused to the N-terminal part of 
the PGC-1α fragments and these GST fusion proteins were isolated by binding to 
glutathione-agarose beads, the methylated PGC-1α fragment apparently represents only 
the N-terminal portion (corresponding to the E or Glu-rich region) of amino acids 640-798. 
The lack of methylation of the full-length PGC-1α (640-798) fragment suggests that 
folding of the fragment may make the methylation site in the N-terminal portion of this 
fragment inaccessible. The C-terminal portion of PGC-1α was further subdivided into 
three fragments representing discreet domains of PGC-1α. The acidic E region and the RS 
region were both substrates for PRMT1, but the RNA recognition motif (RRM) by itself 
was not (Fig. 2B, right panels).  
 
We focused on identifying the methylated residues of the E domain, because deletion of 
this small region abolished the enhancement of PGC-1α coactivator activity by PRMT1, 
whereas deletion of the RS region did not eliminate the functional synergy between these 
two coactivators (Supplement Fig. 4); these results suggest that the E region plays an 
important role in the stimulation of PGC-1α activity by PRMT1. Two groups of Arg 
residues within the E region were modified to Lys. A mutant GST-E(R4K) fragment with 
Lys substitutions at Arg residues 644, 647, 651 and 652 was methylated efficiently by 
PRMT1 (Fig. 2C), at levels indistinguishable to the wild type GST-E fragment (data not 
shown). However, conversion of Arg residues 665, 667 and 669 to lysines in the GST-
E(R3K) mutant fragment completely abolished methylation by PRMT1 (Fig. 2C), showing 
that these residues are important for the methylation and presumably contain the 
methylation site(s). Individual lysine substitutions at Arg residues 665, 667, and 669 failed 
to eliminate the methylation of GST-E, suggesting that more than one of these three 
residues are methylation sites for PRMT1 (data not shown). 
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Figure 5.2. Methylation of PGC-1α by PRMT1.  
(A) Full-length PGC-1α fused to GST was incubated with GST-CARM1 or GST-PRMT1 in 
presence of [3H]AdoMet for 1 h at 30°C. The products were analyzed by SDS-PAGE followed by 
fluorography.  
(B) PGC-1α fragments fused to GST were incubated with GST-PRMT1 and [3H]AdoMet, and the 
products were analyzed by SDS-PAGE followed by fluorography (upper panels) and Coomassie 
blue staining (lower panels). Amino acid numbers of the PGC-1α fragments are shown below the 
diagram and above the panels. The asterisks show the methylated fragments, and positions of 
molecular weight are indicated beside the panels.  
(C) GST fusion proteins representing mutated forms of the PGC-1α E fragment (sequence shown) 
were incubated with GST-PRMT1 and [3H]AdoMet and analyzed as in A, by fluorography (left 
panel) and Coomassie blue staining (right panel). In the R4K and R3K mutants, the numbered and 
bracketed Arg residues (R) were changed to Lys. The results presented are from a single 
experiment representative of three independent experiments. 
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Importance of Arg methylation in PGC-1α coactivator function 
To investigate the role of the C-terminal region and the three apparent Arg methylation 
sites in the stimulation of PGC-1α activity by PRMT1, we tested mutants of PGC-1α (Fig. 
3A) for their ability to induce the expression of the ERRα promoter, which is an important 
regulatory target of PGC-1α in the process of mitochondrial biogenesis (Schreiber et al, 
2004; Mootha et al, 2004). ERRα binds to and stimulates transcription from its own gene 
promoter, and this stimulation is highly dependent on the coactivator function of PGC-1α 
(Laganiere et al, 2004; Mootha et al, 2004). As observed previously (Laganiere et al, 2004; 
Mootha et al, 2004), over-expression of wild type PGC-1α dramatically enhanced the 
expression of a transiently transfected reporter gene controlled by the upstream regulatory 
region of the ERRα promoter (Fig. 3B). Deletion of a C-terminal part of PGC-1α (∆C) or 
mutation of the three apparent Arg methylation sites (Arg665, Arg667, and Arg669) to Lys 
(R3K mutant) reduced, but did not abolish the coactivator function of PGC-1α; the mutant 
proteins still caused substantial enhancement of ERRα promoter activity (Fig. 3B) and 
were expressed at wild type levels (data not shown). The observation that the C-terminal 
deletion mutant was more active than the R3K mutant suggests that both inhibitory and 
stimulatory activities reside within this C-terminal region. Importantly, over-expression of 
PRMT1 enhanced the ability of wild type PGC-1α to stimulate transcription from the 
ERRα promoter, but failed to stimulate the activity of the two mutant PGC-1α proteins 
(Fig. 3C). Similarly, PRMT1 failed to cooperate with the R3K PGC-1α mutant in the 
context of another NR, ERα, and its respective target (Supplement Fig. 5). Thus, the 
inherent activity of PGC-1α as well as its ability to be stimulated by over-expression of 
PRMT1 depends on the three Arg residues that are substrates for methylation by PRMT1. 
These results strongly suggest that the methylation of PGC-1α by PRMT1 plays a key role 
in its activity and ability to function cooperatively with PRMT1.  
 
The dramatically reduced activity of the R3K mutant in the absence of over-expressed 
PRMT1 suggests that the activity of the wild type PGC-1α protein depends on methylation 
by endogenous PRMT1, which is present in these cells (data not shown). To test this, we 
determined the effect of reducing endogenous levels of PRMT1 on the ability of over-
expressed PGC-1α to stimulate expression of the transiently transfected ERRα-Luc 
reporter. Two different siRNAs targeting the human PRMT1 sequence reduced efficiently 
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the level of PRMT1 protein, but not β-actin protein, in COS7 cells in a dose-dependent 
manner (Fig. 4, lower panel). The siRNA-treated or untreated cells were subsequently 
transfected with a firefly luciferase gene reporter plasmid controlled by the ERRα 
promoter, a PGC-1α expression plasmid, and a control Renilla luciferase reporter plasmid 
driven by a constitutive cytomegalovirus promoter. Both siRNAs against PRMT1 caused a 
dose-dependent decrease in expression of the ERRα promoter-driven firefly luciferase 
reporter gene, which paralleled the decrease in PRMT1 protein levels (Fig. 4). Since the 
firefly luciferase data is normalized against the Renilla luciferase activity, these results 
demonstrate that reduction in endogenous PRMT1 levels causes a gene-specific decrease 
in the ability of PGC-1α to stimulate expression from the transiently transfected ERRα 
promoter. 
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Figure 5.3. Role of the methylated Arg residues of the PGC-1α E region in coactivator 
function.  
(A) Functional domains of PGC-1α and mutants examined for coactivator function. AD, activation 
domain, Leu-motif, LXXLL motifs; asterisks represent three Arg-to-Lys mutations in the E region 
(see Fig. 2C).  
(B) COS7 cells were transiently transfected with pERRα-LUC reporter plasmid (250 ng) and the 
indicated amounts of expression vectors encoding PGC-1α wild type or mutant proteins. Extracts 
of the harvested cells were tested for luciferase activity.  
(C) COS7 cells were transiently transfected with pERRα-LUC reporter plasmid (250 ng) and 
expression vectors encoding PRMT1 (250 ng) and PGC-1α wild type or mutants (50 ng), as 
indicated. Extracts of the harvested cells were tested for luciferase activity. The results presented 
are from a single experiment representative of three independent experiments. 
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Figure 5.4. Role of endogenous PRMT1 in PGC-1α coactivator function.  
COS7 cells, plated in 24-well plates, were transfected with increasing amounts (20 pmol; 40 pmol; 
60 pmol) of two different siRNAs (si#1 and si#2) against PRMT1. Two days later, cells were 
transfected with a firefly luciferase reporter plasmid driven by the ERRα promoter (pERRα-Luc, 
125 ng), a PGC-1α expression vector (25 ng), and a Renilla luciferase reporter plasmid driven by a 
cytomegalovirus promoter (12.5 ng). Luciferase activities were quantified 48 h later, and firefly 
luciferase activity was normalized by Renilla luciferase activity. Data shown are from a single 
experiment representative of three independent experiments, each performed in triplicate. Protein 
levels were determined by immunoblots from cell extracts of a fourth siRNA transfected well.  
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Arg methylation of PGC-1α and endogenous PRMT1 contribute to the induction of 
endogenous PGC-1α target genes 
Wild type PGC-1α and the R3K mutant were expressed in SAOS2 osteosarcoma cells by 
infection with adenovirus vectors, to test their ability to stimulate expression of the 
endogenous ERRα and cytochrome c (Cyt c) genes, which are targets of PGC-1α and 
important for mitochondrial biogenesis (Schreiber et al, 2003; Schreiber et al, 2004; 
Mootha et al, 2004). A viral vector expressing green fluorescent protein (GFP) was used as 
a control. Although equivalent expression of mutant and wild type proteins was observed 
(Fig. 5A), the PGC-1α R3K mutant was substancially less efficient than the wild type 
protein in inducing the expression of ERRα and Cyt c mRNA (Fig. 5A), suggesting that 
arginine methylation is important for PGC-1α function at endogenous target genes in their 
native chromatin state.  
 
To determine the role of endogenous PRMT1 in PGC-1α-dependent transcriptional 
programs, we next used the siRNA#1 to reduce PRMT1 mRNA levels in SAOS2 cells 
(Fig. 5B). The siRNA-treated or untreated SAOS2 cells were subsequently infected with 
adenovirus vectors encoding GFP or PGC-1α. PGC-1α expression led to increases in the 
levels of the endogenous Cyt c and ERRα mRNAs; however, this induction by PGC-1α 
was partially inhibited in the cells treated with siRNA against PRMT1, compared with the 
cells that were not exposed to the siRNA (Fig. 5B). The effects of PGC-1α and the siRNA 
against PRMT1 were gene specific, since the data shown are normalized against the 
expression of GAPDH mRNA. Thus, endogenous levels of PRMT1 contribute to the 
ability of PGC-1α to induce the expression of target genes that are important for 
mitochondrial biogenesis. 
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Figure. 5.5. Role of Arg-methylation in the induction of endogenous genes important for the 
biogenesis or function of mitochondria.  
(A) SAOS2 cells in 6-well plates were infected with adenoviruses expressing GFP, PGC-1α wild 
type or PGC-1α R3K mutant (moi 40) and harvested 24 h later. mRNA levels for the ERRα and 
Cyt c genes were determined by quantitative PCR and normalized to the level of GAPDH mRNA.  
(B) SAOS2 cells in 6-well plates were transfected with siRNA#1 against PRMT1 (100 pmol/well). 
One day later, cells were infected with adenoviruses expressing GFP or PGC-1α (moi 10) and 
harvested 24 h later. mRNA levels for the indicated genes were determined by quantitative PCR 
and normalized to the GAPDH mRNA level. Data shown are from a single experiment 
representative of three independent experiments, each performed in duplicate. 
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Discussion 
Post-translational regulation of PGC-1α coactivator function 
PGC-1α controls a number of metabolic processes that are important for energy 
homeostasis. Accordingly, PGC-1α expression is highly regulated at the transcription 
level, in a tissue specific manner and in response to several physiologic signals (Knutti & 
Kralli 2001; Puigserver & Spiegelman 2003; Kelly & Scarpulla 2004). In addition, the 
important roles of PGC-1α in metabolic regulation also appear to be modulated by a 
variety of post-translational modifications and interactions with other proteins. The 
docking of PPARγ to PGC-1α induces an apparent conformational change that allows 
binding of coactivators SRC-1 and CBP/p300 to the N-terminal activation domain of PGC-
1α, thereby increasing the transcriptional activation potential of PGC-1α (Puigserver et al, 
1999). Moreover, there is evidence that an unknown repressor protein competes with NRs 
for binding to PGC-1α, and this competition appears to be regulated by MAPK p38 
signaling (Knutti et al, 2001). p38 MAPK directly phosphorylates sites within this 
suppression domain of PGC-1α and thereby enhances its transcriptional activity 
(Puigserver et al, 2001), by inhibiting the binding of the repressor p160 myb binding 
protein to PGC-1α (Fan et al, 2004). Our data add arginine methylation to the list of post-
translational regulatory mechanisms that govern PGC-1α activity and, in addition, 
implicate PRMT1 as an important component cooperating with PGC-1α in metabolic 
processes such as mitochondrial biogenesis. Mitochondrial dysfunction contributes to 
several inherited and acquired human diseases, including insulin resistance and type 2 
diabetes (Bjorntorp et al, 1967; Wallace 1999; Petersen et al, 2003). Decreases in PGC-1α 
in particular, have been suggested to contribute to the development of diabetes in humans 
(Patti et al, 2003; Mootha et al, 2003; Mootha et al, 2004). Understanding the signals and 
mechanisms that enable PRMT1 to modify PGC-1α may lead to ways to enhance PGC-1α 
activity and intervene in diseases associated with reduced mitochondrial function, such as 
diabetes.  
 
Methylation of PGC-1α by PRMT1 
We have provided evidence that PGC-1α coactivator function is stimulated by arginine 
methylation by the major mammalian methyltransferase PRMT1. This enzyme, which 
serves as a coactivator for many different types of DNA-binding transcription factors, 
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enhances PGC-1α activity, and this effect is dependent on and specific for the PRMT1 
enzymatic activity. Our evidence indicates that two or three of the Arg residues in an 
RERQR sequence, found within the Glu-rich E region located between the RS domain and 
the RRM, are methylated by PRMT1 in vitro; furthermore, methylation of these Arg 
residues plays a critical role in the coactivator function of PGC-1α and its ability to 
function synergistically with PRMT1. PRMT1 has previously been shown to methylate 
other proteins at RXR sequences (Smith et al, 1999). We also observed methylation of the 
RS domain of PGC-1α but currently have no evidence that methylation of the RS domain 
is important for PGC-1α function.  
 
Detecting methylation of specific proteins in vivo is still a developing art, as witnessed by 
a variety of recent methodological papers demonstrating success in specific cases 
(Rappsilber et al, 2003; Boisvert et al, 2003). We have been unable to demonstrate 
methylation of the PGC-1α E region in vivo by mass spectrometry, labeling of cells with 
methyl-labeled methionine, or antibodies with supposedly general specificity towards 
proteins containing methyl-arginine. Our experience suggests that success with each of 
these approaches depends on the specific protein under investigation. It is possible that 
methylation of PGC-1α by PRMT1 is highly regulated and occurs in vivo only under 
specific conditions, e.g. when they are both recruited into a transcription complex on a 
target gene promoter and PGC-1α adopts the appropriate conformation to allow 
methylation by PRMT1. In fact, as discussed above, the conformation of PGC-1α is 
regulated by protein-protein interactions (Puigserver et al, 1999), and our data 
demonstrated that certain fragments of PGC-1α that contain the E region are not 
methylated and must be partially degraded to allow methylation of the E region to occur 
(Fig. 2, PGC-1α (640-798)). 
 
In spite of our lack of direct evidence for in vivo methylation, our data provide strong 
indirect evidence that methylation of PGC-1α by PRMT1 does occur in vivo and plays an 
important role in facilitating PGC-1α coactivator function: 1) PGC-1α and its E region are 
good substrates for PRMT1 in vitro. 2) PRMT1 and PGC-1α act synergistically as 
coactivators and this synergy depends on the methyltransferase activity of PRMT1. 3) 
CARM1, another protein arginine methyltransferase which also acts as a coactivator for 
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NRs and other types of transcription factors, does not methylate PGC-1α or cooperate 
functionally with PGC-1α as a coactivator. 4) The Arg residues that are methylated by 
PRMT1 are very important for the synergy between PGC-1α and PRMT1 and for the 
ability of PGC-1α to stimulate expression of transiently transfected and endogenous target 
genes. 5) Endogenous PRMT1 is important for the coactivator function of PGC-1α in the 
induction of transiently transfected and endogenous target genes.  
 
PGC-1α has both methylation-dependent and methylation-independent coactivator 
activities 
While PRMT1 and its methyltransferase activity clearly affect the coactivator function of 
PGC-1α, considerable PGC-1α coactivator activity remains when PRMT1 levels are 
severely reduced (Fig. 5B), when the Arg methylation sites in the E region are mutated 
(Figs. 3 & 5A), or even when the entire C-terminal region (RS, E, and RRM domains) is 
deleted (Fig. 3). These data indicate that there are two components of PGC-1α coactivator 
function, one independent of PRMT1 and one dependent on PRMT1. The strong N-
terminal activation domain appears to be important for both of these activities (Supplement 
Fig. 1), and the specific downstream mechanisms that mediate these two components of 
PGC-1α activity remain to be defined.  
 
How does PGC-1α methylation affect its function? 
PGC-1α arginine methylation may influence PGC-1α activity at various levels. Arginine 
methylation of PGC-1α occurs in the E region, which contains a subnuclear localization 
signal (Monsalve et al, 2000), and thus could modulate the subcellular distribution of 
PGC-1α, as it has been shown for the methylation of some RNA-binding proteins (Shen et 
al, 1998; Nichols et al, 2000; Cote et al, 2003). A PGC-1α mutant lacking the C-terminal 
region exhibited reduced coactivator function (Fig. 3) and was deficient in binding to RNA 
polymerase II and some SR-type splicing factors (Monsalve et al, 2000), suggesting that 
this region is required for both transcriptional activation and regulation of mRNA splicing 
by PGC-1α. Methylation of arginine residues within this domain could enhance or inhibit 
specific protein-protein interactions (intramolecular or intermolecular) involving PGC-1α. 
The positive effect of PRMT1-mediated methylation suggests that methylation may cause 
an activating conformational change in PGC-1α, enhance binding of positively acting 
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proteins, such as TRAPP220 (Wallberg et al, 2003) and/or inhibit binding of repressor 
proteins. Further investigations will be required to elucidate the downstream effects of 
PGC-1α methylation and how they contribute to enhanced transcriptional activation.  
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CHAPTER V SUPPLEMENTARY FIGURES 
Supplementary figures 
 
 
Figure 5S.1 Functional synergy between PRMT1 and PGC-1α requires the coactivator 
functions of PGC-1α.  
(A) Schematic representation of PGC-1α mutants used in B. The plasmids expressing PGC-
1α.L2A, PGC-1α.L2/3A (PGC-1α bearing point mutations within the Leu-rich motifs, as 
indicated) and PGC-1α.91C (PGC-1α lacking the N-terminal activation domain AD) have been 
described (Knutti et al, 2000).  
(B) CV-1 cells were transiently transfected with MMTV(ERE)-LUC reporter plasmid (250 ng) and 
expression vectors encoding ER (0.1 ng), PGC-1α wild type or mutants as indicated (50 ng) in 
absence (white boxes) or in presence (black boxes) of PRMT1 (200 ng). Transfected cells were 
grown in culture medium with 20 nM estradiol, and extracts of the harvested cells were tested for 
luciferase activity. The results presented are from a single experiment representative of three 
independent experiments. 
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Figure 5S.2. PGC-1α and PRMT1 cooperate to enhance TR- and GR-mediated transcription.  
CV-1 cells were transiently transfected with MMTV(TRE)-LUC reporter plasmid (250 ng) 
(Umesono & Evans 1989) and expression vector pCMX.hTRβ1 encoding the human thyroid 
hormone receptor (TR) β1 (Huang & Stallcup 2000) (1 ng) (upper panel) or with MMTV-LUC 
reporter plasmid and expression vector pKSX encoding the mouse glucocorticoid receptor (GR) 
(Huang & Stallcup 2000) (1 ng) (bottom panel), and PRMT1 (200 ng) in absence (white boxes) or 
in presence (black boxes) of PGC-1α wild type (50 ng). Transfected cells were grown in culture 
medium with 20 nM thyroid hormone (upper panel) or dexamethasone (lower panel), and extracts 
of the harvested cells were tested for luciferase activity. The results presented are from a single 
experiment representative of three independent experiments. 
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Figure 5S.3. Expression levels and methyltransferase activity of PRMT1 wild type and E153Q 
mutant.  
(A) COS7 cells were transfected with vectors encoding HA-PRMT1 wild type or E153Q mutant 
and the enzymes were immunoprecipitated from cell extracts with anti-HA antibodies, as 
previously described (Teyssier et al, 2002). The expression level of the proteins was determined by 
immunoblot using anti-HA tag antibodies (monoclonal antibody 3F10, Roche Molecular 
Biochemicals).  
(B) 1µg of histone H4 was incubated for 1 h at 30 °C with the immunoprecipitated 
methyltransferases and 7 µM [3H]AdoMet (specific activity 14.7 Ci/mmol) in HMT buffer. 
Reactions were stopped by addition of SDS loading buffer and analyzed by 15% SDS-PAGE and 
fluorography. Methylated histone H4 is indicated by the arrow.  
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Figure 5S.4 Role of PGC-1α C-terminal domains in synergy with PRMT1.  
(A) Schematic representation of PGC-1α deletion mutants used in B. Expression constructs 
pcDNA3-HA-PGC-1α.∆RS (566-632), pcDNA3-HA-PGC-1α.∆E (632-676), pcDNA3-HA-
PGC-1α.∆RRM (676-755) were generated by fusion PCR and verified by sequencing.  
(B) CV-1 cells were transiently transfected with MMTV(ERE)-LUC reporter plasmid (250 ng) and 
expression vectors encoding ER (0.1 ng), PGC-1α wild type or mutants as indicated (50 ng), in 
absence (white boxes) or in presence (black boxes) of PRMT1 (200 ng). Transfected cells were 
grown in culture medium with 20 nM estradiol, and extracts of the harvested cells were tested for 
luciferase activity. The results presented are from a single experiment representative of three 
independent experiments. 
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Figure 5S.5. Role of the methylated Arg residues in the synergy between PGC-1α and 
PRMT1 in CV-1 cells.  
CV-1 cells were transiently transfected with MMTV(ERE)-LUC reporter plasmid (250 ng) and 
expression vectors encoding ER (0.1 ng), PGC-1α wild type or R3K mutant as indicated (50 ng), in 
absence (white boxes) or in presence (black boxes) of PRMT1 (200 ng). Transfected cells were 
grown in culture medium with 20 nM estradiol, and extracts of the harvested cells were tested for 
luciferase activity. The results presented are from a single experiment representative of five 
independent experiments. 
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CHAPTER VI: DISCUSSION 
Aim 
Before this study started, results from our laboratory suggested that the C-terminal half of 
PGC-1α plays an important role in the transcriptional activation of PGC-1α target genes 
(Knutti et al., 2000). The presence of two SR-rich domains and a putative RNA-
recognition motif in the C-terminal half of PGC-1α pointed to function of PGC-1α in pre-
mRNA processing. Besides the SR-rich domains and the RRM, no other protein motifs 
could be identified that would have allowed to predict possible functions of the PGC-1α C-
terminal domains. The goal of this thesis was to identify the role of the PGC-1α C-terminal 
domains in the regulation of gene expression.  
 
A yeast two-hybrid screen identified new PGC-1α interacting proteins 
We first tried to narrow down the region in the C-terminal part of PGC-1α that contributes 
to the transcriptional activity of PGC-1α in our transient transfection assays. Deletion of a 
glutamate-rich region between the SR-rich domain and the RRM turned out to be the only 
domain that would reduce the transcriptional activity of PGC-1α. We knew that PGC-1α 
can dimerize via its C-terminal half, but we did not know which domains contribute to this 
dimerization. To test the possibility that the glutamate-rich region contributes to the 
transcriptional activity of PGC-1α by mediating the dimerization of PGC-1α, we mapped 
the domains of PGC-1α that are required for dimerization. We found that a region 
encompassing the SR-rich, the glutamate-rich, and the RRM are required for dimerization 
of PGC-1α. These results suggest that dimerization is not essential for full activity of PGC-
1α in our assays and that the glutamate-rich region contains another function. 
 
To identify the function of the glutamate-rich region, but also of the other domains in the 
C-terminal part of PGC-1α, we wanted to identify PGC-1α-interacting protein by using a 
yeast two-hybrid screen. A human skeletal muscle cDNA library was screened and a 
number of interesting PGC-1α-interacting proteins were identified. We have grouped the 
identified proteins according to their function as far as possible (Table 3.1). One group 
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consists of proteins that have a clear or possible function in the regulation of transcription. 
Among them are the two transcription factors ERRα and NRF-1, both of which have been 
shown to interact with PGC-1α in other studies (Schreiber et al., 2003; Wu et al., 1999). 
ERRα and NRF-1 were isolated with the bait construct 294C, which contains part the 
region that has been proposed to interact with NRF-1. However, The isolation of ERRα 
was surprising, since the two L-motifs L2 and L3 of PGC-1α, which have been shown to 
mediate the interaction with ERRα, were not present in the bait constructs (Schreiber et al., 
2003). This result suggests that regions of PGC-1α other than the L-motifs contribute to 
the interaction with ERRα. Importantly, the identification of two proteins already known 
to be important for PGC-1α function shows that the screen is identifying proteins relevant 
to the PGC-1α pathway. 
 
We found that the acetyltransferase Tip60 forms a stable complex with PGC-1α in 
mammalian cells as demonstrated by co-immunoprecipitation assays. We therefore 
analyzed function of Tip60 in the PGC-1α signaling pathway in detail. The results of these 
studies are discussed in chapter IV and in a later section of this chapter.  
 
Skip is known to interact with the coactivators p300 and SRC-1 (Leong et al., 2004; Zhang 
et al., 2001), both of which are also recruited by PGC-1α (Puigserver et al., 1999). Another 
interesting connection between PGC-1α and Skip is that both proteins seem to be involved 
in the processing of pre-mRNA (Figueroa and Hayman, 2004; Monsalve et al., 2000; 
Zhang et al., 2003). Thus, studies on the functional consequence of the PGC-1α-Skip 
interaction could involve assays that determine the ability of proteins to regulate RNA 
splicing. 
 
Not much is known about the remaining proteins of this group, TSPYL (Vogel et al., 1998) 
and HPIP (Abramovich et al., 2002; Abramovich et al., 2000). If a direct interaction of the 
two proteins with PGC-1α can be demonstrated in mammalian cells, it will be interesting 
to study the effect of overexpression or knock-down by siRNA of TSPYL and HPIP on 
PGC-1α-dependent gene expression.   
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A second group of PGC-1α-interacting proteins is formed by proteins that have been 
shown to be involved in the processing of pre-mRNA (Table 3.1). Identification of these 
proteins supports the proposed role of PGC-1α in the regulation of pre-mRNA processing. 
Monsalve et al. have shown that PGC-1α can influence the alternative splicing of an 
exogenous reporter construct. There are no reports on whether PGC-1α can change the 
ratio of the splice variants of a specific endogenous gene. Identification and study of PGC-
1α-induced genes that can also be alternatively spliced will be important to show that 
PGC-1α is indeed a regulator of RNA splicing and to determine the effects of the 
identified splice regulators in a physiologic context.  
 
The three related kinases Clk1, Clk3, and Clk4 have been implicated in the regulation of 
alternative splicing, because they phosphorylate splicing factors and thereby regulate their 
subnuclear localization (Colwill et al., 1996; Duncan et al., 1997; Duncan et al., 1998; 
Hartmann et al., 2001; Prasad et al., 1999). It would be interesting and relatively easy to 
test if PGC-1α is phosphorylated by one of the Clk kinases. Possibly, such phosphorylation 
could regulate PGC-1α function not only in pre-mRNA processing but also in transcription 
regulation. 
 
The third group is composed of proteins with a connection to the small protein modifiers 
ubiquitin or the related SUMO. Both ubiquitination and SUMOylation have established 
roles in the regulation of transcription factors and cofactors (Gill, 2003; Herrera and 
Triezenberg, 2004). Ubiquitin is a conserved 76 amino acid protein that has been 
discovered as macromolecular tag that can be covalently attached to certain target proteins 
to mark them for degradation by the proteasome, what is now called the classic ubiquitin-
dependent proteolysis pathway (Pickart, 2001). The activity of a number of transcription 
regulators is known to be determined by their steady-state protein level. Therefore, 
regulation of the ubiquitination of a specific transcription factor by signaling pathways can 
determine its expression levels (Muratani and Tansey, 2003). A variety of evidence 
suggests that ubiquitin can also play more direct roles in transcription activation. Several 
studies suggest that ubiquitination of transcription factors not only targets them for 
destruction, but is also contributing to the activation of transcription. It could be observed 
that the half-lives of a set of model transcription factors correlated inversely with the 
potencies of their transcription activation domains suggesting that certain transcription 
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factors are degraded during or after they have activated transcription (Molinari et al., 
1999). In addition, ligand-dependent transcription activation by the estrogen receptor was 
found to depend on an intact ubiquitin-dependent proteolysis pathway (Lonard et al., 
2000), suggesting a necessary turnover of certain components of the transcription 
machinery. A very recent study presents a model, where ubiquitin has a function in 
transcription, which does not involve the degradation of proteins. The authors propose that 
ubiquitination of the VP16 activation domain increases its interaction with a transcription 
elongation factor (Kurosu and Peterlin, 2004). The proteins identified in the yeast two-
hybrid screen that have a connection to ubiquitination may therefore have important 
function in the regulation of transcription by PGC-1α. The PGC-1α-interacting protein 
hHR23A and its isoform hHR23B are the two human homologues of the yeast protein 
Rad23, which has been shown to have a function in nucleotide excision DNA repair 
(Game, 2000). They belong to a class of proteins that contain ubiquitin-like (UbL) and 
ubiquitin-associated (UBA) domains. UbL domains resemble ubiquitin and allow 
interaction with the proteasome (Mueller and Feigon, 2003), while UBA domains bind to 
polyubiquitin chains (Raasi et al., 2004). This is consistent with their role as adapters for 
substrate-proteasome recognition. It has been reported that hHR23 can enhance, but also 
reduce the degradation of the transcription factor p53, possibly by mediating the 
interaction of p53 with the proteasome in one case (Glockzin et al., 2003) or by blocking 
this interaction in the other case (Brignone et al., 2004; Raasi and Pickart, 2003). Such a 
function of hRR23A could also be possible in the regulation of PGC-1α protein levels. It is 
known that PGC-1α is stabilized by phosphorylation by p38 kinase (Puigserver et al., 
2001), but the mechanism for this is not known. It is also worth to mention that hHR23A 
can interact with the coactivator p300/CBP and thereby downregulate p53-dependent 
transcription (Zhu et al., 2001).  
 
Ubiquitin-specific protease 25 is a recently identified protein that shares high homology 
with members of the ubiquitin protease (UBP) family. UBPs are a family of 
deubiquitinating enzymes that cleave ubiquitin conjugates on a variety of substrates 
(Valero et al., 2001; Valero et al., 1999). USP25 could theoretically increase the 
transcriptional activity of PGC-1α by cleaving ubiquitin tags that would otherwise target 
PGC-1α for degradation.  
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The involvement of PGC-1α ubiquitination in PGC-1α-dependent transcription requires 
that PGC-1α is a ubiquitinated protein. We have shown that PGC-1α can indeed be 
ubiquitinated (data not shown).  
 
Ubc9 and PIASx have been shown to contain SUMO conjugating (Johnson and Blobel, 
1997; Schwarz et al., 1998) and SUMO ligase activities (Kotaja et al., 2002), respectively. 
SUMO, like ubiquitin, is a small polypeptide that comprises 97 amino acids and is attached 
to lysine residues in substrate proteins. Some transcriptional regulator proteins have been 
shown to be modified by SUMO. Similar to other post-translational modifications, SUMO-
modification can increase or repress the activity of transcriptional activators. These effects 
may be through alteration of protein-protein interactions that are important for 
transcriptional activation (Gill, 2003). Since lysine residues are also targets for other 
modifications, such as ubiquitination, acetylation, and methylation, SUMO may block 
other modifications that contribute to the activity of a specific protein (Gill, 2003). A 
consensus SUMO acceptor site has been identified, consisting of the sequence ΨKXE, 
where Ψ is a large hydrophobic amino acid and where K is the site of SUMO conjugation 
(Rodriguez et al., 2001). Two such motifs exist in PGC-1α. Mutation of each motif 
individually has however no effect on the activity of PGC-1α as a transcriptional 
coactivator (see appendix A). No evidence exists yet on whether PGC-1α becomes 
SUMOylated, but the identification of Ubc9 and PIASx suggest that it would be worth 
pursuing this possibility. 
 
The yeast-two hybrid screen also identified several structural proteins that do not have an 
obvious functional relation to PGC-1α. Although a biological significance of these 
interactions can not be excluded, the identification of these proteins is probably due to the 
high abundance of the their cDNAs in the skeletal muscle library used for the yeast two-
hybrid screen.  
 
The last group of PGC-1α interacting proteins also contains proteins, whose functions are 
not related to PGC-1α. Further experiments will be necessary to get more evidence for an 
interaction of these proteins with PGC-1α. Confirmation of such an interaction may lead to 
the identification of unknown functions of PGC-1α. 
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Functional interaction between PGC-1α and Tip60 
The interaction of PGC-1α with the acetyltransferase Tip60 identified in the yeast two-
hybrid screen could be confirmed in other experiments, such as GST-pulldowns and 
coimmunoprecipitations in mammalian cells (FIG. 3.3 and 4.1D). The functional 
interaction between PGC-1α and Tip60 was therefore studied in more detail during this 
work. In several experiments, we found that overexpression of Tip60 inhibited PGC-1α-
dependent gene expression. Interestingly, the repressive effect of Tip60 depended in one 
case entirely, in some experiments partly, and in other experiment not on the 
acetyltransferase activity of Tip60. We then found that the expression of p21, a gene that 
can be induced by the transcription factor p53 and Tip60, was enhanced by the 
overexpression of PGC-1α. In contrast to the previous results, overexpression of Tip60 did 
not affect the PGC-1α-dependent expression of p21. Instead, ectopic expression of a Tip60 
variant lacking acetyltransferase activity or knock-down of endogenous Tip60 strongly 
inhibited PGC-1α-dependent p21 expression (FIG. 4.5). These results suggest that Tip60 is 
required for the induction of p21 by PGC-1α. The acetyltransferase mutant of Tip60 seems 
to act as a dominant negative protein. This suggests that the acetyltransferase activity of 
Tip60 is necessary for PGC-1α-dependent expression of p21.  
 
Why does Tip60 on one side repress PGC-1α-dependent gene expression and why is it on 
the other hand required for PGC-1α-dependent gene expression? There may be at least two 
types of PGC-1α induced genes; (i) genes for which Tip60 is required and (ii) genes for 
which Tip60 is not required. The repressive effect of Tip60 overexpression on PGC-1α-
dependent gene expression may be explained by a recruitment of PGC-1α away from 
promoters that do not require Tip60 to promoters that are coregulated by PGC-1α and 
Tip60. Further experiments will be necessary to determine if and how PGC-1α is recruited 
to the p21 promoter. Is it through Tip60 alone or does PGC-1α also bind to transcription 
factors, such as p53? 
 
Western blot analysis and pulse-chase experiments revealed that overexpression of Tip60 
leads to a dramatic increase in the steady-state PGC-1α protein levels by increasing the 
half-life of PGC-1α. Analysis of the NP-40-soluble and insoluble cell fractions showed 
that overexpression of Tip60 led to small reduction of PGC-1α protein levels in the NP-40-
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soluble cellular fraction (FIG. S4.3). While in the absence of overexpressed Tip60 no 
PGC-1α could be found in the NP-40-insoluble cell fraction, Tip60 overexpression led to a 
dramatic accumulation of PGC-1α in the NP-40-insoluble fraction. Interestingly, the PGC-
1α protein in the insoluble fraction and about half of the NP40-soluble PGC-1α displayed 
a slightly smaller apparent molecular weight than PGC-1α in the absence of overexpressed 
Tip60 (FIG. S4.3). This change in migration may be a consequence of a posttranslational 
modification that is required for the relocalization or that is a consequence of the 
relocalization of PGC-1α to the NP-40- insoluble cellular compartment. What could this 
NP-40-insoluble compartment be, and why does Tip60 recruit PGC-1α into this 
compartment? Nuclear bodies, also called PML-bodies, are subnuclear structures formed 
by PML and other proteins and have been shown to be important for the regulation of 
several cellular processes (Borden, 2002; Takahashi et al., 2004). Previous studies have 
demonstrated that proteins localized in PML-bodies are insoluble in NP-40 lysis buffer 
(Muller et al., 1998), suggesting that PGC-1α may be translocated to PML-bodies upon 
overexpression of Tip60. Both p53 and Tip60 have been shown to be partly localized in 
PML-bodies. Although the functions of PML-bodies are not well understood, they have 
been suggested to serve as platforms, where interaction of p53 with specific cofactors is 
favored (Gostissa et al., 2003). Further experiments will be necessary to determine if PGC-
1α is really directed to PML-bodies by the overexpression of Tip60 and what modification 
of PGC-1α is associated with this subcellular relocalization. 
 
Despite an obvious role for the acetyltransferase activity of Tip60 in PGC-1α-dependent 
transcription, we were not able to show conclusively that PGC-1α is acetylated by Tip60. 
We immunoprecipitated PGC-1α from mammalian cells and tried to show that PGC-1α is 
acetylated by western blot analysis using antibodies that are able to recognize acetylated 
lysine residues. These antibodies are not able to detect any acetylated protein, maybe due 
to the nature of the amino acids surrounding the acetylated lysine. It cannot be excluded 
that the amino acid sequence of PGC-1α does not allow the detection of one or several 
acetylated lysines by these antibodies. In a second approach, we performed an in vitro 
acetylation assay with purified, recombinant Tip60 and PGC-1α. Although Tip60 nicely 
acetylated a mix of histone proteins, there was no detectable acetylation of full length 
PGC-1α and only a very weak band that may correspond to a shorter PGC-1α fragment 
(FIG. S4.3). Not every acetylation reaction happening in vivo also works efficiently in 
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vitro. Tip60 itself is a good example for this, since only the purified Tip60 complex, but 
not recombinant Tip60 is able to acetylate chromatin templates (Ikura et al., 2000). 
Therefore, additional proteins may be required for Tip60 to be able to acetylate PGC-1α 
efficiently. 
 
Synergy between PGC-1α and PRMT1  
In collaboration with the group of Michael Stallcup, we have shown that the coactivator 
function of PGC-1α is enhanced by methylation by the methyltransferase PRMT1. Three 
arginines in the E-rich region of PGC-1α are methylated by PRMT1. Methylation of these 
arginine residues plays an important role in the coactivator function of PGC-1α and its 
ability to function synergistically with PRMT1. The mechanism by which methylation 
affects the function of PGC-1α is not known. Methylation may change the interaction of  
PGC-1α with other proteins that either regulate its function or that act as downstream 
effectors for the activation of transcription or for other functions, such as pre-mRNA 
processing. PGC-1α is a highly regulated protein at the transcriptional level and seems to 
be regulated also at the post-translational level. Several signaling pathways may converge 
upon PGC-1α and regulate its activity positively or negatively to result in an appropriate 
response. Methylation of PGC-1α may be a signal that allows another activating 
posttranslational modification to take place, for example, by creating a new interaction 
surface for another enzyme. In such a model, only the simultaneous action of two 
independent signaling pathways would result in an increase of the PGC-1α activity. On the 
other hand, methylation may block the attachment of a posttranslational modification that 
would otherwise inhibit the PGC-1α activity. Identification of the kinases Clk 1, 3, and 4, 
the SUMO-conjugating enzyme Ubc9, and the SUMO ligase PIASx as potential PGC-1α-
interacting proteins suggests that PGC-1α is regulated by a number of posttranslational 
modifications, some of which might have synergistic and some of which might have 
antagonistic effects. How can posttranslational modifications influence the activity of 
PGC-1α? MAP kinase p38 has been shown to directly phosphorylate PGC-1α and thereby 
enhances its transcriptional activity, by inhibiting the binding of the repressor p160MBP 
binding protein to PGC-1α (Fan et al., 2004). PRMT1, like p38, may regulate the 
interaction of proteins with PGC-1α, most likely with its C-terminal part. It will be 
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interesting to determine whether the interaction of PGC-1α with some of its possible 
downstream effectors are regulated by PRMT1. Previous reports and especially this study 
have identified several proteins with either a role in transcription activation or pre-mRNA 
processing that could be tested for their ability to distinguish methylated or non-methylated 
variants of PGC-1α.  
 
Summary and conclusions 
Many different coactivators have been identified and studied in the last years and their 
number is still increasing. Some of them were found to be components of large 
multiprotein complexes that serve to recruit the basal transcription machinery to DNA-
bound transcription factors or to remodel chromatin structures for easier access of the 
transcription machinery to specific promoter  regions. 
 
The coactivator PGC-1α seems to be highly regulated, both at the transcriptional and post-
translational level. Due to the central role of PGC-1α in energy metabolism, 
missregulation of this protein has been suggested to contribute to the development of 
diabetes and obesity. PGC-1α has not been shown to contain any enzymatic activities and 
despite a lot of research, its mechanisms regulating gene expression are far from being 
understood. To better understand the mechanism of gene regulation by PGC-1α or to 
identify new posttranslational regulatory mechanisms for PGC-1α, we used a yeast two-
hybrid screen to find new PGC-1α-interacting proteins. Of the identified proteins, the 
acetyltransfease Tip60 was chosen for more detailed analysis. Tip60 appears to negatively 
regulate the transcriptional activity of PGC-1α in several biological contexts, but we also 
found evidence that PGC-1α and Tip60 collaborate in the expression of p21. We have also 
provided evidence that PGC-1α coactivator function is stimulated by arginine methylation 
by the major mammalian methyltransferase PRMT1. Future work will have to address how 
methylation affects the activity of PGC-1α as a coactivator.  
 
The identification of novel PGC-1α-interacting proteins may provide new targets for the 
development of drugs for the treatment of metabolic diseases caused by missregulation of 
PGC-1α or PGC-1α-regulated genes. 
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APPENDIX A: MUTATION OF THE PUTATIVE SUMOYLATION 
MOTIFS DOES NOT AFFECT THE PGC-1α ACTIVITY 
Results and discussion 
The yeast two-hybrid screen identified the proteins PIASx and UBC9 as PGC-1α− 
interacting proteins, both of which have been suggested to play important roles in the 
modification of proteins with the small ubiquitin-like modifier (SUMO) (Johnson and 
Blobel, 1997; Kotaja et al., 2002; Schwarz et al., 1998) . We didn’t try or weren’t able to 
confirm the interactions between those two proteins and PGC-1α in experiments other than 
yeast two-hybrid assays. Despite a lack of evidence for an interaction of PGC-1α with 
Ubc9 or PIASx in mammalian cell, we searched the PGC-1α protein sequence for putative 
SUMOylation motifs. A consensus SUMOylation motif has been identified consisting of 
the protein sequence ΨKXE, where Ψ is a large hydrophobic amino acid and K the residue 
where SUMO is attached (Rodriguez et al., 2001). The PGC-1α protein sequence contains 
two putative SUMOylation sites ranging from amino acids 183-186 and amino acids 645-
648, respectively. To determine whether those SUMOylation motifs play a role in the 
regulation of transcription by PGC-1α, we introduced changes in the nucleotide sequence 
of the PGC-1α cDNA leading to the insertion of arginines instead of a lysines at amino 
acid positions 184 and 646 in the putative SUMOylation motifs. COS7 cells were 
transfected with a PGC-1α-inducible luciferase reporter under control of the ERRα-
promoter and expression vectors for either wild type PGC-1α or PGC-1α variants having 
lysine to arginine substitutions in either of the two SUMOylation motifs. As shown in FIG. 
A1.1, transfection of wild type PGC-1α induces the expression of the reporter construct 
approximately 27 fold. A similar induction of the luciferase reporter was observed, when 
the two PGC-1α variants harboring lysine to arginine substitution in the putative 
SUMOylation motifs were transfected. This result suggests that the predicted 
SUMOylation of the lysine residues at positions 184 and 646 does not positively or 
negatively affect the PGC-1α transcriptional activity under those conditions. This results 
does not exclude that SUMOylation of PGC-1α can be important in a different biological 
context or that PGC-1α gets SUMOylated on other amino acids residues. PGC-1α contains 
40 lysines, which all are potential sites for SUMO attachment. Even if the mutated lysine 
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residues are indeed targets for SUMO modification, mutation of a single lysine may not 
always be a clear indication of the effect of loss of SUMO- modification, since multiple 
signaling pathways may converge upon critical lysine residues to determine transcription 
factor activity. Further experiments will be necessary to determine if PGC-1α can be 
modified by SUMO and how such a modification would influence the function of PGC-1α.  
 
 
 
 
 
Figure A.1. Mutation of two putative SUMOylation motifs does not affect the activity 
of PGC-1α as a coactivator. 
COS7 cells were transfected with a luciferase reporter under control of the ERRα gene 
promoter (pERRα-luc) and plasmids expressing wildtype or mutant PGC-1α. Cells were 
assayed for luciferase activty 40 h after transfection. Results show the enhancement of the 
luciferase activty by the  different PGC-1α variants. 
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